primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
100146543,10014654,5,C,LISPRO,INSULIN LISPRO,1,,"20 MG, DAILY",,,,,,,,20.0,MG,,,2016,Q1,Type 2 diabetes mellitus,,2016,Q1,3,F,2003.0,20160113.0,20140317,20160120,EXP,,US-PFIZER INC-2014067554,PFIZER,,45.0,YR,,F,Y,,,20160120.0,,LW,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Acne,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Alopecia,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Angina pectoris,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Blood glucose fluctuation,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Cardiac disorder,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Dizziness,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Drug effect prolonged,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Drug ineffective for unapproved indication,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Dyspnoea,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Eye infection,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Glycosylated haemoglobin increased,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Hypertension,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Oedema,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Pruritus,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Rash,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Somnolence,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Stress,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Thyroid disorder,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Vascular pain,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Visual acuity reduced,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
103958935,10395893,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Weight increased,,2016,Q1,5,F,2013.0,20160317.0,20140820,20160323,EXP,,US-PFIZER INC-2014229180,PFIZER,,53.0,YR,,F,Y,56.69,KG,20160323.0,,MD,US,US,2016,Q1,Adult
104659835,10465983,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Febrile bone marrow aplasia,,2016,Q1,5,F,20140812.0,20160108.0,20140922,20160113,EXP,,FR-ROCHE-1462355,ROCHE,,70.0,YR,,M,Y,67.0,KG,20160113.0,,MD,FR,FR,2016,Q1,Elderly
104964853,10496485,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, INSULIN LISPRO SLIDING SCALE SQ TID AC(PRIOR TO MEAL)",,,,U,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,3,F,20140321.0,20160315.0,20141004,20160329,EXP,,US-AUROBINDO-AUR-APL-2014-10435,AUROBINDO,HAMMERSTROM AE.. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT.. ANNALS OF PHARMACOTHERAPY. 2015?49(1):135-139,34.0,YR,,M,Y,,,20160329.0,,MD,US,US,2016,Q1,Young Adult
104964853,10496485,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, INSULIN LISPRO SLIDING SCALE SQ TID AC(PRIOR TO MEAL)",,,,U,,,,,,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,3,F,20140321.0,20160315.0,20141004,20160329,EXP,,US-AUROBINDO-AUR-APL-2014-10435,AUROBINDO,HAMMERSTROM AE.. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT.. ANNALS OF PHARMACOTHERAPY. 2015?49(1):135-139,34.0,YR,,M,Y,,,20160329.0,,MD,US,US,2016,Q1,Young Adult
104964853,10496485,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, INSULIN LISPRO SLIDING SCALE SQ TID AC(PRIOR TO MEAL)",,,,U,,,,,,,,2016,Q1,Drug-induced liver injury,,2016,Q1,3,F,20140321.0,20160315.0,20141004,20160329,EXP,,US-AUROBINDO-AUR-APL-2014-10435,AUROBINDO,HAMMERSTROM AE.. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT.. ANNALS OF PHARMACOTHERAPY. 2015?49(1):135-139,34.0,YR,,M,Y,,,20160329.0,,MD,US,US,2016,Q1,Young Adult
104964853,10496485,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, INSULIN LISPRO SLIDING SCALE SQ TID AC(PRIOR TO MEAL)",,,,U,,,,,,,,2016,Q1,Headache,,2016,Q1,3,F,20140321.0,20160315.0,20141004,20160329,EXP,,US-AUROBINDO-AUR-APL-2014-10435,AUROBINDO,HAMMERSTROM AE.. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT.. ANNALS OF PHARMACOTHERAPY. 2015?49(1):135-139,34.0,YR,,M,Y,,,20160329.0,,MD,US,US,2016,Q1,Young Adult
106538655,10653865,29,C,INSULIN HUMAN LISPRO,,2,Unknown,,,,,,,,,,,,,2016,Q1,Bronchitis,,2016,Q1,5,F,20141007.0,20160120.0,20141216,20160126,EXP,,JP-ROCHE-1473529,ROCHE,,48.0,YR,,F,Y,61.1,KG,20160126.0,,MD,JP,JP,2016,Q1,Adult
107026833,10702683,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Anaemia,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107026833,10702683,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,20140802.0,20150106.0,20150109,20160118,EXP,,US-ASTRAZENECA-2015SE02757,ASTRAZENECA,,24401.0,DY,,M,Y,,,20160118.0,,MD,US,US,2016,Q1,Elderly
107753453,10775345,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2016,Q1,Alanine aminotransferase increased,,2016,Q1,3,F,201403.0,20160316.0,20150205,20160325,EXP,US-MLMSERVICE-20150909-0020756-1,US-H14001-15-00161,WESTWARD,HAMMERSTROM A. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANNALS OF PHARMACOTHERAPY 2015 JAN?49(1):135-139.,34.0,YR,,M,Y,105.0,KG,20160325.0,,MD,US,US,2016,Q1,Young Adult
107753453,10775345,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,3,F,201403.0,20160316.0,20150205,20160325,EXP,US-MLMSERVICE-20150909-0020756-1,US-H14001-15-00161,WESTWARD,HAMMERSTROM A. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANNALS OF PHARMACOTHERAPY 2015 JAN?49(1):135-139.,34.0,YR,,M,Y,105.0,KG,20160325.0,,MD,US,US,2016,Q1,Young Adult
107753453,10775345,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2016,Q1,Drug-induced liver injury,,2016,Q1,3,F,201403.0,20160316.0,20150205,20160325,EXP,US-MLMSERVICE-20150909-0020756-1,US-H14001-15-00161,WESTWARD,HAMMERSTROM A. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANNALS OF PHARMACOTHERAPY 2015 JAN?49(1):135-139.,34.0,YR,,M,Y,105.0,KG,20160325.0,,MD,US,US,2016,Q1,Young Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Abdominal discomfort,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Diarrhoea,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Headache,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Incorrect dose administered,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Nausea,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
112863212,11286321,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 UNIT, PRN",,,,,,,,300.0,DF,INJECTION,,2016,Q1,Vomiting,,2016,Q1,2,F,20150413.0,20150929.0,20150721,20160125,PER,,US-UNITED THERAPEUTICS-UNT-2015-004376,UNITED THERAPEUTICS,,58.0,YR,,F,Y,71.2,KG,20160125.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
114999702,11499970,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID, PRIOR TO MEALS",,,,,,,,,,,TID,2016,Q1,Alanine aminotransferase increased,,2016,Q1,2,F,,20160308.0,20150914,20160317,EXP,,US-ACTAVIS-2015-18954,WATSON,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9,34.0,YR,,M,Y,105.0,KG,20160317.0,,PH,US,US,2016,Q1,Young Adult
114999702,11499970,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID, PRIOR TO MEALS",,,,,,,,,,,TID,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,2,F,,20160308.0,20150914,20160317,EXP,,US-ACTAVIS-2015-18954,WATSON,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9,34.0,YR,,M,Y,105.0,KG,20160317.0,,PH,US,US,2016,Q1,Young Adult
114999702,11499970,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID, PRIOR TO MEALS",,,,,,,,,,,TID,2016,Q1,Blood pressure increased,,2016,Q1,2,F,,20160308.0,20150914,20160317,EXP,,US-ACTAVIS-2015-18954,WATSON,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9,34.0,YR,,M,Y,105.0,KG,20160317.0,,PH,US,US,2016,Q1,Young Adult
114999702,11499970,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID, PRIOR TO MEALS",,,,,,,,,,,TID,2016,Q1,Diabetes mellitus,,2016,Q1,2,F,,20160308.0,20150914,20160317,EXP,,US-ACTAVIS-2015-18954,WATSON,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9,34.0,YR,,M,Y,105.0,KG,20160317.0,,PH,US,US,2016,Q1,Young Adult
114999702,11499970,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, TID, PRIOR TO MEALS",,,,,,,,,,,TID,2016,Q1,Hepatotoxicity,,2016,Q1,2,F,,20160308.0,20150914,20160317,EXP,,US-ACTAVIS-2015-18954,WATSON,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9,34.0,YR,,M,Y,105.0,KG,20160317.0,,PH,US,US,2016,Q1,Young Adult
115278622,11527862,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE TID AC (PRIOR TO MEAL),,,,,,,,,,,,2016,Q1,Drug-induced liver injury,,2016,Q1,2,F,,20160308.0,20150920,20160318,EXP,,US-TEVA-594896USA,TEVA,HAMMERSTROM AE. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT.ANNALS OF PHARMACOTHERAPY. 2015? 49(1):135-139,34.0,YR,,,Y,105.0,KG,20160318.0,,MD,US,US,2016,Q1,Young Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Colectomy,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Colon cancer,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Colon operation,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Colonoscopy,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Drug hypersensitivity,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Neoplasm malignant,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Peripheral coldness,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Peripheral swelling,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Skin lesion,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Surgery,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115361814,11536181,18,C,HUMALOG (INSULIN LISPRO RDNA ORIGIN),,2,,,,,,,,,,,,,,2016,Q1,Swelling face,,2016,Q1,4,F,20150603.0,20160301.0,20150922,20160304,EXP,,US-GLAXOSMITHKLINE INC.-US2015GSK134879,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Adult
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Alanine aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Autoimmune hepatitis,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Gamma-glutamyltransferase increased,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Hypercalcaemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
115919056,11591905,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE: 100 (UNIT: OTHER),,,,,,,,,,,,2016,Q1,Hypophosphataemia,,2016,Q1,6,F,20150922.0,20160317.0,20151005,20160323,EXP,,US-ROCHE-1641435,ROCHE,,72.0,YR,,M,Y,81.37,KG,20160323.0,,MD,US,US,2016,Q1,Elderly
116567843,11656784,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Bacteraemia,,2016,Q1,3,F,20151014.0,20160216.0,20151023,20160223,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-071260,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,82.0,KG,20160223.0,,OT,US,US,2016,Q1,Elderly
116567843,11656784,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Rectal haemorrhage,,2016,Q1,3,F,20151014.0,20160216.0,20151023,20160223,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-071260,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,82.0,KG,20160223.0,,OT,US,US,2016,Q1,Elderly
116829093,11682909,16,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,LOW DOSE,,,,,,,,,,UNKNOWN,TID,2016,Q1,Blood sodium decreased,,2016,Q1,3,F,201508.0,20151229.0,20151029,20160105,PER,,US-CELGENEUS-USA-2015104873,CELGENE,,92.0,YR,,M,Y,48.8,KG,20160105.0,,MD,US,US,2016,Q1,Elderly
116829093,11682909,16,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,LOW DOSE,,,,,,,,,,UNKNOWN,TID,2016,Q1,Confusional state,,2016,Q1,3,F,201508.0,20151229.0,20151029,20160105,PER,,US-CELGENEUS-USA-2015104873,CELGENE,,92.0,YR,,M,Y,48.8,KG,20160105.0,,MD,US,US,2016,Q1,Elderly
116829093,11682909,16,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,LOW DOSE,,,,,,,,,,UNKNOWN,TID,2016,Q1,Urinary tract infection,,2016,Q1,3,F,201508.0,20151229.0,20151029,20160105,PER,,US-CELGENEUS-USA-2015104873,CELGENE,,92.0,YR,,M,Y,48.8,KG,20160105.0,,MD,US,US,2016,Q1,Elderly
117715053,11771505,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Acute myeloid leukaemia,,2016,Q1,3,F,20151113.0,20160105.0,20151124,20160108,EXP,,US-ROCHE-1663374,ROCHE,,76.0,YR,,M,Y,107.8,KG,20160108.0,,MD,US,US,2016,Q1,Elderly
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Diabetic retinopathy,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Fungal infection,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Malaise,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"93.6 IU, QD",,,,,,,20563.0,93.6,IU,INJECTION,QD,2016,Q1,Ovarian cyst,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Diabetic retinopathy,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Fungal infection,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Malaise,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118207232,11820723,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"76.4 IU, QD",,,,,,,20563.0,76.4,IU,INJECTION,QD,2016,Q1,Ovarian cyst,,2016,Q1,2,F,2011.0,20160113.0,20151210,20160125,EXP,,FR-ELI_LILLY_AND_COMPANY-FR201511004095,ELI LILLY AND CO,,27.0,YR,,F,Y,77.0,KG,20160125.0,,CN,FR,FR,2016,Q1,Young Adult
118696564,11869656,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Myocarditis,,2016,Q1,4,F,20151218.0,20160129.0,20151228,20160203,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20160203.0,,OT,US,US,2016,Q1,Adult
118696564,11869656,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Rhabdomyolysis,,2016,Q1,4,F,20151218.0,20160129.0,20151228,20160203,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20160203.0,,OT,US,US,2016,Q1,Adult
118696564,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Myocarditis,,2016,Q1,4,F,20151218.0,20160129.0,20151228,20160203,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20160203.0,,OT,US,US,2016,Q1,Adult
118696564,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q1,Rhabdomyolysis,,2016,Q1,4,F,20151218.0,20160129.0,20151228,20160203,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20160203.0,,OT,US,US,2016,Q1,Adult
118741693,11874169,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"TOTAL DAILY DOSE: 25 IU, (3-14-8)",,,,U,,,,25.0,IU,,QD,2016,Q1,Glaucoma,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"TOTAL DAILY DOSE: 25 IU, (3-14-8)",,,,U,,,,25.0,IU,,QD,2016,Q1,Vogt-Koyanagi-Harada syndrome,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"TOTAL DAILY DOSE: 45 IU, (23-10-12)",,,,U,,,,45.0,IU,,QD,2016,Q1,Glaucoma,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118741693,11874169,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"TOTAL DAILY DOSE: 45 IU, (23-10-12)",,,,U,,,,45.0,IU,,QD,2016,Q1,Vogt-Koyanagi-Harada syndrome,,2016,Q1,3,F,201211.0,20160227.0,20151229,20160304,EXP,,JP-009507513-1512JPN013177,MERCK,,61.0,YR,,M,Y,,,20160304.0,,CN,JP,JP,2016,Q1,Adult
118824454,11882445,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"TID, LATENCY: 50 DAYS.DOSE (11-12-11)",,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"TID, LATENCY: 50 DAYS.DOSE (11-12-11)",,,,,,,,,,,,2016,Q1,Exposure during pregnancy,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"TID, LATENCY: 50 DAYS.DOSE (11-12-11)",,,,,,,,,,,,2016,Q1,Off label use,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"TID, LATENCY: 50 DAYS.DOSE (11-12-11)",,,,,,,,,,,,2016,Q1,Product use issue,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"TID, LATENCY: 50 DAYS.DOSE (11-12-11)",,,,,,,,,,,,2016,Q1,Stress,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU/KG,,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU/KG,,,,,,,,,,,,2016,Q1,Exposure during pregnancy,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU/KG,,,,,,,,,,,,2016,Q1,Off label use,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU/KG,,,,,,,,,,,,2016,Q1,Product use issue,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118824454,11882445,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU/KG,,,,,,,,,,,,2016,Q1,Stress,,2016,Q1,4,F,20151215.0,20160303.0,20151231,20160311,EXP,,ES-ASTRAZENECA-2015SF30318,ASTRAZENECA,,8442.0,DY,,F,Y,52.8,KG,20160311.0,,MD,ES,ES,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Altered state of consciousness,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Hypovolaemic shock,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Myocardial ischaemia,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Upper gastrointestinal haemorrhage,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118862942,11886294,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"48 IU, TID",,,,,,,20563.0,48.0,IU,,TID,2016,Q1,Urinary tract infection,,2016,Q1,2,F,20151021.0,20160128.0,20160104,20160205,EXP,,TW-ELI_LILLY_AND_COMPANY-TW201512005005,ELI LILLY AND CO,,70.0,YR,,F,Y,62.0,KG,20160203.0,,MD,TW,TW,2016,Q1,Elderly
118931002,11893100,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,45 UNITS TID,,,,,,,,,,INJECTION,,2016,Q1,Ankle fracture,,2016,Q1,2,F,20151219.0,20160101.0,20160106,20160108,EXP,,US-ASTRAZENECA-2015SF31964,ASTRAZENECA,,64.0,YR,,F,Y,93.0,KG,20160108.0,,MD,US,US,2016,Q1,Adult
119070841,11907084,5,C,Humalog - insulin lispro,,2,,DF,,,,,,,,,,,,2016,Q1,Non-cardiac chest pain,,2016,Q1,1,I,20151221.0,20151230.0,20160111,20160111,EXP,,GB-DEP_13364_2016,DEPOMED,,31.0,YR,,M,Y,106.0,KG,20160111.0,,MD,GB,GB,2016,Q1,Young Adult
119103161,11910316,6,C,INSULIN LISPRO SLIDING SCALE,,2,,,,,,,,,,,,,,2016,Q1,"Hallucination, visual",,2016,Q1,1,I,20160108.0,,20160111,20160111,DIR,,,,,81.0,YR,,F,N,67.5,KG,20160108.0,N,PH,US,,2016,Q1,Elderly
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Abdominal hernia,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Blood cholesterol increased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Blood triglycerides increased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Constipation,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Diabetic neuropathy,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Haemoglobin decreased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Hysterectomy,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Pancreatitis acute,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 UNITS, QD",,,,U,,,,5.0,DF,,QD,2016,Q1,Renal impairment,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Abdominal hernia,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Blood cholesterol increased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Blood triglycerides increased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Constipation,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Diabetic neuropathy,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Haemoglobin decreased,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Hysterectomy,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Pancreatitis acute,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119103612,11910361,7,C,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO, ISOPHANE",,2,Subcutaneous,"25 UNITS, BID",,,,U,,,,25.0,DF,,BID,2016,Q1,Renal impairment,,2016,Q1,2,F,20150911.0,20160205.0,20160112,20160209,EXP,,US-009507513-1601USA002917,MERCK,,50.0,YR,,F,Y,94.79,KG,20160209.0,,CN,US,US,2016,Q1,Adult
119150773,11915077,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Bile duct obstruction,,2016,Q1,3,F,20151115.0,20160307.0,20160114,20160315,EXP,,US-HOSPIRA-3107483,HOSPIRA,,59.0,YR,A,M,Y,69.0,KG,20160316.0,,MD,US,US,2016,Q1,Adult
119150773,11915077,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Blood bilirubin increased,,2016,Q1,3,F,20151115.0,20160307.0,20160114,20160315,EXP,,US-HOSPIRA-3107483,HOSPIRA,,59.0,YR,A,M,Y,69.0,KG,20160316.0,,MD,US,US,2016,Q1,Adult
119150773,11915077,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Hyperglycaemia,,2016,Q1,3,F,20151115.0,20160307.0,20160114,20160315,EXP,,US-HOSPIRA-3107483,HOSPIRA,,59.0,YR,A,M,Y,69.0,KG,20160316.0,,MD,US,US,2016,Q1,Adult
119195563,11919556,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Cerebral haemorrhage,,2016,Q1,3,F,20140429.0,20160314.0,20160115,20160321,EXP,,US-JNJFOC-20160100992,JANSSEN,,51.0,YR,A,F,Y,,,20160321.0,,CN,US,US,2016,Q1,Adult
119195563,11919556,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Fall,,2016,Q1,3,F,20140429.0,20160314.0,20160115,20160321,EXP,,US-JNJFOC-20160100992,JANSSEN,,51.0,YR,A,F,Y,,,20160321.0,,CN,US,US,2016,Q1,Adult
119195563,11919556,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,3,F,20140429.0,20160314.0,20160115,20160321,EXP,,US-JNJFOC-20160100992,JANSSEN,,51.0,YR,A,F,Y,,,20160321.0,,CN,US,US,2016,Q1,Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Acute lymphocytic leukaemia refractory,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,BK virus infection,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Bile duct obstruction,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Bladder obstruction,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Duodenitis,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Gastritis erosive,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Hypotension,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Malignant neoplasm progression,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Urinary bladder haemorrhage,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119248932,11924893,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AT UNITS SLIDING SCALE INJECTABLE; TPN (TOTAL PARENTERAL NUTRITION),,,,,,,,,,INJECTION,,2016,Q1,Viral haemorrhagic cystitis,,2016,Q1,2,F,201510.0,20160208.0,20160118,20160215,EXP,,US-BAXTER-2016BAX001087,BAXTER,,25.0,YR,,F,Y,46.0,KG,20160215.0,,MD,US,US,2016,Q1,Young Adult
119395721,11939572,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q1,Drug hypersensitivity,,2016,Q1,1,I,,20160104.0,20160122,20160122,PER,,US-PFIZER INC-2016002951,PFIZER,,80.0,YR,,F,Y,,,20160122.0,,OT,US,US,2016,Q1,Elderly
119450191,11945019,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE: 6 UNITS BEFORE BREAKFAST,,,,,,,,,,UNKNOWN,,2016,Q1,Blood pressure decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119450191,11945019,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE: 6 UNITS BEFORE BREAKFAST,,,,,,,,,,UNKNOWN,,2016,Q1,Weight decreased,,2016,Q1,1,I,,20160113.0,20160125,20160125,EXP,,BR-JNJFOC-20160118391,JANSSEN,,55.0,YR,A,F,Y,85.0,KG,20160125.0,,MD,BR,BR,2016,Q1,Adult
119454142,11945414,41,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,12.0,IU,INJECTION,,2016,Q1,Deep vein thrombosis,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,41,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,12.0,IU,INJECTION,,2016,Q1,Dyspnoea,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,41,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,12.0,IU,INJECTION,,2016,Q1,Metastases to lung,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,41,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,12.0,IU,INJECTION,,2016,Q1,Tachycardia,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,42,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,INJECTION,QID,2016,Q1,Deep vein thrombosis,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,42,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,INJECTION,QID,2016,Q1,Dyspnoea,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,42,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,INJECTION,QID,2016,Q1,Metastases to lung,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119454142,11945414,42,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,INJECTION,QID,2016,Q1,Tachycardia,,2016,Q1,2,F,20151010.0,20160119.0,20160125,20160310,EXP,,US-CELGENE-USA-2015103486,CELGENE,,80.0,YR,,F,Y,72.5,KG,20160310.0,,MD,US,US,2016,Q1,Elderly
119482641,11948264,7,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q1,Pneumonia,,2016,Q1,1,I,20151228.0,20151229.0,20160125,20160125,EXP,,CO-BAXTER-2015BAX070835,BAXTER,,65.0,YR,,M,Y,79.8,KG,20160125.0,,OT,CO,CO,2016,Q1,Elderly
119513271,11951327,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Bradycardia,,2016,Q1,1,I,20151204.0,,20160122,20160122,DIR,,,,,43.0,YR,,F,N,109.0,KG,20160121.0,N,PH,US,,2016,Q1,Adult
119513271,11951327,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Cardiac arrest,,2016,Q1,1,I,20151204.0,,20160122,20160122,DIR,,,,,43.0,YR,,F,N,109.0,KG,20160121.0,N,PH,US,,2016,Q1,Adult
119513271,11951327,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Drug interaction,,2016,Q1,1,I,20151204.0,,20160122,20160122,DIR,,,,,43.0,YR,,F,N,109.0,KG,20160121.0,N,PH,US,,2016,Q1,Adult
119513271,11951327,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Respiratory arrest,,2016,Q1,1,I,20151204.0,,20160122,20160122,DIR,,,,,43.0,YR,,F,N,109.0,KG,20160121.0,N,PH,US,,2016,Q1,Adult
119513271,11951327,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Seizure,,2016,Q1,1,I,20151204.0,,20160122,20160122,DIR,,,,,43.0,YR,,F,N,109.0,KG,20160121.0,N,PH,US,,2016,Q1,Adult
119519971,11951997,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Asthenia,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119519971,11951997,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Dehydration,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119519971,11951997,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119519971,11951997,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Mental status changes,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119519971,11951997,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Subdural haematoma,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Asthenia,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Dehydration,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Mental status changes,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Respiratory distress,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119521531,11952153,21,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Subdural haematoma,,2016,Q1,1,I,20151110.0,,20160122,20160122,DIR,,,,,80.0,YR,,M,N,155.0,LBS,20160121.0,N,MD,US,,2016,Q1,Elderly
119526322,11952632,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 DF, EACH MORNING",,,,,,,20563.0,10.0,DF,INJECTION,QD,2016,Q1,Fall,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 DF, EACH MORNING",,,,,,,20563.0,10.0,DF,INJECTION,QD,2016,Q1,Feeling abnormal,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 DF, EACH MORNING",,,,,,,20563.0,10.0,DF,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 DF, EACH MORNING",,,,,,,20563.0,10.0,DF,INJECTION,QD,2016,Q1,Hypophagia,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 DF, EACH MORNING",,,,,,,20563.0,10.0,DF,INJECTION,QD,2016,Q1,Weight increased,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DF, EACH EVENING",,,,,,,20563.0,8.0,DF,INJECTION,QD,2016,Q1,Fall,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DF, EACH EVENING",,,,,,,20563.0,8.0,DF,INJECTION,QD,2016,Q1,Feeling abnormal,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DF, EACH EVENING",,,,,,,20563.0,8.0,DF,INJECTION,QD,2016,Q1,Hypoglycaemia,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DF, EACH EVENING",,,,,,,20563.0,8.0,DF,INJECTION,QD,2016,Q1,Hypophagia,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119526322,11952632,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DF, EACH EVENING",,,,,,,20563.0,8.0,DF,INJECTION,QD,2016,Q1,Weight increased,,2016,Q1,2,F,201511.0,20160126.0,20160126,20160208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201601000276,ELI LILLY AND CO,,59.0,YR,,M,Y,70.0,KG,20160205.0,,CN,CN,CN,2016,Q1,Adult
119535921,11953592,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20151225.0,20151226.0,20160125,20160125,PER,,US-ELI_LILLY_AND_COMPANY-US201512009057,ELI LILLY AND CO,,36.0,YR,,M,Y,77.0,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119535921,11953592,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Drug dose omission,,2016,Q1,1,I,20151225.0,20151226.0,20160125,20160125,PER,,US-ELI_LILLY_AND_COMPANY-US201512009057,ELI LILLY AND CO,,36.0,YR,,M,Y,77.0,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119535921,11953592,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q1,Wrong technique in product usage process,,2016,Q1,1,I,20151225.0,20151226.0,20160125,20160125,PER,,US-ELI_LILLY_AND_COMPANY-US201512009057,ELI LILLY AND CO,,36.0,YR,,M,Y,77.0,KG,20160125.0,,CN,US,US,2016,Q1,Adult
119541081,11954108,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,,20160118.0,20160126,20160126,EXP,,CA-ASTRAZENECA-2016SE06373,ASTRAZENECA,,57.0,YR,,F,Y,78.0,KG,20160126.0,,MD,CA,CA,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Abdominal distension,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Abdominal pain,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Aspartate aminotransferase increased,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Asthenia,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Blood pressure increased,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Bowel movement irregularity,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Cancer pain,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Constipation,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Cough,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Decreased appetite,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Dyspnoea,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Fatigue,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Hydronephrosis,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Hydroureter,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Hypoaesthesia,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Leukocytosis,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Malignant neoplasm progression,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Myocardial oedema,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Nausea,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Paraesthesia,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Performance status decreased,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Renal failure,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Stomatitis,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Urinary tract infection,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Vomiting,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119657021,11965702,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, Q6H",,,,,,,,2.0,DF,,Q6H,2016,Q1,Weight decreased,,2016,Q1,1,I,201508.0,20160121.0,20160127,20160127,EXP,,PHEH2016US001794,NOVARTIS,,56.0,YR,,F,Y,,,20160127.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q1,Adult
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Cardio-respiratory arrest,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Cardiogenic shock,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Chest pain,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Death,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Lactic acidosis,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Malaise,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Multiple organ dysfunction syndrome,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
119863121,11986312,9,C,INSULIN LISPRO RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q1,Septic shock,,2016,Q1,1,I,20151009.0,20160121.0,20160202,20160202,EXP,GB-MHRA-EYC 00133766,GB-HOSPIRA-3151445,HOSPIRA,,66.0,YR,E,M,Y,90.0,KG,20160202.0,,MD,GB,GB,2016,Q1,Elderly
120128791,12012879,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,1,I,,20121106.0,20160205,20160205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-17132895,BRISTOL MYERS SQUIBB,,24.0,YR,,F,Y,,,20160205.0,,CN,DE,US,2016,Q1,Young Adult
120128791,12012879,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2016,Q1,Live birth,,2016,Q1,1,I,,20121106.0,20160205,20160205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-17132895,BRISTOL MYERS SQUIBB,,24.0,YR,,F,Y,,,20160205.0,,CN,DE,US,2016,Q1,Young Adult
120128791,12012879,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2016,Q1,Maternal exposure during pregnancy,,2016,Q1,1,I,,20121106.0,20160205,20160205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-17132895,BRISTOL MYERS SQUIBB,,24.0,YR,,F,Y,,,20160205.0,,CN,DE,US,2016,Q1,Young Adult
120128791,12012879,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2016,Q1,Off label use,,2016,Q1,1,I,,20121106.0,20160205,20160205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-17132895,BRISTOL MYERS SQUIBB,,24.0,YR,,F,Y,,,20160205.0,,CN,DE,US,2016,Q1,Young Adult
120170271,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q1,Blood glucose decreased,,2016,Q1,1,I,20160106.0,20160106.0,20160205,20160205,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160205.0,,CN,US,US,2016,Q1,Adult
120170271,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20160106.0,20160106.0,20160205,20160205,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160205.0,,CN,US,US,2016,Q1,Adult
120170271,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q1,Incorrect dose administered,,2016,Q1,1,I,20160106.0,20160106.0,20160205,20160205,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160205.0,,CN,US,US,2016,Q1,Adult
120170271,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q1,Wrong technique in product usage process,,2016,Q1,1,I,20160106.0,20160106.0,20160205,20160205,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160205.0,,CN,US,US,2016,Q1,Adult
120369681,12036968,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Drug ineffective,,2016,Q1,1,I,20160102.0,,20160204,20160204,DIR,,,,,50.0,YR,,M,N,240.0,LBS,20160203.0,N,,US,,2016,Q1,Adult
120369681,12036968,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pain,,2016,Q1,1,I,20160102.0,,20160204,20160204,DIR,,,,,50.0,YR,,M,N,240.0,LBS,20160203.0,N,,US,,2016,Q1,Adult
120396621,12039662,9,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20150113.0,,20160205,20160205,DIR,,,,,57.0,YR,,F,N,55.0,KG,20160204.0,N,PH,US,,2016,Q1,Adult
120965011,12096501,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"21 UNIT, QD",,,,,,,,21.0,DF,,QD,2016,Q1,Renal impairment,,2016,Q1,1,I,,20160203.0,20160220,20160220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-010417,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20160220.0,,CN,JP,JP,2016,Q1,Elderly
120984342,12098434,9,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, SQ VIA INSULIN PUMP",,,,,,,,,,,,2016,Q1,Cellulitis,,2016,Q1,2,F,20151220.0,20160218.0,20160222,20160225,EXP,,US-UCBSA-2016005834,UCB,,74.0,YR,,M,Y,70.0,KG,20160225.0,,MD,US,US,2016,Q1,Elderly
121089801,12108980,19,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q1,Vision blurred,,2016,Q1,1,I,20160220.0,,20160223,20160223,DIR,,,,,43.0,YR,,M,N,155.0,KG,20160222.0,N,PH,US,,2016,Q1,Adult
121092701,12109270,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Blister,,2016,Q1,1,I,20151207.0,,20160222,20160222,DIR,,,,,95.0,YR,,M,N,,,20160203.0,N,,US,,2016,Q1,Elderly
121092701,12109270,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Documented hypersensitivity to administered product,,2016,Q1,1,I,20151207.0,,20160222,20160222,DIR,,,,,95.0,YR,,M,N,,,20160203.0,N,,US,,2016,Q1,Elderly
121092701,12109270,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pain,,2016,Q1,1,I,20151207.0,,20160222,20160222,DIR,,,,,95.0,YR,,M,N,,,20160203.0,N,,US,,2016,Q1,Elderly
121092701,12109270,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Rash erythematous,,2016,Q1,1,I,20151207.0,,20160222,20160222,DIR,,,,,95.0,YR,,M,N,,,20160203.0,N,,US,,2016,Q1,Elderly
121103691,12110369,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Diabetic ketoacidosis,,2016,Q1,1,I,20160122.0,,20160223,20160223,DIR,,,,,40.0,YR,,M,N,114.0,KG,20160222.0,N,PH,US,,2016,Q1,Adult
121103691,12110369,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Metabolic acidosis,,2016,Q1,1,I,20160122.0,,20160223,20160223,DIR,,,,,40.0,YR,,M,N,114.0,KG,20160222.0,N,PH,US,,2016,Q1,Adult
121130381,12113038,15,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,(100UNIT/ML) 5-35 U SUBCUTANEOUS THIRTY MIN AC AND HS,,,,,,,,,,UNKNOWN,,2016,Q1,Upper respiratory tract infection,,2016,Q1,1,I,20160217.0,20160217.0,20160225,20160225,PER,,US-CELGENEUS-USA-2016024317,CELGENE,,56.0,YR,,M,Y,140.5,KG,20160224.0,,MD,US,US,2016,Q1,Adult
121151531,12115153,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Musculoskeletal pain,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121151531,12115153,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Paraesthesia,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121151531,12115153,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pelvic pain,,2016,Q1,1,I,20151223.0,20151223.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00726,LANTHEUS MEDICAL IMAGING,,30.0,YR,,M,Y,96.0,KG,20160225.0,,OT,US,US,2016,Q1,Young Adult
121159271,12115927,14,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Muscle spasms,,2016,Q1,1,I,20151021.0,20151021.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00583,LANTHEUS MEDICAL IMAGING,,50.0,YR,,M,Y,175.0,KG,20160225.0,,CN,US,US,2016,Q1,Adult
121159371,12115937,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Back pain,,2016,Q1,1,I,20150901.0,20150903.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00486,LANTHEUS MEDICAL IMAGING,,51.0,YR,,M,Y,198.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121159371,12115937,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20150901.0,20150903.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00486,LANTHEUS MEDICAL IMAGING,,51.0,YR,,M,Y,198.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121159371,12115937,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Neck pain,,2016,Q1,1,I,20150901.0,20150903.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00486,LANTHEUS MEDICAL IMAGING,,51.0,YR,,M,Y,198.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121159371,12115937,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Photophobia,,2016,Q1,1,I,20150901.0,20150903.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00486,LANTHEUS MEDICAL IMAGING,,51.0,YR,,M,Y,198.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121159531,12115953,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Back pain,,2016,Q1,1,I,20151015.0,20151015.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00564,LANTHEUS MEDICAL IMAGING,,42.0,YR,,F,Y,104.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121159531,12115953,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pain in extremity,,2016,Q1,1,I,20151015.0,20151015.0,20160225,20160225,PER,,US-LANTHEUS-LMI-2015-00564,LANTHEUS MEDICAL IMAGING,,42.0,YR,,F,Y,104.0,KG,20160225.0,,OT,US,US,2016,Q1,Adult
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Acute kidney injury,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Anaemia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Death,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Fall,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Haemorrhage intracranial,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Pyrexia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121163022,12116302,6,C,Isulin Lispro,,2,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,,2016,Q1,Thrombocytopenia,,2016,Q1,2,F,20160131.0,20160223.0,20160225,20160302,EXP,,US-CELGENE-USA-2016023999,CELGENE,,65.0,YR,,M,Y,133.4,KG,20160302.0,,OT,US,US,2016,Q1,Elderly
121185101,12118510,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,B-cell lymphoma,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Diplopia,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Headache,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121185101,12118510,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Malaise,,2016,Q1,1,I,20160129.0,,20160224,20160224,DIR,,,,,69.0,YR,,M,N,,,,N,CN,US,,2016,Q1,Elderly
121344271,12134427,1,PS,"LIPROLOG 25% LISPRO, 75% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q1,Blood glucose abnormal,,2016,Q1,1,I,,20160218.0,20160301,20160301,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201602007321,ELI LILLY AND CO,,70.0,YR,,M,Y,100.0,KG,20160301.0,,CN,IT,DE,2016,Q1,Elderly
121344271,12134427,1,PS,"LIPROLOG 25% LISPRO, 75% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q1,Diabetes mellitus inadequate control,,2016,Q1,1,I,,20160218.0,20160301,20160301,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201602007321,ELI LILLY AND CO,,70.0,YR,,M,Y,100.0,KG,20160301.0,,CN,IT,DE,2016,Q1,Elderly
121344271,12134427,1,PS,"LIPROLOG 25% LISPRO, 75% NPL",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q1,Fall,,2016,Q1,1,I,,20160218.0,20160301,20160301,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201602007321,ELI LILLY AND CO,,70.0,YR,,M,Y,100.0,KG,20160301.0,,CN,IT,DE,2016,Q1,Elderly
121351121,12135112,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,3-4 UNITS,,,,, C481182A,,20563.0,,,INJECTION,,2016,Q1,Blood glucose increased,,2016,Q1,1,I,201601.0,20160201.0,20160301,20160301,PER,,US-ELI_LILLY_AND_COMPANY-US201602001865,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20160301.0,,CN,US,US,2016,Q1,Elderly
121361711,12136171,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q1,Acute kidney injury,,2016,Q1,1,I,20160209.0,20160223.0,20160302,20160302,EXP,,GB-APOTEX-2016AP006751,APOTEX,,76.0,YR,,M,Y,85.0,KG,20160302.0,,CN,GB,GB,2016,Q1,Elderly
121361711,12136171,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q1,Blood creatinine increased,,2016,Q1,1,I,20160209.0,20160223.0,20160302,20160302,EXP,,GB-APOTEX-2016AP006751,APOTEX,,76.0,YR,,M,Y,85.0,KG,20160302.0,,CN,GB,GB,2016,Q1,Elderly
121361711,12136171,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q1,Hyperkalaemia,,2016,Q1,1,I,20160209.0,20160223.0,20160302,20160302,EXP,,GB-APOTEX-2016AP006751,APOTEX,,76.0,YR,,M,Y,85.0,KG,20160302.0,,CN,GB,GB,2016,Q1,Elderly
121361711,12136171,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q1,Hypovolaemia,,2016,Q1,1,I,20160209.0,20160223.0,20160302,20160302,EXP,,GB-APOTEX-2016AP006751,APOTEX,,76.0,YR,,M,Y,85.0,KG,20160302.0,,CN,GB,GB,2016,Q1,Elderly
121606721,12160672,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 U, EACH MORNING",,,,U,,,20563.0,8.0,IU,INJECTION,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20160205.0,20160208.0,20160308,20160308,PER,,US-ELI_LILLY_AND_COMPANY-US201602003231,ELI LILLY AND CO,,76.0,YR,,,Y,,,20160308.0,,CN,US,US,2016,Q1,Elderly
121606721,12160672,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,U,,,20563.0,8.0,IU,INJECTION,QD,2016,Q1,Blood glucose increased,,2016,Q1,1,I,20160205.0,20160208.0,20160308,20160308,PER,,US-ELI_LILLY_AND_COMPANY-US201602003231,ELI LILLY AND CO,,76.0,YR,,,Y,,,20160308.0,,CN,US,US,2016,Q1,Elderly
121647901,12164790,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2016,Q1,Drug dispensing error,,2016,Q1,1,I,20160209.0,20160209.0,20160309,20160309,PER,,US-ELI_LILLY_AND_COMPANY-US201602004089,ELI LILLY AND CO,,30.0,YR,,F,Y,,,20160309.0,,OT,US,US,2016,Q1,Young Adult
121683271,12168327,21,C,INSULIN HUMAN LISPRO,,2,,,,,,,,,,,,,,2016,Q1,Confusional state,,2016,Q1,1,I,20160307.0,,20160309,20160309,DIR,,,,,69.0,YR,,F,N,206.0,LBS,20160308.0,N,PH,US,,2016,Q1,Elderly
121683271,12168327,21,C,INSULIN HUMAN LISPRO,,2,,,,,,,,,,,,,,2016,Q1,Hallucination,,2016,Q1,1,I,20160307.0,,20160309,20160309,DIR,,,,,69.0,YR,,F,N,206.0,LBS,20160308.0,N,PH,US,,2016,Q1,Elderly
121796431,12179643,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 UNIT/ML SOLOUTION PEN-INJECTOR, UP TO 100 UNITS PER DAY",,,,,,,,,,,,2016,Q1,Device related infection,,2016,Q1,1,I,20160228.0,20160302.0,20160315,20160315,EXP,,US-ELI_LILLY_AND_COMPANY-US201603001104,ELI LILLY AND CO,,61.0,YR,,M,Y,72.0,KG,20160314.0,,CN,US,US,2016,Q1,Adult
121796431,12179643,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 UNIT/ML SOLOUTION PEN-INJECTOR, UP TO 100 UNITS PER DAY",,,,,,,,,,,,2016,Q1,White blood cell count decreased,,2016,Q1,1,I,20160228.0,20160302.0,20160315,20160315,EXP,,US-ELI_LILLY_AND_COMPANY-US201603001104,ELI LILLY AND CO,,61.0,YR,,M,Y,72.0,KG,20160314.0,,CN,US,US,2016,Q1,Adult
121942852,12194285,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INSULIN LISPRO SLIDING SCALE SQ TID AC(PRIOR TO MEAL),,,,,,,,,,,TID,2016,Q1,Drug-induced liver injury,,2016,Q1,2,F,,20160318.0,20160321,20160331,EXP,,US-DRREDDYS-USA/USA/16/0078096,DR REDDYS,HAMMERSTROM A. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANN PHARMACOTHER. 2015?49(1):135-9.,34.0,YR,,,Y,,,20160331.0,,MD,COUNTRY NOT SPECIFIED,US,2016,Q1,Young Adult
121990341,12199034,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Rash generalised,,2016,Q1,1,I,20160301.0,20160314.0,20160322,20160322,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-16322UK",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,96.0,KG,20160322.0,,OT,GB,GB,2016,Q1,Adult
121990341,12199034,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Rash macular,,2016,Q1,1,I,20160301.0,20160314.0,20160322,20160322,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-16322UK",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,96.0,KG,20160322.0,,OT,GB,GB,2016,Q1,Adult
121990341,12199034,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q1,Vomiting,,2016,Q1,1,I,20160301.0,20160314.0,20160322,20160322,EXP,,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-16322UK",BOEHRINGER INGELHEIM,,58.0,YR,,M,Y,96.0,KG,20160322.0,,OT,GB,GB,2016,Q1,Adult
122047741,12204774,9,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q1,Blood creatine phosphokinase increased,,2016,Q1,1,I,20160301.0,,20160322,20160322,DIR,,,,,71.0,YR,,M,N,70.0,KG,20160321.0,N,PH,US,,2016,Q1,Elderly
122047741,12204774,9,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q1,Fall,,2016,Q1,1,I,20160301.0,,20160322,20160322,DIR,,,,,71.0,YR,,M,N,70.0,KG,20160321.0,N,PH,US,,2016,Q1,Elderly
122047741,12204774,9,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q1,Muscular weakness,,2016,Q1,1,I,20160301.0,,20160322,20160322,DIR,,,,,71.0,YR,,M,N,70.0,KG,20160321.0,N,PH,US,,2016,Q1,Elderly
122107461,12210746,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Blood bilirubin increased,,2016,Q1,1,I,20160314.0,,20160324,20160324,DIR,,,,,58.0,YR,,F,N,72.0,KG,20160323.0,N,PH,US,,2016,Q1,Adult
122107461,12210746,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Cholestasis,,2016,Q1,1,I,20160314.0,,20160324,20160324,DIR,,,,,58.0,YR,,F,N,72.0,KG,20160323.0,N,PH,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Arrhythmia,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Cardiac ablation,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Cardiac perforation,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pericardial effusion,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Ventricular tachycardia,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122133791,12213379,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Weight decreased,,2016,Q1,1,I,20150709.0,,20160325,20160325,DIR,,,,,62.0,YR,,F,N,208.0,LBS,20160324.0,N,,US,,2016,Q1,Adult
122144161,12214416,13,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Pancreatitis,,2016,Q1,1,I,20160314.0,,20160325,20160325,DIR,,,,,40.0,YR,,M,N,128.5,KG,20160324.0,N,PH,US,,2016,Q1,Adult
122171681,12217168,2,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Device expulsion,,2016,Q1,1,I,20160204.0,20160302.0,20160329,20160329,PER,,US-TEVA-642286ACC,TEVA,,17.0,YR,,F,Y,55.84,KG,20160329.0,,CN,US,US,2016,Q1,Youth
122171681,12217168,2,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q1,Dysmenorrhoea,,2016,Q1,1,I,20160204.0,20160302.0,20160329,20160329,PER,,US-TEVA-642286ACC,TEVA,,17.0,YR,,F,Y,55.84,KG,20160329.0,,CN,US,US,2016,Q1,Youth
122258331,12225833,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Epistaxis,,2016,Q1,1,I,201506.0,20160125.0,20160331,20160331,EXP,,US-BAYER-2016-019533,BAYER,,62.0,YR,A,M,Y,,,20160331.0,,CN,US,US,2016,Q1,Adult
122258331,12225833,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Gastrointestinal haemorrhage,,2016,Q1,1,I,201506.0,20160125.0,20160331,20160331,EXP,,US-BAYER-2016-019533,BAYER,,62.0,YR,A,M,Y,,,20160331.0,,CN,US,US,2016,Q1,Adult
122258331,12225833,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q1,Hypotension,,2016,Q1,1,I,201506.0,20160125.0,20160331,20160331,EXP,,US-BAYER-2016-019533,BAYER,,62.0,YR,A,M,Y,,,20160331.0,,CN,US,US,2016,Q1,Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Diabetic ketoacidosis,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Gastroenteritis,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Hypertension,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Hypoglycaemia,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Impaired gastric emptying,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
98621374,9862137,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2016,Q1,Leukocytosis,,2016,Q1,4,F,20131029.0,20160301.0,20140203,20160304,EXP,,US-ROCHE-1328108,ROCHE,,34.0,YR,,F,Y,,,20160304.0,,MD,US,US,2016,Q1,Young Adult
104659836,10465983,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Febrile bone marrow aplasia,,2016,Q2,6,F,20140812.0,20160530.0,20140922,20160531,EXP,,FR-ROCHE-1462355,ROCHE,,70.0,YR,,M,Y,67.0,KG,20160531.0,,MD,FR,FR,2016,Q2,Elderly
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Aspergillus infection,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Bone erosion,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Cardiac failure congestive,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Decreased appetite,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Diplopia,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Migraine,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Optic nerve disorder,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Sinus operation,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Sinusitis fungal,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,VIth nerve paralysis,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
116401446,11640144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,6,F,201509.0,20160616.0,20151019,20160629,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-064509,BRISTOL MYERS SQUIBB,,43.0,YR,,M,Y,115.9,KG,20160629.0,,OT,US,US,2016,Q2,Adult
117245102,11724510,5,C,Insulin lispro mix,,2,Unknown,75/25,,,,,,,,,,UNKNOWN,,2016,Q2,Dizziness,,2016,Q2,2,F,201510.0,20160406.0,20151111,20160418,PER,,US-CELGENEUS-USA-2015106354,CELGENE,,72.0,YR,,M,Y,71.28,KG,20160416.0,,MD,US,US,2016,Q2,Elderly
117245102,11724510,5,C,Insulin lispro mix,,2,Unknown,75/25,,,,,,,,,,UNKNOWN,,2016,Q2,Motion sickness,,2016,Q2,2,F,201510.0,20160406.0,20151111,20160418,PER,,US-CELGENEUS-USA-2015106354,CELGENE,,72.0,YR,,M,Y,71.28,KG,20160416.0,,MD,US,US,2016,Q2,Elderly
117245102,11724510,5,C,Insulin lispro mix,,2,Unknown,75/25,,,,,,,,,,UNKNOWN,,2016,Q2,Nausea,,2016,Q2,2,F,201510.0,20160406.0,20151111,20160418,PER,,US-CELGENEUS-USA-2015106354,CELGENE,,72.0,YR,,M,Y,71.28,KG,20160416.0,,MD,US,US,2016,Q2,Elderly
117245102,11724510,5,C,Insulin lispro mix,,2,Unknown,75/25,,,,,,,,,,UNKNOWN,,2016,Q2,Treatment noncompliance,,2016,Q2,2,F,201510.0,20160406.0,20151111,20160418,PER,,US-CELGENEUS-USA-2015106354,CELGENE,,72.0,YR,,M,Y,71.28,KG,20160416.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Asthenia,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dehydration,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Disease progression,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Off label use,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Prescribed underdose,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Pulmonary sepsis,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Rectal haemorrhage,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Sepsis,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117782455,11778245,15,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Subdural haematoma,,2016,Q2,5,F,2015.0,20160411.0,20151125,20160415,EXP,,US-JNJFOC-20151122322,PHARMACYCLICS,,80.0,YR,E,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
117819295,11781929,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,10.0,IU,INJECTION,BID,2016,Q2,Pancreatitis acute,,2016,Q2,5,F,20151113.0,20160404.0,20151126,20160412,EXP,,US-ASTRAZENECA-2015SF13083,ASTRAZENECA,,20544.0,DY,,F,Y,70.3,KG,20160413.0,,MD,US,US,2016,Q2,Elderly
118689102,11868910,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Haemorrhagic stroke,,2016,Q2,2,F,20131220.0,20160330.0,20151225,20160405,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-089271,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20160405.0,,CN,US,US,2016,Q2,Elderly
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Abdominal pain,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Asthenia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Catheterisation cardiac,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Chest pain,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Device related infection,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Drug delivery device implantation,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Fall,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Hernia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Lethargy,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Muscle spasms,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Muscle spasticity,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Pain in extremity,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Paraesthesia,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Pulmonary embolism,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Urinary retention,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118763832,11876383,23,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,SOLN FOR INJECT IN PRE-FILLED SYRINGE,,2016,Q2,Urinary tract infection,,2016,Q2,2,F,2011.0,20160407.0,20151229,20160419,EXP,,US-BIOGEN-2015BI00165775,BIOGEN,,60.0,YR,,M,Y,,,20160419.0,,MD,US,US,2016,Q2,Adult
118791983,11879198,14,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Subcutaneous,"90 IU, 2X/DAY",,,,,,,,90.0,IU,,BID,2016,Q2,Drug effect incomplete,,2016,Q2,3,F,,20160425.0,20151230,20160428,PER,,US-PFIZER INC-2015473045,PFIZER,,62.0,YR,,M,Y,,,20160428.0,,MD,US,US,2016,Q2,Adult
118857363,11885736,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,3,F,20150920.0,20160401.0,20160104,20160408,EXP,,US-SA-2015SA222803,AVENTIS,,65.0,YR,E,M,Y,,,20160408.0,,MD,US,US,2016,Q2,Elderly
119414303,11941430,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Dehydration,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Metabolic acidosis,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Off label use,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Renal failure,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119414303,11941430,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, UNK",,,,,,,,6.0,IU,,,2016,Q2,Septic shock,,2016,Q2,3,F,20151127.0,20160413.0,20160122,20160419,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-001883,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20160419.0,,CN,IT,IT,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Blood glucose decreased,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Chest discomfort,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Hospitalisation,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Infusion related reaction,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Malaise,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Metabolic disorder,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Off label use,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Product use issue,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Psoriasis,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Seizure,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Stoma site abscess,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119768927,11976892,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ML,,,,,,,,,,UNKNOWN,,2016,Q2,Syncope,,2016,Q2,7,F,20151130.0,20160613.0,20160129,20160622,EXP,,CA-JNJFOC-20151213549,JANSSEN,,44.0,YR,A,F,Y,120.0,KG,20160622.0,,CN,CA,CA,2016,Q2,Adult
119934973,11993497,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Bile duct obstruction,,2016,Q2,3,F,20151115.0,20160429.0,20160203,20160513,EXP,,"US-ROXANE LABORATORIES, INC.-2016-RO-00171RO",ROXANE,,59.0,YR,,M,Y,69.0,KG,20160513.0,,MD,US,US,2016,Q2,Adult
119934973,11993497,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Blood bilirubin increased,,2016,Q2,3,F,20151115.0,20160429.0,20160203,20160513,EXP,,"US-ROXANE LABORATORIES, INC.-2016-RO-00171RO",ROXANE,,59.0,YR,,M,Y,69.0,KG,20160513.0,,MD,US,US,2016,Q2,Adult
119934973,11993497,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Hyperglycaemia,,2016,Q2,3,F,20151115.0,20160429.0,20160203,20160513,EXP,,"US-ROXANE LABORATORIES, INC.-2016-RO-00171RO",ROXANE,,59.0,YR,,M,Y,69.0,KG,20160513.0,,MD,US,US,2016,Q2,Adult
120170272,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q2,Blood glucose decreased,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q2,Blood glucose increased,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q2,Incorrect dose administered,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,U,,,20563.0,3.0,IU,INJECTION,,2016,Q2,Wrong technique in product usage process,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,, C311009A,,,3.0,IU,INJECTION,,2016,Q2,Blood glucose decreased,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,, C311009A,,,3.0,IU,INJECTION,,2016,Q2,Blood glucose increased,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,, C311009A,,,3.0,IU,INJECTION,,2016,Q2,Incorrect dose administered,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120170272,12017027,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"3 U, OTHER",,,,, C311009A,,,3.0,IU,INJECTION,,2016,Q2,Wrong technique in product usage process,,2016,Q2,2,F,20160106.0,20160106.0,20160205,20160621,PER,,US-ELI_LILLY_AND_COMPANY-US201601004371,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20160621.0,,CN,US,US,2016,Q2,Adult
120603462,12060346,12,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2016,Q2,Drug ineffective,,2016,Q2,2,F,2014.0,20160324.0,20160210,20160405,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20160405.0,,MD,US,US,2016,Q2,Adult
120603462,12060346,12,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2016,Q2,Multiple sclerosis,,2016,Q2,2,F,2014.0,20160324.0,20160210,20160405,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20160405.0,,MD,US,US,2016,Q2,Adult
120603462,12060346,12,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2016,Q2,Prescribed underdose,,2016,Q2,2,F,2014.0,20160324.0,20160210,20160405,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20160405.0,,MD,US,US,2016,Q2,Adult
120603462,12060346,12,C,Lispro,INSULIN LISPRO,1,Subcutaneous,100UNIT/ML,,,,,,,,,,INJECTION,TID,2016,Q2,Seizure,,2016,Q2,2,F,2014.0,20160324.0,20160210,20160405,EXP,,US-BIOGEN-2016BI00185571,BIOGEN,,37.0,YR,,M,Y,86.26,KG,20160405.0,,MD,US,US,2016,Q2,Adult
121319693,12131969,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Gastrointestinal haemorrhage,,2016,Q2,3,F,20150528.0,20160413.0,20160301,20160507,PER,,US-JNJFOC-20160214859,JANSSEN,,77.0,YR,E,F,Y,,,20160507.0,,CN,US,US,2016,Q2,Elderly
121421782,12142178,49,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,UNKNOWN,,2016,Q2,Atrial fibrillation,,2016,Q2,2,F,20160216.0,20160511.0,20160303,20160517,EXP,,US-CELGENEUS-USA-2016030319,CELGENE,,72.0,YR,,F,Y,106.28,KG,20160517.0,,OT,US,US,2016,Q2,Elderly
121421782,12142178,49,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,UNKNOWN,,2016,Q2,Sepsis,,2016,Q2,2,F,20160216.0,20160511.0,20160303,20160517,EXP,,US-CELGENEUS-USA-2016030319,CELGENE,,72.0,YR,,F,Y,106.28,KG,20160517.0,,OT,US,US,2016,Q2,Elderly
121612022,12161202,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,,U,,,20563.0,35.0,IU,INJECTION,BID,2016,Q2,Blood glucose increased,,2016,Q2,2,F,20160127.0,20160208.0,20160308,20160420,PER,,US-ELI_LILLY_AND_COMPANY-US201602003215,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160420.0,,CN,US,US,2016,Q2,Adult
121612022,12161202,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,,U,,,20563.0,35.0,IU,INJECTION,BID,2016,Q2,Chest pain,,2016,Q2,2,F,20160127.0,20160208.0,20160308,20160420,PER,,US-ELI_LILLY_AND_COMPANY-US201602003215,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20160420.0,,CN,US,US,2016,Q2,Adult
121637022,12163702,16,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,5 UNITS,,,,,,,,,,INJECTION,TID,2016,Q2,Enterococcal bacteraemia,,2016,Q2,2,F,20160104.0,20160513.0,20160309,20160518,PER,,US-CELGENEUS-USA-2016030370,CELGENE,,71.0,YR,,M,Y,,,20160518.0,,MD,US,US,2016,Q2,Elderly
121637022,12163702,16,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,5 UNITS,,,,,,,,,,INJECTION,TID,2016,Q2,Urinary tract infection enterococcal,,2016,Q2,2,F,20160104.0,20160513.0,20160309,20160518,PER,,US-CELGENEUS-USA-2016030370,CELGENE,,71.0,YR,,M,Y,,,20160518.0,,MD,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Fungal test positive,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Nephrolithiasis,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Pneumonia,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Respiratory failure,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Sepsis,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
121713833,12171383,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Urinary tract infection,,2016,Q2,3,F,20160130.0,20160606.0,20160311,20160617,EXP,,US-JNJFOC-20160304703,JANSSEN,,69.0,YR,E,M,Y,86.18,KG,20160617.0,,PH,US,US,2016,Q2,Elderly
122091814,12209181,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNIT-4 UNIT-5 UNIT,,,,,,,,,,,TID,2016,Q2,Enterocolitis,,2016,Q2,4,F,20160317.0,20160518.0,20160324,20160525,EXP,,JP-ABBVIE-16P-087-1589884-00,ABBVIE,,58.0,YR,,F,Y,51.2,KG,20160525.0,,MD,JP,JP,2016,Q2,Adult
122091814,12209181,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNIT-4 UNIT-5 UNIT,,,,,,,,,,,TID,2016,Q2,Pyrexia,,2016,Q2,4,F,20160317.0,20160518.0,20160324,20160525,EXP,,JP-ABBVIE-16P-087-1589884-00,ABBVIE,,58.0,YR,,F,Y,51.2,KG,20160525.0,,MD,JP,JP,2016,Q2,Adult
122091814,12209181,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNIT-4 UNIT-5 UNIT,,,,,,,,,,,TID,2016,Q2,Rash,,2016,Q2,4,F,20160317.0,20160518.0,20160324,20160525,EXP,,JP-ABBVIE-16P-087-1589884-00,ABBVIE,,58.0,YR,,F,Y,51.2,KG,20160525.0,,MD,JP,JP,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Acute kidney injury,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Anaemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Diabetic ketoacidosis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Hypernatraemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Hypophosphataemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Metabolic encephalopathy,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Sepsis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2016,Q2,Urinary tract infection,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Acute kidney injury,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Anaemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Hypernatraemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Hypophosphataemia,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Metabolic encephalopathy,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Sepsis,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122119393,12211939,6,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q2,Urinary tract infection,,2016,Q2,3,F,20151019.0,20160601.0,20160325,20160607,EXP,,US-BIOGEN-2015BI160126,BIOGEN,,39.0,YR,,F,Y,69.92,KG,20160607.0,,MD,US,US,2016,Q2,Adult
122571561,12257156,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SINGLE",,,,, C303183N,,20563.0,,,INJECTION,,2016,Q2,Blood glucose decreased,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SINGLE",,,,, C303183N,,20563.0,,,INJECTION,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SINGLE",,,,, C303183N,,20563.0,,,INJECTION,,2016,Q2,Loss of consciousness,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SINGLE",,,,, C303183N,,20563.0,,,INJECTION,,2016,Q2,Pallor,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, SINGLE",,,,, C303183N,,20563.0,,,INJECTION,,2016,Q2,Wrong drug administered,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Blood glucose decreased,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Loss of consciousness,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Pallor,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122571561,12257156,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,,,,,,2016,Q2,Wrong drug administered,,2016,Q2,1,I,201503.0,20160401.0,20160412,20160412,EXP,,BR-ELI_LILLY_AND_COMPANY-BR201604000747,ELI LILLY AND CO,,4.0,YR,,F,Y,18.0,KG,20160408.0,,CN,BR,BR,2016,Q2,Child
122650711,12265071,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q2,Blindness,,2016,Q2,1,I,201408.0,20160401.0,20160413,20160413,EXP,,US-ELI_LILLY_AND_COMPANY-US201604001849,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20160413.0,,CN,US,US,2016,Q2,Elderly
122650711,12265071,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q2,Diabetic retinopathy,,2016,Q2,1,I,201408.0,20160401.0,20160413,20160413,EXP,,US-ELI_LILLY_AND_COMPANY-US201604001849,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20160413.0,,CN,US,US,2016,Q2,Elderly
122650711,12265071,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q2,Glaucoma,,2016,Q2,1,I,201408.0,20160401.0,20160413,20160413,EXP,,US-ELI_LILLY_AND_COMPANY-US201604001849,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20160413.0,,CN,US,US,2016,Q2,Elderly
122650711,12265071,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,U,,,20563.0,,,INJECTION,,2016,Q2,Nephropathy,,2016,Q2,1,I,201408.0,20160401.0,20160413,20160413,EXP,,US-ELI_LILLY_AND_COMPANY-US201604001849,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20160413.0,,CN,US,US,2016,Q2,Elderly
122709261,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Hypoxia,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122709261,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Myocardial infarction,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122709261,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Pneumonia,,2016,Q2,1,I,20150727.0,20150729.0,20160415,20160415,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20160415.0,,OT,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Acute kidney injury,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Cardiac failure congestive,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Chronic obstructive pulmonary disease,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Deep vein thrombosis,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Escherichia infection,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Prostatitis,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122710461,12271046,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q2,Ventricular tachycardia,,2016,Q2,1,I,20090501.0,20160125.0,20160415,20160415,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-000682,ENDO,,67.0,YR,,M,Y,113.5,KG,20160415.0,,LW,US,US,2016,Q2,Elderly
122737311,12273731,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Urinary retention,,2016,Q2,1,I,,20150618.0,20160415,20160415,PER,,ADR-2015-01197,MEDTRONIC,,84.0,YR,,M,Y,,,20160415.0,,MD,US,US,2016,Q2,Elderly
122759813,12275981,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,3,F,20160321.0,20160503.0,20160418,20160510,EXP,,US-GILEAD-2016-0207391,GILEAD,,63.0,YR,A,F,Y,104.0,KG,20160510.0,,CN,US,US,2016,Q2,Adult
122759813,12275981,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Off label use,,2016,Q2,3,F,20160321.0,20160503.0,20160418,20160510,EXP,,US-GILEAD-2016-0207391,GILEAD,,63.0,YR,A,F,Y,104.0,KG,20160510.0,,CN,US,US,2016,Q2,Adult
122765021,12276502,16,C,INSULIN LISPRO (HUMALOG KWIKPEN),,2,,,,,,,,,,,,,,2016,Q2,Laboratory test abnormal,,2016,Q2,1,I,20160322.0,,20160415,20160415,DIR,,,,,69.0,YR,,F,N,,,20160414.0,Y,PH,US,,2016,Q2,Elderly
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Abdominal pain,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Acidosis,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Alcohol use,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Blood glucose increased,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Creatinine renal clearance decreased,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dehydration,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dizziness,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Food poisoning,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Lethargy,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Lipase increased,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Nausea,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Nodal arrhythmia,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Polydipsia,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Tachypnoea,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822411,12282241,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,20160414.0,,20160418,20160418,DIR,,,,,55.0,YR,,M,N,121.5,KG,20160415.0,N,PH,US,,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Arthralgia,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Gait disturbance,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Hepatic enzyme increased,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Musculoskeletal stiffness,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Pain in extremity,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Peripheral swelling,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Pharyngitis,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Poor venous access,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Swelling,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Therapeutic response decreased,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Tremor,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122822851,12282285,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,UNK,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,,20160404.0,20160419,20160419,EXP,,"CA-DEPOMED, INC.-CA-2016DEP009397",DEPOMED,,62.0,YR,,F,Y,,,20160419.0,,OT,CA,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Arthralgia,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Gait disturbance,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Hepatic enzyme increased,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Musculoskeletal stiffness,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pain in extremity,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Peripheral swelling,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pharyngitis,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Poor venous access,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Swelling,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Therapeutic response decreased,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Tremor,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122876171,12287617,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,UNK,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,,20160404.0,20160420,20160420,EXP,,PHHY2016CA052425,NOVARTIS,,62.0,YR,,F,Y,,,20160420.0,,CN,COUNTRY NOT SPECIFIED,CA,2016,Q2,Adult
122943541,12294354,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-ALKEM-001580,ALKEM,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943541,12294354,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-ALKEM-001580,ALKEM,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943661,12294366,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INDICUS PHARMA-000408,INDICUS,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943661,12294366,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INDICUS PHARMA-000408,INDICUS,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943721,12294372,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Diarrhoea,,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INVENTIA-000108,INVENTIA HEALTHCARE,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122943721,12294372,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2016,Q2,Fixed drug eruption,Fixed drug eruption,2016,Q2,1,I,,20160411.0,20160422,20160422,EXP,,US-INVENTIA-000108,INVENTIA HEALTHCARE,"STEBER CJ, PERKINS SL, HARRIS KB. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM J CASE REP. 2016 APR 8;17:231-4.",56.0,YR,,F,Y,118.0,KG,20160422.0,,OT,US,US,2016,Q2,Adult
122996831,12299683,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,D,,,,45.0,IU,,TID,2016,Q2,Coma,,2016,Q2,1,I,20160419.0,,20160422,20160422,DIR,,,,,82.0,YR,,M,N,81.6,KG,20160421.0,N,PH,US,,2016,Q2,Elderly
122996831,12299683,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,D,,,,45.0,IU,,TID,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,20160419.0,,20160422,20160422,DIR,,,,,82.0,YR,,M,N,81.6,KG,20160421.0,N,PH,US,,2016,Q2,Elderly
122996831,12299683,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,D,,,,45.0,IU,,TID,2016,Q2,Treatment noncompliance,,2016,Q2,1,I,20160419.0,,20160422,20160422,DIR,,,,,82.0,YR,,M,N,81.6,KG,20160421.0,N,PH,US,,2016,Q2,Elderly
123003161,12300316,5,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Blood glucose decreased,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,5,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Cardiac murmur,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,5,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Foetal exposure during pregnancy,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,5,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Premature baby,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,5,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Red blood cell count increased,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,6,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Blood glucose decreased,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,6,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Cardiac murmur,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,6,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Foetal exposure during pregnancy,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,6,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Premature baby,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003161,12300316,6,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,,,,,4.0,IU,,,2016,Q2,Red blood cell count increased,,2016,Q2,1,I,201502.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604004874,ELI LILLY AND CO,,0.0,YR,,,Y,3.5,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003171,12300317,3,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,U,,,,4.0,IU,,,2016,Q2,Cardiac murmur,,2016,Q2,1,I,20150811.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604006003,ELI LILLY AND CO,,0.0,DY,,,Y,3.0,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003171,12300317,3,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,U,,,,4.0,IU,,,2016,Q2,Foetal exposure during pregnancy,,2016,Q2,1,I,20150811.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604006003,ELI LILLY AND CO,,0.0,DY,,,Y,3.0,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123003171,12300317,3,SS,Lispro,INSULIN LISPRO,1,Transplacental,"4 U, BEFORE EVERY MEAL",,,,U,,,,4.0,IU,,,2016,Q2,Premature baby,,2016,Q2,1,I,20150811.0,20160412.0,20160425,20160425,EXP,,PY-ELI_LILLY_AND_COMPANY-PY201604006003,ELI LILLY AND CO,,0.0,DY,,,Y,3.0,KG,20160422.0,,CN,PY,PY,2016,Q2,Child
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Cardiac arrest,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Cough,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Diabetic ketoacidosis,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Dyspnoea,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123048171,12304817,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Hyperkalaemia,,2016,Q2,1,I,20160406.0,,20160425,20160425,DIR,,,,,68.0,YR,,M,N,101.2,KG,20160422.0,N,PH,US,,2016,Q2,Elderly
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Arthralgia,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Gait disturbance,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Hepatic enzyme increased,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Musculoskeletal stiffness,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pain in extremity,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Peripheral swelling,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pharyngitis,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Poor venous access,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Swelling,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Therapeutic response decreased,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Tremor,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123098681,12309868,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,,20160404.0,20160427,20160427,EXP,,CA-GLAXOSMITHKLINE-CA2016GSK056585,GLAXOSMITHKLINE,,62.0,YR,,F,Y,,,20160427.0,,OT,CA,CA,2016,Q2,Adult
123255321,12325532,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSE,,,,,,,,,,,,2016,Q2,Anaphylactic shock,,2016,Q2,1,I,20160202.0,20160422.0,20160503,20160503,EXP,,US-HOSPIRA-3266731,HOSPIRA,,19.0,YR,A,F,Y,50.9,KG,20160503.0,,PH,US,US,2016,Q2,Youth
123261271,12326127,7,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Blood pressure fluctuation,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123261271,12326127,7,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Cardio-respiratory arrest,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123261271,12326127,7,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q2,Wheezing,,2016,Q2,1,I,20160416.0,20160422.0,20160503,20160503,EXP,,CO-BAXTER-2016BAX021522,BAXTER,,76.0,YR,,M,Y,57.0,KG,20160503.0,,OT,CO,CO,2016,Q2,Elderly
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Arthralgia,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Gait disturbance,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Hepatic enzyme increased,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Musculoskeletal stiffness,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Pain in extremity,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Peripheral swelling,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Pharyngitis,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Poor venous access,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Pruritus,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Swelling,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Therapeutic response decreased,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Tremor,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123359181,12335918,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Vomiting,,2016,Q2,1,I,,20160427.0,20160505,20160505,EXP,,CA-TEVA-656724USA,TEVA,,62.0,YR,,M,Y,,,20160505.0,,OT,CA,CA,2016,Q2,Adult
123394322,12339432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PER SLIDING SCALE",,,,,,,,,,,,2016,Q2,Drug ineffective,,2016,Q2,2,F,201502.0,20151209.0,20160505,20160606,PER,,US-AMGEN-USASP2015132302,AMGEN,,63.0,YR,A,F,Y,,,20160606.0,,PH,US,US,2016,Q2,Adult
123507671,12350767,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5-7-0,,,,,,,,,,UNSPECIFIED,,2016,Q2,Back pain,,2016,Q2,1,I,20150510.0,20160428.0,20160510,20160510,EXP,,CA-JNJFOC-20160427776,JANSSEN,,23.0,YR,A,F,Y,65.7,KG,20160510.0,,MD,CA,CA,2016,Q2,Youth
123507671,12350767,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5-7-0,,,,,,,,,,UNSPECIFIED,,2016,Q2,Diabetic neuropathy,,2016,Q2,1,I,20150510.0,20160428.0,20160510,20160510,EXP,,CA-JNJFOC-20160427776,JANSSEN,,23.0,YR,A,F,Y,65.7,KG,20160510.0,,MD,CA,CA,2016,Q2,Youth
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Diabetes mellitus inadequate control,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Dyspepsia,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Folliculitis,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Impetigo,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Injection site reaction,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Lipodystrophy acquired,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123619421,12361942,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNK,,,,,,,2016,Q2,Therapeutic response decreased,,2016,Q2,1,I,2013.0,20160503.0,20160512,20160512,EXP,,CZ-SA-2016SA089175,AVENTIS,"PELIKANOVA M. THE TREATMENT OF A PATIENT WITH DIABETES AND LIPODYSTROPHY - THE PROBLEM THAT HAS A SOLUTION, IN. KAZUISTIKY V DIABETOLOGII. 2016;1:10-1.",60.0,YR,A,M,Y,,,20160512.0,,OT,CZ,CZ,2016,Q2,Adult
123730791,12373079,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0-12 UNITS, TID WC",,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,20151106.0,20151208.0,20160516,20160516,PER,,US-MALLINCKRODT-T201505717,MALLINCKRODT,,83.0,YR,,M,Y,65.7,KG,20160516.0,,OT,US,US,2016,Q2,Elderly
123730791,12373079,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"0-6 UNITS, NIGHTLY",,,,,,,,,,,,2016,Q2,Pneumonia,,2016,Q2,1,I,20151106.0,20151208.0,20160516,20160516,PER,,US-MALLINCKRODT-T201505717,MALLINCKRODT,,83.0,YR,,M,Y,65.7,KG,20160516.0,,OT,US,US,2016,Q2,Elderly
123755422,12375542,11,C,INSULINA LISPRO,,2,,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123755422,12375542,11,C,INSULINA LISPRO,,2,,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123755422,12375542,11,C,INSULINA LISPRO,,2,,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160517,20160525,EXP,,IT-PFIZER INC-2016252856,PFIZER,,82.0,YR,,M,Y,,,20160525.0,,MD,IT,IT,2016,Q2,Elderly
123815132,12381513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123815132,12381513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123815132,12381513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160518,20160525,EXP,,PHHY2016IT066137,SANDOZ,,82.0,YR,,M,Y,,,20160526.0,,OT,IT,IT,2016,Q2,Elderly
123820381,12382038,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Drug level decreased,,2016,Q2,1,I,20160510.0,,20160517,20160517,DIR,,,,,49.0,YR,,M,N,113.4,KG,20160516.0,N,PH,US,,2016,Q2,Adult
123837972,12383797,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Prurigo,,2016,Q2,2,F,20160315.0,20160524.0,20160519,20160527,EXP,,BR-ROCHE-1760150,ROCHE,,80.0,YR,,M,Y,55.0,KG,20160527.0,,PH,BR,BR,2016,Q2,Elderly
123837972,12383797,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Rash,,2016,Q2,2,F,20160315.0,20160524.0,20160519,20160527,EXP,,BR-ROCHE-1760150,ROCHE,,80.0,YR,,M,Y,55.0,KG,20160527.0,,PH,BR,BR,2016,Q2,Elderly
123899652,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123899652,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123899652,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160520,20160526,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160526.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,11,C,INSULIN LISPRO DNA RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,11,C,INSULIN LISPRO DNA RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q2,Pyrexia,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,11,C,INSULIN LISPRO DNA RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123909112,12390911,11,C,INSULIN LISPRO DNA RECOMBINANT,,2,,,,,,,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160519.0,20160520,20160602,EXP,IT-MINISAL02-358470,IT-TEVA-660271ACC,TEVA,,82.0,YR,,M,Y,,,20160601.0,,MD,IT,IT,2016,Q2,Elderly
123973122,12397312,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q2,Hypercapnia,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
123973122,12397312,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q2,Respiratory depression,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
123973122,12397312,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,U,,,,,,,,2016,Q2,Sopor,,2016,Q2,2,F,20160404.0,20160518.0,20160524,20160602,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117111,RANBAXY,,82.0,YR,,M,Y,,,20160602.0,,OT,IT,IT,2016,Q2,Elderly
124430252,12443025,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Cerebrovascular accident,,2016,Q2,2,F,,20160613.0,20160607,20160617,EXP,,US-GILEAD-2016-0217148,GILEAD,,41.0,YR,A,F,Y,,,20160617.0,,OT,US,US,2016,Q2,Adult
124430252,12443025,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Fluid overload,,2016,Q2,2,F,,20160613.0,20160607,20160617,EXP,,US-GILEAD-2016-0217148,GILEAD,,41.0,YR,A,F,Y,,,20160617.0,,OT,US,US,2016,Q2,Adult
124430252,12443025,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Oedema,,2016,Q2,2,F,,20160613.0,20160607,20160617,EXP,,US-GILEAD-2016-0217148,GILEAD,,41.0,YR,A,F,Y,,,20160617.0,,OT,US,US,2016,Q2,Adult
124430252,12443025,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q2,Right ventricular failure,,2016,Q2,2,F,,20160613.0,20160607,20160617,EXP,,US-GILEAD-2016-0217148,GILEAD,,41.0,YR,A,F,Y,,,20160617.0,,OT,US,US,2016,Q2,Adult
124483481,12448348,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Peripheral ischaemia,,2016,Q2,1,I,,20160606.0,20160608,20160608,EXP,,GB-JNJFOC-20160605025,JANSSEN,,49.0,YR,A,F,Y,104.0,KG,20160608.0,,PH,GB,GB,2016,Q2,Adult
124483481,12448348,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Skin ulcer,,2016,Q2,1,I,,20160606.0,20160608,20160608,EXP,,GB-JNJFOC-20160605025,JANSSEN,,49.0,YR,A,F,Y,104.0,KG,20160608.0,,PH,GB,GB,2016,Q2,Adult
124483481,12448348,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q2,Vascular graft occlusion,,2016,Q2,1,I,,20160606.0,20160608,20160608,EXP,,GB-JNJFOC-20160605025,JANSSEN,,49.0,YR,A,F,Y,104.0,KG,20160608.0,,PH,GB,GB,2016,Q2,Adult
124697081,12469708,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Cellulitis,,2016,Q2,1,I,20160523.0,20160610.0,20160615,20160615,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046416,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,108.39,KG,20160615.0,,PH,US,US,2016,Q2,Elderly
124747571,12474757,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Anaemia,,2016,Q2,1,I,20160523.0,20160609.0,20160617,20160617,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046016,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,83.0,KG,20160617.0,,PH,BR,BR,2016,Q2,Adult
124747571,12474757,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Blister,,2016,Q2,1,I,20160523.0,20160609.0,20160617,20160617,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046016,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,83.0,KG,20160617.0,,PH,BR,BR,2016,Q2,Adult
124747571,12474757,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Erythema nodosum,,2016,Q2,1,I,20160523.0,20160609.0,20160617,20160617,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046016,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,83.0,KG,20160617.0,,PH,BR,BR,2016,Q2,Adult
124747571,12474757,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Hypoglycaemia,,2016,Q2,1,I,20160523.0,20160609.0,20160617,20160617,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046016,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,83.0,KG,20160617.0,,PH,BR,BR,2016,Q2,Adult
124866841,12486684,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, BID",,,,,,,20563.0,16.0,IU,INJECTION,BID,2016,Q2,Blood glucose increased,,2016,Q2,1,I,,20160608.0,20160621,20160621,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003562,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20160617.0,,CN,KR,KR,2016,Q2,Elderly
124866841,12486684,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, BID",,,,,,,20563.0,16.0,IU,INJECTION,BID,2016,Q2,Daydreaming,,2016,Q2,1,I,,20160608.0,20160621,20160621,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003562,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20160617.0,,CN,KR,KR,2016,Q2,Elderly
124866841,12486684,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, BID",,,,,,,20563.0,16.0,IU,INJECTION,BID,2016,Q2,Renal failure,,2016,Q2,1,I,,20160608.0,20160621,20160621,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003562,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20160617.0,,CN,KR,KR,2016,Q2,Elderly
124866841,12486684,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, BID",,,,,,,20563.0,16.0,IU,INJECTION,BID,2016,Q2,Swelling,,2016,Q2,1,I,,20160608.0,20160621,20160621,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003562,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20160617.0,,CN,KR,KR,2016,Q2,Elderly
124900211,12490021,11,C,lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2016,Q2,Cardio-respiratory arrest,,2016,Q2,1,I,20150909.0,20150924.0,20160622,20160622,EXP,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-1224850-2015-00054,FRESENIUS MEDICAL CARE,,57.0,YR,,M,Y,106.0,KG,20160622.0,,OT,US,US,2016,Q2,Adult
124974771,12497477,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Infection,,2016,Q2,1,I,20160527.0,20160606.0,20160624,20160624,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160624.0,,CN,CA,CA,2016,Q2,Young Adult
124974771,12497477,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Oedema peripheral,,2016,Q2,1,I,20160527.0,20160606.0,20160624,20160624,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160624.0,,CN,CA,CA,2016,Q2,Young Adult
124974771,12497477,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,,,,,,,,UNSPECIFIED,,2016,Q2,Thrombosis,,2016,Q2,1,I,20160527.0,20160606.0,20160624,20160624,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160624.0,,CN,CA,CA,2016,Q2,Young Adult
125045241,12504524,2,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2016,Q2,Chronic kidney disease,,2016,Q2,1,I,,20160622.0,20160628,20160628,EXP,,IT-GILEAD-2016-0220438,GILEAD,,58.0,YR,A,M,Y,61.0,KG,20160628.0,,MD,IT,IT,2016,Q2,Adult
125045241,12504524,2,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2016,Q2,Proteinuria,,2016,Q2,1,I,,20160622.0,20160628,20160628,EXP,,IT-GILEAD-2016-0220438,GILEAD,,58.0,YR,A,M,Y,61.0,KG,20160628.0,,MD,IT,IT,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Cardiac disorder,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Drug dose omission,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Drug hypersensitivity,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Gastric disorder,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Gastric ulcer haemorrhage,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
80379605,8037960,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-32 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2016,Q2,Off label use,,2016,Q2,5,F,20150522.0,20160615.0,20110715,20160623,EXP,,US-ASTRAZENECA-2011SE40566,ASTRAZENECA,,59.0,YR,,M,Y,,,20160623.0,,CN,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Anterior chamber flare,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Blindness,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Choroidal detachment,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Corneal abrasion,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Cytomegalovirus hepatitis,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Cytomegalovirus viraemia,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Diabetes mellitus inadequate control,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Eye inflammation,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Hyperlipidaemia,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Hypotony of eye,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Iris adhesions,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Kidney transplant rejection,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Liver function test increased,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
988025612,9880256,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q2,Uveitis,,2016,Q2,12,F,2014.0,20160429.0,20140207,20160511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20132080,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,117.9,KG,20160511.0,,OT,US,US,2016,Q2,Adult
105183913,10518391,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE:17 UNIT(S),,,,,,,,,,INJECTION,TID,2016,Q3,Nausea,,2016,Q3,3,F,2013.0,20160712.0,20141015,20160721,EXP,,US-SA-2014SA138717,AVENTIS,,79.0,YR,E,F,Y,203.0,KG,20160721.0,,CN,US,US,2016,Q3,Elderly
105183913,10518391,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE:17 UNIT(S),,,,,,,,,,INJECTION,TID,2016,Q3,Vomiting,,2016,Q3,3,F,2013.0,20160712.0,20141015,20160721,EXP,,US-SA-2014SA138717,AVENTIS,,79.0,YR,E,F,Y,203.0,KG,20160721.0,,CN,US,US,2016,Q3,Elderly
113086723,11308672,2,C,INSULIN HUMAN LISPRO,,2,Unknown,1 ACCUCHECK SUB-Q,,,,,,,,,,,,2016,Q3,Asthma,,2016,Q3,3,F,20150528.0,20150806.0,20150724,20160822,EXP,,US-ROCHE-1608947,ROCHE,,80.0,YR,,F,Y,,,20160822.0,,MD,US,US,2016,Q3,Elderly
113086723,11308672,2,C,INSULIN HUMAN LISPRO,,2,Unknown,1 ACCUCHECK SUB-Q,,,,,,,,,,,,2016,Q3,Dyspnoea,,2016,Q3,3,F,20150528.0,20150806.0,20150724,20160822,EXP,,US-ROCHE-1608947,ROCHE,,80.0,YR,,F,Y,,,20160822.0,,MD,US,US,2016,Q3,Elderly
113086723,11308672,2,C,INSULIN HUMAN LISPRO,,2,Unknown,1 ACCUCHECK SUB-Q,,,,,,,,,,,,2016,Q3,Infection,,2016,Q3,3,F,20150528.0,20150806.0,20150724,20160822,EXP,,US-ROCHE-1608947,ROCHE,,80.0,YR,,F,Y,,,20160822.0,,MD,US,US,2016,Q3,Elderly
113086723,11308672,2,C,INSULIN HUMAN LISPRO,,2,Unknown,1 ACCUCHECK SUB-Q,,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,3,F,20150528.0,20150806.0,20150724,20160822,EXP,,US-ROCHE-1608947,ROCHE,,80.0,YR,,F,Y,,,20160822.0,,MD,US,US,2016,Q3,Elderly
113086723,11308672,2,C,INSULIN HUMAN LISPRO,,2,Unknown,1 ACCUCHECK SUB-Q,,,,,,,,,,,,2016,Q3,Respiratory failure,,2016,Q3,3,F,20150528.0,20150806.0,20150724,20160822,EXP,,US-ROCHE-1608947,ROCHE,,80.0,YR,,F,Y,,,20160822.0,,MD,US,US,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Alanine aminotransferase increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Blood creatinine increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,C-reactive protein increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Malaise,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Nitrite urine present,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Proteinuria,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,Pyrexia,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"2 IU, QD",,,,,,,20563.0,2.0,IU,,QD,2016,Q3,White blood cells urine positive,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Alanine aminotransferase increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Blood creatinine increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,C-reactive protein increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Malaise,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Nitrite urine present,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Proteinuria,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,Pyrexia,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,20563.0,4.0,IU,,QD,2016,Q3,White blood cells urine positive,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Alanine aminotransferase increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Blood creatinine increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,C-reactive protein increased,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Malaise,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Nitrite urine present,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Proteinuria,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,Pyrexia,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118244072,11824407,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, QD",,,,,,,20563.0,6.0,IU,,QD,2016,Q3,White blood cells urine positive,,2016,Q3,2,F,201511.0,20160711.0,20151210,20160722,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201512000532,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20160721.0,,CN,DE,DE,2016,Q3,Elderly
118682762,11868276,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q3,Rash,Rash,2016,Q3,2,F,201511.0,20160727.0,20151224,20160821,EXP,,US-CELGENEUS-USA-2015125565,CELGENE,,72.0,YR,,M,Y,,,20160821.0,,OT,US,US,2016,Q3,Elderly
120965012,12096501,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"21 UNIT, QD",,,U,,,,,21.0,DF,,QD,2016,Q3,Renal impairment,,2016,Q3,2,F,,20160825.0,20160220,20160825,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-010417,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,,,20160825.0,,CN,JP,JP,2016,Q3,Elderly
122785622,12278562,32,C,Insulin Lispro,INSULIN LISPRO,1,Intravenous drip,,,,,,,,,10.0,IU,INJECTION,,2016,Q3,Pneumonia,,2016,Q3,2,F,20160406.0,20160725.0,20160418,20160801,PER,,US-CELGENEUS-USA-2016043307,CELGENE,,62.0,YR,,M,Y,213.38,KG,20160801.0,,MD,US,US,2016,Q3,Adult
123238783,12323878,9,C,Insulin lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,UNKNOWN,,2016,Q3,Arrhythmia,,2016,Q3,3,F,201602.0,20160803.0,20160502,20160815,EXP,,US-CELGENEUS-USA-2016045089,CELGENE,,50.0,YR,,F,Y,,,20160815.0,,OT,US,US,2016,Q3,Adult
123238783,12323878,9,C,Insulin lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,UNKNOWN,,2016,Q3,Sinusitis,,2016,Q3,3,F,201602.0,20160803.0,20160502,20160815,EXP,,US-CELGENEUS-USA-2016045089,CELGENE,,50.0,YR,,F,Y,,,20160815.0,,OT,US,US,2016,Q3,Adult
123863712,12386371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q3,Diarrhoea,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123863712,12386371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q3,Fixed drug eruption,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123863712,12386371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q3,Pain,,2016,Q3,2,F,,20160420.0,20160519,20160802,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-036605,BRISTOL MYERS SQUIBB,,56.0,YR,,F,Y,118.0,KG,20160802.0,,OT,US,US,2016,Q3,Adult
123899653,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q3,Hypercapnia,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q3,Hypoxia,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q3,Respiratory acidosis,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123899653,12389965,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q3,Sopor,,2016,Q3,3,F,20160404.0,20160811.0,20160520,20160826,EXP,,IT-PURDUE PHARMA-GBR-2016-0036271,PURDUE,,82.0,YR,,M,Y,,,20160826.0,,MD,IT,IT,2016,Q3,Elderly
123956542,12395654,21,C,INSULINUM LISPRO ISOPHANUM,,2,,,,,,,,,,,,,,2016,Q3,Disease progression,,2016,Q3,2,F,2016.0,20160629.0,20160523,20160708,EXP,,US-GILEAD-2016-0213333,GILEAD,,86.0,YR,E,M,Y,,,20160708.0,,OT,US,US,2016,Q3,Elderly
123956542,12395654,21,C,INSULINUM LISPRO ISOPHANUM,,2,,,,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,2,F,2016.0,20160629.0,20160523,20160708,EXP,,US-GILEAD-2016-0213333,GILEAD,,86.0,YR,E,M,Y,,,20160708.0,,OT,US,US,2016,Q3,Elderly
123956542,12395654,21,C,INSULINUM LISPRO ISOPHANUM,,2,,,,,,,,,,,,,,2016,Q3,Pyelonephritis,,2016,Q3,2,F,2016.0,20160629.0,20160523,20160708,EXP,,US-GILEAD-2016-0213333,GILEAD,,86.0,YR,E,M,Y,,,20160708.0,,OT,US,US,2016,Q3,Elderly
123956542,12395654,21,C,INSULINUM LISPRO ISOPHANUM,,2,,,,,,,,,,,,,,2016,Q3,Urinary tract infection,,2016,Q3,2,F,2016.0,20160629.0,20160523,20160708,EXP,,US-GILEAD-2016-0213333,GILEAD,,86.0,YR,E,M,Y,,,20160708.0,,OT,US,US,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH MORNING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, QD",,,U,U,,,,6.0,IU,,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, EACH EVENING",,,U,U,,,,4.0,IU,,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Face injury,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Hypoglycaemic coma,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Loss of consciousness,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Prothrombin time shortened,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124172432,12417243,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, QD",,,U,U,,,,14.0,IU,,QD,2016,Q3,Syncope,,2016,Q3,2,F,20140822.0,20160714.0,20160530,20160725,EXP,,IT-ELI_LILLY_AND_COMPANY-IT201605006247,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20160722.0,,CN,IT,IT,2016,Q3,Elderly
124229032,12422903,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Blood pressure decreased,,2016,Q3,2,F,20160331.0,20160712.0,20160601,20160721,PER,,PHEH2016US013464,NOVARTIS,,73.0,YR,,M,Y,92.97,KG,20160721.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
124229032,12422903,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,2,F,20160331.0,20160712.0,20160601,20160721,PER,,PHEH2016US013464,NOVARTIS,,73.0,YR,,M,Y,92.97,KG,20160721.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
124229032,12422903,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,2,F,20160331.0,20160712.0,20160601,20160721,PER,,PHEH2016US013464,NOVARTIS,,73.0,YR,,M,Y,92.97,KG,20160721.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
124229032,12422903,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Lethargy,,2016,Q3,2,F,20160331.0,20160712.0,20160601,20160721,PER,,PHEH2016US013464,NOVARTIS,,73.0,YR,,M,Y,92.97,KG,20160721.0,,CN,COUNTRY NOT SPECIFIED,US,2016,Q3,Elderly
124306422,12430642,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160506.0,20160708.0,20160602,20160716,EXP,,US-BIOGEN-2016BI00240856,BIOGEN,,40.0,YR,,F,Y,65.83,KG,20160716.0,,MD,US,US,2016,Q3,Adult
124312713,12431271,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"10 UNIT, TID",,,U,,,,,10.0,DF,,TID,2016,Q3,Brain neoplasm,,2016,Q3,3,F,20160512.0,20160726.0,20160603,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-042557,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20160803.0,,MD,US,US,2016,Q3,Elderly
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Atrial fibrillation,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Liver function test increased,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124676263,12467626,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, Q6H",,,,,,,,,,,,2016,Q3,Respiratory failure,,2016,Q3,3,F,201606.0,20160729.0,20160615,20160808,EXP,,US-UNITED THERAPEUTICS-UNT-2016-009414,UNITED THERAPEUTICS,,60.0,YR,,F,Y,,,20160808.0,,OT,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Dizziness,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Fall,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Femur fracture,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Postural orthostatic tachycardia syndrome,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Relapsing-remitting multiple sclerosis,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Tachycardia,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Treatment failure,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124690422,12469042,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4-17 UNITS BEFORE MEALS,,,,,,,,,,INJECTION,TID,2016,Q3,Urinary tract infection,,2016,Q3,2,F,20160601.0,20160722.0,20160615,20160801,EXP,,US-BIOGEN-2016BI00250002,BIOGEN,,48.0,YR,,M,Y,,,20160801.0,,MD,US,US,2016,Q3,Adult
124697082,12469708,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Cellulitis,,2016,Q3,2,F,20160523.0,20160825.0,20160615,20160831,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-046416,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,108.39,KG,20160831.0,,CN,US,US,2016,Q3,Elderly
124783613,12478361,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Cerebral infarction,,2016,Q3,3,F,20160608.0,20160706.0,20160618,20160712,EXP,,JP-ASTRAZENECA-2016SE62295,ASTRAZENECA,,21217.0,DY,,M,Y,,,20160712.0,,MD,JP,JP,2016,Q3,Elderly
124829842,12482984,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2016,Q3,Cephalo-pelvic disproportion,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2016,Q3,Exposure during breast feeding,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2016,Q3,Gestational diabetes,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"18 U, EACH MORNING",,,,,,,20563.0,18.0,IU,,QD,2016,Q3,Thyroid disorder,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2016,Q3,Cephalo-pelvic disproportion,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2016,Q3,Exposure during breast feeding,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2016,Q3,Gestational diabetes,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"8 U, EACH EVENING",,,,,,,20563.0,8.0,IU,,QD,2016,Q3,Thyroid disorder,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,,,,,20563.0,20.0,IU,,QD,2016,Q3,Cephalo-pelvic disproportion,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,,,,,20563.0,20.0,IU,,QD,2016,Q3,Exposure during breast feeding,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,,,,,20563.0,20.0,IU,,QD,2016,Q3,Gestational diabetes,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,,,,,20563.0,20.0,IU,,QD,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"20 IU, EACH MORNING",,,,,,,20563.0,20.0,IU,,QD,2016,Q3,Thyroid disorder,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"68 IU, QD",,,,,,,20563.0,68.0,IU,,QD,2016,Q3,Cephalo-pelvic disproportion,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"68 IU, QD",,,,,,,20563.0,68.0,IU,,QD,2016,Q3,Exposure during breast feeding,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"68 IU, QD",,,,,,,20563.0,68.0,IU,,QD,2016,Q3,Gestational diabetes,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"68 IU, QD",,,,,,,20563.0,68.0,IU,,QD,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"68 IU, QD",,,,,,,20563.0,68.0,IU,,QD,2016,Q3,Thyroid disorder,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"15 IU, EACH EVENING",,,,,,,20563.0,15.0,IU,,QD,2016,Q3,Cephalo-pelvic disproportion,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"15 IU, EACH EVENING",,,,,,,20563.0,15.0,IU,,QD,2016,Q3,Exposure during breast feeding,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"15 IU, EACH EVENING",,,,,,,20563.0,15.0,IU,,QD,2016,Q3,Gestational diabetes,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"15 IU, EACH EVENING",,,,,,,20563.0,15.0,IU,,QD,2016,Q3,Maternal exposure during pregnancy,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124829842,12482984,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"15 IU, EACH EVENING",,,,,,,20563.0,15.0,IU,,QD,2016,Q3,Thyroid disorder,,2016,Q3,2,F,20160129.0,20160203.0,20160620,20160824,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201602002770,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20160824.0,,CN,MX,MX,2016,Q3,Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Colitis ulcerative,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,General physical health deterioration,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Haematochezia,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Herpes zoster,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Infection,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Oedema peripheral,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Off label use,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Product use issue,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Rash,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124974774,12497477,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 TO 30 UNITS FOLLOWING SCALE,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Thrombosis,,2016,Q3,4,F,20160101.0,20160916.0,20160624,20160923,EXP,,CA-JNJFOC-20160606870,JANSSEN,,25.0,YR,A,M,Y,36.29,KG,20160923.0,,CN,CA,CA,2016,Q3,Young Adult
124997086,12499708,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, QD",,,,,,,,25.0,DF,,QD,2016,Q3,Acute kidney injury,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, QD",,,,,,,,25.0,DF,,QD,2016,Q3,Asthenia,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, QD",,,,,,,,25.0,DF,,QD,2016,Q3,Conversion disorder,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
124997086,12499708,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, QD",,,,,,,,25.0,DF,,QD,2016,Q3,Dehydration,,2016,Q3,6,F,20160613.0,20160906.0,20160627,20160916,EXP,,PHHO2016US008777,SANDOZ,,65.0,YR,,F,Y,72.6,KG,20160916.0,,OT,US,US,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypophagia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Intentional product misuse,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Nausea,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Thirst,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Vomiting,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Hypophagia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Intentional product misuse,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Nausea,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Thirst,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, EACH EVENING",,,,,,,20563.0,16.0,IU,INJECTION,QD,2016,Q3,Vomiting,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Hypophagia,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Intentional product misuse,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Nausea,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Thirst,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125307111,12530711,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2016,Q3,Vomiting,,2016,Q3,1,I,20160614.0,20160608.0,20160706,20160706,EXP,,KR-ELI_LILLY_AND_COMPANY-KR201606003546,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20160630.0,,CN,KR,KR,2016,Q3,Elderly
125364682,12536468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Acute respiratory failure,,2016,Q3,2,F,20160614.0,20160720.0,20160707,20160725,EXP,,US-GILEAD-2016-0222435,GILEAD,,81.0,YR,E,F,Y,76.0,KG,20160725.0,,CN,US,US,2016,Q3,Elderly
125364682,12536468,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dyspnoea,,2016,Q3,2,F,20160614.0,20160720.0,20160707,20160725,EXP,,US-GILEAD-2016-0222435,GILEAD,,81.0,YR,E,F,Y,76.0,KG,20160725.0,,CN,US,US,2016,Q3,Elderly
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dizziness postural,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Injury,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403251,12540325,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Stenosis,,2016,Q3,1,I,20160115.0,,20160707,20160707,DIR,,,,,60.0,YR,,M,N,100.0,KG,20160706.0,N,CN,US,,2016,Q3,Adult
125403321,12540332,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dehydration,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Nausea,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125403321,12540332,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Vomiting,,2016,Q3,1,I,20160701.0,,20160707,20160707,DIR,,,,,58.0,YR,,M,N,74.6,KG,20160706.0,N,OT,US,,2016,Q3,Adult
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Haemoglobin decreased,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Haemorrhagic anaemia,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Large intestine polyp,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Lower gastrointestinal haemorrhage,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Melaena,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125434901,12543490,21,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Rectal polyp,,2016,Q3,1,I,20160530.0,,20160708,20160708,DIR,,,,,81.0,YR,,F,N,113.4,KG,20160707.0,N,PH,US,,2016,Q3,Elderly
125524631,12552463,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q3,Injection site extravasation,,2016,Q3,1,I,20160707.0,20160707.0,20160713,20160713,PER,,US-009507513-1607USA003683,MERCK,,54.0,YR,,F,Y,,,20160713.0,,PH,US,US,2016,Q3,Adult
125528381,12552838,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Burkholderia test positive,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,General physical health deterioration,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Ischaemic hepatitis,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528381,12552838,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Shock,,2016,Q3,1,I,20160207.0,,20160712,20160712,DIR,,,,,83.0,YR,,F,N,76.0,KG,20160711.0,N,PH,US,,2016,Q3,Elderly
125528921,12552892,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, BID",,,,,,,20563.0,20.0,IU,INJECTION,BID,2016,Q3,Fall,,2016,Q3,1,I,201606.0,20160629.0,20160713,20160713,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201607000352,ELI LILLY AND CO,,56.0,YR,,F,Y,60.0,KG,20160708.0,,CN,CN,CN,2016,Q3,Adult
125528921,12552892,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, BID",,,,,,,20563.0,20.0,IU,INJECTION,BID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,201606.0,20160629.0,20160713,20160713,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201607000352,ELI LILLY AND CO,,56.0,YR,,F,Y,60.0,KG,20160708.0,,CN,CN,CN,2016,Q3,Adult
125528921,12552892,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, BID",,,,,,,20563.0,20.0,IU,INJECTION,BID,2016,Q3,Syncope,,2016,Q3,1,I,201606.0,20160629.0,20160713,20160713,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201607000352,ELI LILLY AND CO,,56.0,YR,,F,Y,60.0,KG,20160708.0,,CN,CN,CN,2016,Q3,Adult
125589861,12558986,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Diabetic ketoacidosis,,2016,Q3,1,I,20160701.0,20160713.0,20160715,20160715,EXP,,GB-JNJFOC-20160711301,JANSSEN,,40.0,YR,A,M,Y,,,20160715.0,,MD,GB,GB,2016,Q3,Adult
125589861,12558986,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2016,Q3,Vomiting,,2016,Q3,1,I,20160701.0,20160713.0,20160715,20160715,EXP,,GB-JNJFOC-20160711301,JANSSEN,,40.0,YR,A,M,Y,,,20160715.0,,MD,GB,GB,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Anaemia,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Dizziness,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125609103,12560910,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Stent placement,,2016,Q3,3,F,20160115.0,20160725.0,20160715,20160803,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-055908,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,99.1,KG,20160803.0,,CN,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Acute kidney injury,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Acute myocardial infarction,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Atrioventricular block complete,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Cardiac arrest,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Pneumonia,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125662622,12566262,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-10 IU, THRICE DAILY",,,D,U,,,,,,INJECTION,TID,2016,Q3,Sepsis,,2016,Q3,2,F,20160325.0,20160908.0,20160718,20160916,EXP,,US-ASTELLAS-2016US012317,ASTELLAS,,54.0,YR,,F,Y,,,20160916.0,,MD,US,US,2016,Q3,Adult
125670562,12567056,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 U,,,,,,,,10.0,IU,,TID,2016,Q3,Diabetic ketoacidosis,,2016,Q3,2,F,20160612.0,20160815.0,20160718,20160822,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-46054BP",BOEHRINGER INGELHEIM,,37.0,YR,,F,Y,121.4,KG,20160822.0,,MD,US,US,2016,Q3,Adult
125672382,12567238,29,C,Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,QID,2016,Q3,Pneumonia,,2016,Q3,2,F,20160428.0,20160812.0,20160718,20160818,PER,,US-CELGENEUS-USA-2016073435,CELGENE,,72.0,YR,,F,Y,71.4,KG,20160818.0,,OT,US,US,2016,Q3,Elderly
125683192,12568319,43,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,QID,2016,Q3,Pneumonia pseudomonal,,2016,Q3,2,F,20160703.0,20160817.0,20160718,20160824,PER,,US-CELGENEUS-USA-2016073675,CELGENE,,73.0,YR,,F,Y,74.9,KG,20160824.0,,OT,US,US,2016,Q3,Elderly
125683192,12568319,44,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,IU,INJECTION,TID,2016,Q3,Pneumonia pseudomonal,,2016,Q3,2,F,20160703.0,20160817.0,20160718,20160824,PER,,US-CELGENEUS-USA-2016073675,CELGENE,,73.0,YR,,F,Y,74.9,KG,20160824.0,,OT,US,US,2016,Q3,Elderly
125687161,12568716,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Pancreatitis,,2016,Q3,1,I,20160715.0,,20160718,20160718,DIR,,,,,58.0,YR,,M,N,128.0,KG,20160716.0,N,MD,US,,2016,Q3,Adult
125692011,12569201,8,C,INSULIN LISPRO (HUMALOG KWIKPEN),,2,,,,,,,,,,,,,,2016,Q3,Enterococcus test positive,,2016,Q3,1,I,20160704.0,,20160718,20160718,DIR,,,,,69.0,YR,,F,N,,,20160715.0,Y,PH,US,,2016,Q3,Elderly
125692011,12569201,8,C,INSULIN LISPRO (HUMALOG KWIKPEN),,2,,,,,,,,,,,,,,2016,Q3,Proteus test positive,,2016,Q3,1,I,20160704.0,,20160718,20160718,DIR,,,,,69.0,YR,,F,N,,,20160715.0,Y,PH,US,,2016,Q3,Elderly
125692011,12569201,8,C,INSULIN LISPRO (HUMALOG KWIKPEN),,2,,,,,,,,,,,,,,2016,Q3,Urinary tract infection,,2016,Q3,1,I,20160704.0,,20160718,20160718,DIR,,,,,69.0,YR,,F,N,,,20160715.0,Y,PH,US,,2016,Q3,Elderly
125966502,12596650,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Blood glucose abnormal,,2016,Q3,2,F,,20160803.0,20160726,20160811,PER,,BR-SA-2016SA133322,AVENTIS,,59.0,YR,A,M,Y,,,20160811.0,,OT,BR,BR,2016,Q3,Adult
125966502,12596650,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,2,F,,20160803.0,20160726,20160811,PER,,BR-SA-2016SA133322,AVENTIS,,59.0,YR,A,M,Y,,,20160811.0,,OT,BR,BR,2016,Q3,Adult
126003511,12600351,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2016,Q3,Basal ganglia haemorrhage,,2016,Q3,1,I,20141106.0,20160721.0,20160727,20160727,EXP,,PHHY2016ES101761,SANDOZ,,66.0,YR,,M,Y,,,20160727.0,,OT,ES,ES,2016,Q3,Elderly
126047231,12604723,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, BID",,,,, C521572F,,20563.0,24.0,IU,INJECTION,BID,2016,Q3,Blister,,2016,Q3,1,I,20160701.0,20160715.0,20160728,20160728,PER,,US-ELI_LILLY_AND_COMPANY-US201607007262,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20160728.0,,CN,US,US,2016,Q3,Elderly
126047231,12604723,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, BID",,,,, C521572F,,20563.0,24.0,IU,INJECTION,BID,2016,Q3,Injury associated with device,,2016,Q3,1,I,20160701.0,20160715.0,20160728,20160728,PER,,US-ELI_LILLY_AND_COMPANY-US201607007262,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20160728.0,,CN,US,US,2016,Q3,Elderly
126047231,12604723,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"24 U, BID",,,,, C521572F,,20563.0,24.0,IU,INJECTION,BID,2016,Q3,Localised infection,,2016,Q3,1,I,20160701.0,20160715.0,20160728,20160728,PER,,US-ELI_LILLY_AND_COMPANY-US201607007262,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20160728.0,,CN,US,US,2016,Q3,Elderly
126061871,12606187,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,7-15-15,,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,7-15-15,,,,U,,,,,,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,7-14-12,,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,7-14-12,,,,U,,,,,,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,3-6-5,,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,3-6-5,,,,U,,,,,,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 UNITS WITH MEALS,,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 UNITS WITH MEALS,,,,U,,,,,,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,U,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, PRN",,,,U,,,,,,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 UNITS, PRN",,,,U,,,,3.0,DF,,,2016,Q3,Drug ineffective,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126061871,12606187,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 UNITS, PRN",,,,U,,,,3.0,DF,,,2016,Q3,Insulin C-peptide increased,,2016,Q3,1,I,201410.0,20160720.0,20160729,20160729,PER,,US-009507513-1607USA008175,MERCK,,37.0,YR,,M,Y,,,20160729.0,,OT,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Amnesia,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Balance disorder,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Confusional state,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Crying,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Drug ineffective,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Fall,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Subdural haematoma,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126180172,12618017,11,C,LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,,,,,,,,,2016,Q3,Syncope,,2016,Q3,2,F,201606.0,20160825.0,20160803,20160902,EXP,,US-LUNDBECK-DKLU2014831,LUNDBECK,,63.0,YR,,M,Y,,,20160902.0,,MD,US,US,2016,Q3,Adult
126192282,12619228,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 U PER 50G CARBS; BEFORE MEALS AND SNACKS,,,,U,,,,,,,,2016,Q3,Infective pulmonary exacerbation of cystic fibrosis,,2016,Q3,2,F,201607.0,20160818.0,20160803,20160825,EXP,,US-VERTEX PHARMACEUTICALS-2016-004651,VERTEX,,30.0,YR,,M,Y,,,20160825.0,,CN,US,US,2016,Q3,Young Adult
126235131,12623513,11,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,.3 MILLIGRAM,,,,,,,,,,UNKNOWN,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160709.0,20160801.0,20160804,20160804,PER,,US-CELGENEUS-USA-2016080448,CELGENE,,80.0,YR,,F,Y,67.0,KG,20160804.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Bradycardia,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dehydration,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Fluid overload,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hyperkalaemia,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hypotension,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Presyncope,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126250013,12625001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Syncope,,2016,Q3,3,F,201607.0,20160817.0,20160805,20160819,EXP,,US-GILEAD-2016-0226593,GILEAD,,69.0,YR,E,M,Y,,,20160819.0,,MD,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Adverse event,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Anxiety,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Asthenia,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Cardiac disorder,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Chest pain,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Dizziness,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Myocardial infarction,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Pain,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Post procedural stroke,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126254132,12625413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-14 UNITS, AS NEEDED.",,,,,,,,,,INJECTION,,2016,Q3,Visual impairment,,2016,Q3,2,F,201606.0,20160818.0,20160805,20160829,EXP,,US-ASTRAZENECA-2016SE82707,ASTRAZENECA,,615.0,MON,,F,Y,88.5,KG,20160827.0,,,US,US,2016,Q3,Elderly
126257221,12625722,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Blood creatinine increased,,2016,Q3,1,I,20160423.0,,20160804,20160804,DIR,,,,,55.0,YR,,F,N,116.3,KG,20160803.0,N,PH,US,,2016,Q3,Adult
126257221,12625722,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Renal injury,,2016,Q3,1,I,20160423.0,,20160804,20160804,DIR,,,,,55.0,YR,,F,N,116.3,KG,20160803.0,N,PH,US,,2016,Q3,Adult
126272511,12627251,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,,, C541979D,,20563.0,,,INJECTION,,2016,Q3,Blood glucose abnormal,,2016,Q3,1,I,20160731.0,20160801.0,20160805,20160805,PER,,US-ELI_LILLY_AND_COMPANY-US201608002124,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20160805.0,,CN,US,US,2016,Q3,Elderly
126272511,12627251,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,,, C541979D,,20563.0,,,INJECTION,,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,20160731.0,20160801.0,20160805,20160805,PER,,US-ELI_LILLY_AND_COMPANY-US201608002124,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20160805.0,,CN,US,US,2016,Q3,Elderly
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Acute myocardial infarction,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Atrioventricular block complete,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Cardiac arrest,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Pneumonia,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126408181,12640818,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2016,Q3,Sepsis,,2016,Q3,1,I,20160325.0,20160802.0,20160810,20160810,EXP,,US-ENDO PHARMACEUTICALS INC.-2016-004945,ENDO,,54.0,YR,,F,Y,91.0,KG,20160810.0,,MD,US,US,2016,Q3,Adult
126460811,12646081,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C536019D,,,,,INJECTION,,2016,Q3,Intercepted product selection error,,2016,Q3,1,I,20160711.0,20160808.0,20160811,20160811,PER,,US-ELI_LILLY_AND_COMPANY-US201608005737,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20160811.0,,CN,US,US,2016,Q3,Adult
126461401,12646140,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2016,Q3,Haemorrhage intracranial,,2016,Q3,1,I,20150924.0,20160719.0,20160811,20160811,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-066494,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
126461401,12646140,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2016,Q3,Packed red blood cell transfusion,,2016,Q3,1,I,20150924.0,20160719.0,20160811,20160811,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-066494,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,,,20160811.0,,OT,US,US,2016,Q3,Elderly
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Benign prostatic hyperplasia,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Erythema,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Graft versus host disease in skin,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Hypomagnesaemia,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Iron deficiency,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Papule,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Pruritus,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Rash,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Rash maculo-papular,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Skin hyperpigmentation,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Vomiting,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126477111,12647711,29,C,LISPRO,INSULIN LISPRO,1,,SLIDING SCALE MODERATE CORRECTION INSULIN WITH EACH MEAL,,,,,,,,,,,,2016,Q3,Weight decreased,,2016,Q3,1,I,20160614.0,20160513.0,20160812,20160812,EXP,,US-INCYTE CORPORATION-2016IN002880,INCYTE,,63.0,YR,,M,Y,75.6,KG,20160812.0,,CN,US,US,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Apraxia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Atrophy,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Cognitive disorder,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Dementia Alzheimer's type,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemic seizure,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126484731,12648473,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Intentional product misuse,,2016,Q3,1,I,2009.0,20160729.0,20160812,20160812,EXP,,GB-SA-2016SA140920,AVENTIS,"CRABTREE T, ALTAAN S, TARIK A. EARLY-ONSET DEMENTIA IN TYPE 1 DIABETES MELLITUS. PRACTICAL DIABETES 2016;33(4):133-4.",48.0,YR,A,M,Y,,,20160812.0,,OT,GB,GB,2016,Q3,Adult
126506111,12650611,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,1,I,20150209.0,20150212.0,20160815,20160815,EXP,,US-ROCHE-1538098,ROCHE,,71.0,YR,,M,Y,101.0,KG,20160815.0,,MD,US,US,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Blood glucose abnormal,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Eye swelling,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Laceration,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Loss of consciousness,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Pain,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126548761,12654876,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,1,I,20160616.0,20160808.0,20160816,20160816,EXP,,CA-AMGEN-CANSP2016102966,AMGEN,,85.0,YR,E,F,Y,,,20160816.0,,MD,CA,CA,2016,Q3,Elderly
126627971,12662797,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2016,Q3,Treatment failure,,2016,Q3,1,I,,20160803.0,20160818,20160818,EXP,,US-APOTEX-2016AP010486,APOTEX,"KAUFMAN MB, PHAM T, PARAMESWARAN L, CHOY M. PRASUGREL HYPERSENSITIVITY WITH RESPIRATORY DISTRESS AND RASH. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(14):1051-1057",61.0,YR,,F,Y,97.0,KG,20160818.0,,PH,US,US,2016,Q3,Adult
126627971,12662797,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2016,Q3,Vascular stent thrombosis,,2016,Q3,1,I,,20160803.0,20160818,20160818,EXP,,US-APOTEX-2016AP010486,APOTEX,"KAUFMAN MB, PHAM T, PARAMESWARAN L, CHOY M. PRASUGREL HYPERSENSITIVITY WITH RESPIRATORY DISTRESS AND RASH. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(14):1051-1057",61.0,YR,,F,Y,97.0,KG,20160818.0,,PH,US,US,2016,Q3,Adult
126651864,12665186,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"34 IU, 3X/DAY",,,,,,,,34.0,IU,,TID,2016,Q3,Bursitis,,2016,Q3,4,F,20160616.0,20160908.0,20160818,20160914,EXP,,DE-PFIZER INC-2016349456,PFIZER,,65.0,YR,,M,Y,,,20160914.0,,OT,DE,DE,2016,Q3,Elderly
126651864,12665186,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"34 IU, 3X/DAY",,,,,,,,34.0,IU,,TID,2016,Q3,Nephropathy,,2016,Q3,4,F,20160616.0,20160908.0,20160818,20160914,EXP,,DE-PFIZER INC-2016349456,PFIZER,,65.0,YR,,M,Y,,,20160914.0,,OT,DE,DE,2016,Q3,Elderly
126652622,12665262,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 UNIT, TID",,,,,,,,,,,TID,2016,Q3,Intervertebral disc degeneration,,2016,Q3,2,F,20160719.0,20160824.0,20160818,20160830,EXP,,US-AMGEN-USACT2016105684,AMGEN,,66.0,YR,E,F,Y,75.29,KG,20160830.0,,OT,US,US,2016,Q3,Elderly
126652622,12665262,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 UNIT, TID",,,,,,,,,,,TID,2016,Q3,Intervertebral disc protrusion,,2016,Q3,2,F,20160719.0,20160824.0,20160818,20160830,EXP,,US-AMGEN-USACT2016105684,AMGEN,,66.0,YR,E,F,Y,75.29,KG,20160830.0,,OT,US,US,2016,Q3,Elderly
126652622,12665262,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 UNIT, TID",,,,,,,,,,,TID,2016,Q3,Vertebral foraminal stenosis,,2016,Q3,2,F,20160719.0,20160824.0,20160818,20160830,EXP,,US-AMGEN-USACT2016105684,AMGEN,,66.0,YR,E,F,Y,75.29,KG,20160830.0,,OT,US,US,2016,Q3,Elderly
126662241,12666224,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Hypoglycaemic coma,,2016,Q3,1,I,20160808.0,20160810.0,20160818,20160818,EXP,,JP-ASTRAZENECA-2016SE86515,ASTRAZENECA,,19647.0,DY,,F,Y,,,20160819.0,,MD,JP,JP,2016,Q3,Elderly
126664172,12666417,8,C,Humalog/ insulin lispro,,2,Unknown,,,,,,,,,,,,,2016,Q3,Anaemia,,2016,Q3,2,F,20160727.0,20160829.0,20160818,20160921,EXP,IT-MINISAL02-371221,IT-FRI-1000086880,FOREST,,77.0,YR,,F,Y,,,20160921.0,,OT,DK,IT,2016,Q3,Elderly
126664172,12666417,8,C,Humalog/ insulin lispro,,2,Unknown,,,,,,,,,,,,,2016,Q3,Drug interaction,,2016,Q3,2,F,20160727.0,20160829.0,20160818,20160921,EXP,IT-MINISAL02-371221,IT-FRI-1000086880,FOREST,,77.0,YR,,F,Y,,,20160921.0,,OT,DK,IT,2016,Q3,Elderly
126664172,12666417,8,C,Humalog/ insulin lispro,,2,Unknown,,,,,,,,,,,,,2016,Q3,Peritoneal haemorrhage,,2016,Q3,2,F,20160727.0,20160829.0,20160818,20160921,EXP,IT-MINISAL02-371221,IT-FRI-1000086880,FOREST,,77.0,YR,,F,Y,,,20160921.0,,OT,DK,IT,2016,Q3,Elderly
126664172,12666417,8,C,Humalog/ insulin lispro,,2,Unknown,,,,,,,,,,,,,2016,Q3,Spontaneous haematoma,,2016,Q3,2,F,20160727.0,20160829.0,20160818,20160921,EXP,IT-MINISAL02-371221,IT-FRI-1000086880,FOREST,,77.0,YR,,F,Y,,,20160921.0,,OT,DK,IT,2016,Q3,Elderly
126667121,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Bile duct obstruction,,2016,Q3,1,I,20151114.0,20160125.0,20160819,20160819,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,WESTWARD,,59.0,YR,,M,Y,69.0,KG,20160818.0,,MD,US,US,2016,Q3,Adult
126667121,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Blood bilirubin increased,,2016,Q3,1,I,20151114.0,20160125.0,20160819,20160819,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,WESTWARD,,59.0,YR,,M,Y,69.0,KG,20160818.0,,MD,US,US,2016,Q3,Adult
126667121,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Hyperglycaemia,,2016,Q3,1,I,20151114.0,20160125.0,20160819,20160819,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,WESTWARD,,59.0,YR,,M,Y,69.0,KG,20160818.0,,MD,US,US,2016,Q3,Adult
126685262,12668526,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,15 UNITS THREE TIMES A DAY,,,,,,,,,,,,2016,Q3,Posterior reversible encephalopathy syndrome,,2016,Q3,2,F,201608.0,20160825.0,20160819,20160901,EXP,,CA-ASTRAZENECA-2016SE87586,ASTRAZENECA,,72.0,YR,,M,Y,,,20160902.0,,PH,CA,CA,2016,Q3,Elderly
126761621,12676162,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-7 UNITS, 3X/DAY (WITH MEALS)",,,,,,,,,,,TID,2016,Q3,Cardiac disorder,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-7 UNITS, 3X/DAY (WITH MEALS)",,,,,,,,,,,TID,2016,Q3,Chest pain,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-7 UNITS, 3X/DAY (WITH MEALS)",,,,,,,,,,,TID,2016,Q3,Drug tolerance decreased,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126761621,12676162,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-7 UNITS, 3X/DAY (WITH MEALS)",,,,,,,,,,,TID,2016,Q3,Feeding disorder,,2016,Q3,1,I,,20160608.0,20160823,20160823,EXP,,US-PFIZER INC-2016295775,PFIZER,,58.0,YR,,F,Y,73.1,KG,20160823.0,,OT,US,US,2016,Q3,Adult
126781572,12678157,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Oral,100 U / ML-AS SCHEDULED,,,,,,,,,,,,2016,Q3,Bacterial sepsis,,2016,Q3,2,F,201412.0,20160901.0,20160823,20160908,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20160908.0,,CN,COUNTRY NOT SPECIFIED,NL,2016,Q3,Elderly
126781572,12678157,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Oral,100 U / ML-AS SCHEDULED,,,,,,,,,,,,2016,Q3,Fatigue,,2016,Q3,2,F,201412.0,20160901.0,20160823,20160908,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20160908.0,,CN,COUNTRY NOT SPECIFIED,NL,2016,Q3,Elderly
126781572,12678157,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Oral,100 U / ML-AS SCHEDULED,,,,,,,,,,,,2016,Q3,Hot flush,,2016,Q3,2,F,201412.0,20160901.0,20160823,20160908,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20160908.0,,CN,COUNTRY NOT SPECIFIED,NL,2016,Q3,Elderly
126781572,12678157,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Oral,100 U / ML-AS SCHEDULED,,,,,,,,,,,,2016,Q3,Prostatic specific antigen increased,,2016,Q3,2,F,201412.0,20160901.0,20160823,20160908,EXP,,NL-ABBVIE-16P-114-1707289-00,ABBVIE,,66.0,YR,,M,Y,94.0,KG,20160908.0,,CN,COUNTRY NOT SPECIFIED,NL,2016,Q3,Elderly
126837361,12683736,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Cardiac failure congestive,,2016,Q3,1,I,20160818.0,,20160824,20160824,DIR,,,,,59.0,YR,,F,N,112.6,KG,20160823.0,N,CN,US,,2016,Q3,Adult
126837361,12683736,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20160818.0,,20160824,20160824,DIR,,,,,59.0,YR,,F,N,112.6,KG,20160823.0,N,CN,US,,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Foot fracture,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercholesterolaemia,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Nightmare,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Osteoporosis,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126853533,12685353,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Vitamin D deficiency,,2016,Q3,3,F,20140810.0,20160901.0,20160825,20160908,EXP,,IT-GILEAD-2016-0230054,GILEAD,,51.0,YR,A,F,Y,48.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Blood alkaline phosphatase increased,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Foot fracture,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercholesterolaemia,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Nightmare,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Osteoporosis,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Traumatic fracture,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126894802,12689480,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Vitamin D deficiency,,2016,Q3,2,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-GLAXOSMITHKLINE-IT2016123953,GLAXOSMITHKLINE,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Blood alkaline phosphatase increased,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Foot fracture,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercholesterolaemia,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Nightmare,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Osteoporosis,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Traumatic fracture,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126896143,12689614,12,SS,LISPRO-INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Vitamin D deficiency,,2016,Q3,3,F,20140810.0,20160901.0,20160826,20160909,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016123953,VIIV,,51.0,YR,,F,Y,48.0,KG,20160909.0,,MD,IT,IT,2016,Q3,Adult
126973241,12697324,11,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Fall,,2016,Q3,1,I,20160722.0,,20160829,20160829,DIR,,,,,84.0,YR,,F,N,54.9,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973241,12697324,11,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Haematoma,,2016,Q3,1,I,20160722.0,,20160829,20160829,DIR,,,,,84.0,YR,,F,N,54.9,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973241,12697324,11,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,International normalised ratio increased,,2016,Q3,1,I,20160722.0,,20160829,20160829,DIR,,,,,84.0,YR,,F,N,54.9,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973241,12697324,11,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Multiple injuries,,2016,Q3,1,I,20160722.0,,20160829,20160829,DIR,,,,,84.0,YR,,F,N,54.9,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973571,12697357,7,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Bacteraemia,,2016,Q3,1,I,20160714.0,,20160829,20160829,DIR,,,,,75.0,YR,,M,N,81.5,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973571,12697357,7,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Cerebral haematoma,,2016,Q3,1,I,20160714.0,,20160829,20160829,DIR,,,,,75.0,YR,,M,N,81.5,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973571,12697357,7,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Fall,,2016,Q3,1,I,20160714.0,,20160829,20160829,DIR,,,,,75.0,YR,,M,N,81.5,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126973571,12697357,7,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Unresponsive to stimuli,,2016,Q3,1,I,20160714.0,,20160829,20160829,DIR,,,,,75.0,YR,,M,N,81.5,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126978951,12697895,20,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Constipation,,2016,Q3,1,I,20160704.0,,20160829,20160829,DIR,,,,,79.0,YR,,M,N,70.7,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126978951,12697895,20,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Haemoglobin decreased,,2016,Q3,1,I,20160704.0,,20160829,20160829,DIR,,,,,79.0,YR,,M,N,70.7,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126978951,12697895,20,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Haemorrhoids,,2016,Q3,1,I,20160704.0,,20160829,20160829,DIR,,,,,79.0,YR,,M,N,70.7,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126978951,12697895,20,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Rectal haemorrhage,,2016,Q3,1,I,20160704.0,,20160829,20160829,DIR,,,,,79.0,YR,,M,N,70.7,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
126978951,12697895,20,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Ulcer,,2016,Q3,1,I,20160704.0,,20160829,20160829,DIR,,,,,79.0,YR,,M,N,70.7,KG,20160827.0,N,PH,US,,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Acute kidney injury,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Dyspnoea exertional,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Hypoxia,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Peripheral swelling,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Pneumonia,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Pulmonary hypertension,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127021492,12702149,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2-12 UNITS, QID WITH MEALS",,,,,,,,,,,,2016,Q3,Sepsis,,2016,Q3,2,F,201606.0,20160901.0,20160831,20160909,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013636,UNITED THERAPEUTICS,,71.0,YR,,M,Y,47.98,KG,20160909.0,,OT,US,US,2016,Q3,Elderly
127040512,12704051,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS BEFORE DINNER,,,,,,,,,,,,2016,Q3,Lung disorder,,2016,Q3,2,F,20160726.0,20160909.0,20160831,20160914,EXP,,US-GILEAD-2016-0230907,GILEAD,,35.0,YR,A,F,Y,67.4,KG,20160914.0,,CN,US,US,2016,Q3,Adult
127150541,12715054,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, TID",,,,,,,20563.0,10.0,IU,INJECTION,TID,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,20160828.0,20160829.0,20160905,20160905,PER,,US-ELI_LILLY_AND_COMPANY-US201608014445,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20160905.0,,CN,US,US,2016,Q3,Adult
127150541,12715054,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, TID",,,,, C553553E,,20563.0,10.0,IU,INJECTION,TID,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,20160828.0,20160829.0,20160905,20160905,PER,,US-ELI_LILLY_AND_COMPANY-US201608014445,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20160905.0,,CN,US,US,2016,Q3,Adult
127150781,12715078,1,PS,Insulin Lispro,INSULIN LISPRO,1,,ON SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160829.0,20160829.0,20160905,20160905,PER,,US-ELI_LILLY_AND_COMPANY-US201608013796,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20160905.0,,CN,US,US,2016,Q3,Adult
127150781,12715078,2,SS,Insulin Lispro,INSULIN LISPRO,1,,ON SLIDING SCALE,,,,, C376085A,,20563.0,,,INJECTION,,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20160829.0,20160829.0,20160905,20160905,PER,,US-ELI_LILLY_AND_COMPANY-US201608013796,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20160905.0,,CN,US,US,2016,Q3,Adult
127152281,12715228,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,AC (BEFORE MEAL),,,,,,,,,,,TID,2016,Q3,Drug-induced liver injury,,2016,Q3,1,I,,20150908.0,20160906,20160906,PER,,US-LUPIN PHARMACEUTICALS INC.-2015-02866,LUPIN,HAMMERSTROM A. POSSIBLE AMLODIPINE-INDUCED HEPATOTOXICITY AFTER STEM CELL TRANSPLANT. ANNALS OF PHARMACOTHERAPY. 2014;1-5.,34.0,YR,,M,Y,105.0,KG,20160906.0,,OT,US,US,2016,Q3,Young Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Foot fracture,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercholesterolaemia,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Nightmare,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Osteoporosis,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127172252,12717225,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Vitamin D deficiency,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-GLAXOSMITHKLINE-IT2016GSK124581,GLAXOSMITHKLINE,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Depression,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Diabetes mellitus,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Foot fracture,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypercholesterolaemia,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Hypertension,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Insomnia,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Nightmare,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Osteoporosis,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127182362,12718236,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q3,Vitamin D deficiency,,2016,Q3,2,F,201408.0,20160830.0,20160906,20160908,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2016GSK124581,VIIV,,53.0,YR,,F,Y,50.0,KG,20160908.0,,MD,IT,IT,2016,Q3,Adult
127282871,12728287,12,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Hepatic encephalopathy,,2016,Q3,1,I,20151122.0,,20160907,20160907,DIR,US-FDA-349967,,FDA-CTU,,14.0,YR,,M,N,50.7,KG,20160907.0,N,MD,US,US,2016,Q3,Youth
127282871,12728287,12,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Hyperammonaemia,,2016,Q3,1,I,20151122.0,,20160907,20160907,DIR,US-FDA-349967,,FDA-CTU,,14.0,YR,,M,N,50.7,KG,20160907.0,N,MD,US,US,2016,Q3,Youth
127282871,12728287,14,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Hepatic encephalopathy,,2016,Q3,1,I,20151122.0,,20160907,20160907,DIR,US-FDA-349967,,FDA-CTU,,14.0,YR,,M,N,50.7,KG,20160907.0,N,MD,US,US,2016,Q3,Youth
127282871,12728287,14,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2016,Q3,Hyperammonaemia,,2016,Q3,1,I,20151122.0,,20160907,20160907,DIR,US-FDA-349967,,FDA-CTU,,14.0,YR,,M,N,50.7,KG,20160907.0,N,MD,US,US,2016,Q3,Youth
127304301,12730430,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2016,Q3,Hyperkalaemia,,2016,Q3,1,I,20160823.0,20160826.0,20160909,20160909,EXP,,JP-ABBVIE-16P-087-1717727-00,ABBVIE,,77.0,YR,,M,Y,,,20160909.0,,MD,JP,JP,2016,Q3,Elderly
127349872,12734987,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Coagulopathy,,2016,Q3,2,F,201407.0,20160907.0,20160912,20160921,PER,,US-JNJFOC-20160709248,JANSSEN,,36.0,YR,A,F,Y,,,20160921.0,,CN,US,US,2016,Q3,Adult
127349872,12734987,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Rectal haemorrhage,,2016,Q3,2,F,201407.0,20160907.0,20160912,20160921,PER,,US-JNJFOC-20160709248,JANSSEN,,36.0,YR,A,F,Y,,,20160921.0,,CN,US,US,2016,Q3,Adult
127349872,12734987,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Upper gastrointestinal haemorrhage,,2016,Q3,2,F,201407.0,20160907.0,20160912,20160921,PER,,US-JNJFOC-20160709248,JANSSEN,,36.0,YR,A,F,Y,,,20160921.0,,CN,US,US,2016,Q3,Adult
127349872,12734987,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2016,Q3,Vaginal haemorrhage,,2016,Q3,2,F,201407.0,20160907.0,20160912,20160921,PER,,US-JNJFOC-20160709248,JANSSEN,,36.0,YR,A,F,Y,,,20160921.0,,CN,US,US,2016,Q3,Adult
127437262,12743726,10,C,Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q3,Diarrhoea,,2016,Q3,2,F,20160905.0,20160921.0,20160914,20160928,PER,,US-CELGENEUS-USA-2016091809,CELGENE,,73.0,YR,,F,Y,68.9,KG,20160928.0,,MD,US,US,2016,Q3,Elderly
127501051,12750105,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,EVERY MEAL,,,,,,,,,,,,2016,Q3,Vitrectomy,,2016,Q3,1,I,20160910.0,20160913.0,20160915,20160915,EXP,,CO-ABBVIE-16P-036-1728192-00,ABBVIE,,42.0,YR,,M,Y,63.0,KG,20160915.0,,CN,COUNTRY NOT SPECIFIED,CO,2016,Q3,Adult
127584061,12758406,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Blood testosterone abnormal,,2016,Q3,1,I,20160823.0,,20160917,20160917,DIR,US-FDA-350871,,FDA-CTU,,41.0,YR,,M,N,121.5,KG,20160917.0,N,,US,US,2016,Q3,Adult
127584061,12758406,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q3,Product substitution issue,,2016,Q3,1,I,20160823.0,,20160917,20160917,DIR,US-FDA-350871,,FDA-CTU,,41.0,YR,,M,N,121.5,KG,20160917.0,N,,US,US,2016,Q3,Adult
127706111,12770611,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2016,Q3,Diarrhoea,,2016,Q3,1,I,20120212.0,20160914.0,20160922,20160922,EXP,,PE-ELI_LILLY_AND_COMPANY-PE201609005628,ELI LILLY AND CO,,85.0,YR,,F,Y,55.0,KG,20160920.0,,CN,PE,PE,2016,Q3,Elderly
127706111,12770611,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2016,Q3,Haemoglobin decreased,,2016,Q3,1,I,20120212.0,20160914.0,20160922,20160922,EXP,,PE-ELI_LILLY_AND_COMPANY-PE201609005628,ELI LILLY AND CO,,85.0,YR,,F,Y,55.0,KG,20160920.0,,CN,PE,PE,2016,Q3,Elderly
127706111,12770611,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20120212.0,20160914.0,20160922,20160922,EXP,,PE-ELI_LILLY_AND_COMPANY-PE201609005628,ELI LILLY AND CO,,85.0,YR,,F,Y,55.0,KG,20160920.0,,CN,PE,PE,2016,Q3,Elderly
127706111,12770611,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2016,Q3,Mental status changes,,2016,Q3,1,I,20120212.0,20160914.0,20160922,20160922,EXP,,PE-ELI_LILLY_AND_COMPANY-PE201609005628,ELI LILLY AND CO,,85.0,YR,,F,Y,55.0,KG,20160920.0,,CN,PE,PE,2016,Q3,Elderly
127706111,12770611,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2016,Q3,Pneumonia,,2016,Q3,1,I,20120212.0,20160914.0,20160922,20160922,EXP,,PE-ELI_LILLY_AND_COMPANY-PE201609005628,ELI LILLY AND CO,,85.0,YR,,F,Y,55.0,KG,20160920.0,,CN,PE,PE,2016,Q3,Elderly
127769491,12776949,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,,,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,,,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Dizziness,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,,,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Drug dose omission,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,,,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,,,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Visual impairment,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C594435F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C594435F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Dizziness,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C594435F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Drug dose omission,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C594435F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C594435F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Visual impairment,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C563059F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Blood glucose increased,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C563059F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Dizziness,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C563059F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Drug dose omission,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C563059F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Incorrect dose administered,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127769491,12776949,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, QID",,,,, C563059F,,20563.0,12.0,IU,INJECTION,QID,2016,Q3,Visual impairment,,2016,Q3,1,I,2014.0,20160919.0,20160923,20160923,PER,,US-ELI_LILLY_AND_COMPANY-US201609007437,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20160923.0,,CN,US,US,2016,Q3,Adult
127810791,12781079,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Drug dose omission,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypoaesthesia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U,,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Weight loss poor,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH MORNING",,,U,U,,,20563.0,30.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH MORNING",,,U,U,,,20563.0,30.0,IU,INJECTION,QD,2016,Q3,Drug dose omission,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH MORNING",,,U,U,,,20563.0,30.0,IU,INJECTION,QD,2016,Q3,Hypoaesthesia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH MORNING",,,U,U,,,20563.0,30.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 U, EACH MORNING",,,U,U,,,20563.0,30.0,IU,INJECTION,QD,2016,Q3,Weight loss poor,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U, C509939,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U, C509939,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Drug dose omission,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U, C509939,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypoaesthesia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U, C509939,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,U,U, C509939,,20563.0,20.0,IU,INJECTION,QD,2016,Q3,Weight loss poor,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,U,U, C509939,,20563.0,15.0,IU,INJECTION,QD,2016,Q3,Asthenia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,U,U, C509939,,20563.0,15.0,IU,INJECTION,QD,2016,Q3,Drug dose omission,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,U,U, C509939,,20563.0,15.0,IU,INJECTION,QD,2016,Q3,Hypoaesthesia,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,U,U, C509939,,20563.0,15.0,IU,INJECTION,QD,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127810791,12781079,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,U,U, C509939,,20563.0,15.0,IU,INJECTION,QD,2016,Q3,Weight loss poor,,2016,Q3,1,I,201604.0,20160913.0,20160926,20160926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201609005013,ELI LILLY AND CO,,75.0,YR,,F,Y,90.0,KG,20160919.0,,CN,CN,CN,2016,Q3,Elderly
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Blood glucose decreased,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Drug ineffective,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Feeling abnormal,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemic coma,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Injection site necrosis,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Neuropathy peripheral,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,,,,,100.0,IU,INJECTION,TID,2016,Q3,Somnolence,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Blood glucose decreased,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Blood glucose increased,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Drug ineffective,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Feeling abnormal,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemic coma,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Hypoglycaemic unconsciousness,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Injection site necrosis,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Neuropathy peripheral,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127885471,12788547,5,SS,Insulin Lispro,INSULIN LISPRO,1,,"100 U, TID",,,,, C567919C,,,100.0,IU,INJECTION,TID,2016,Q3,Somnolence,,2016,Q3,1,I,20140415.0,20160914.0,20160928,20160928,EXP,,US-ELI_LILLY_AND_COMPANY-US201609006098,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20160926.0,,CN,US,US,2016,Q3,Adult
127896831,12789683,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,TID,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,TID,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,TID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,TID,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,TID,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH AND DINNER DOSE:4 UNIT(S),,,Y,, UNKNOWN,,,,,INJECTION,BID,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH AND DINNER DOSE:4 UNIT(S),,,Y,, UNKNOWN,,,,,INJECTION,BID,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH AND DINNER DOSE:4 UNIT(S),,,Y,, UNKNOWN,,,,,INJECTION,BID,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH AND DINNER DOSE:4 UNIT(S),,,Y,, UNKNOWN,,,,,INJECTION,BID,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,BEFORE LUNCH AND DINNER DOSE:4 UNIT(S),,,Y,, UNKNOWN,,,,,INJECTION,BID,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,,2016,Q3,Diabetic retinal oedema,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,,2016,Q3,Diabetic retinopathy,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,,2016,Q3,Hypoglycaemia,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,,2016,Q3,Visual acuity reduced,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127896831,12789683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4-6 U,,,Y,, UNKNOWN,,,,,INJECTION,,2016,Q3,Weight increased,,2016,Q3,1,I,2014.0,20160916.0,20160928,20160928,EXP,,RU-SA-2016SA174765,AVENTIS,"OVSYANNIKOVA AK, RYMAR OD, SHAKHTSHNEIDER EV, KLIMONTOV VV, KOROLEVA EA, MYAKINA NE, ET AL. ABCC8-RELATED MATURITY-ONSET DIABETES OF THE YOUNG (MODY12): CLINICAL FEATURES AND TREATMENT PERSPECTIVE. DIABETES THER. 2016;7:591-600. DOI: 10.1007/S13300-016-0192-9. ACCESSED: 2016 AUG 18.",27.0,YR,A,M,Y,,,20160928.0,,OT,RU,RU,2016,Q3,Young Adult
127912801,12791280,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 + 20 + 20 IU,,,U,U,,,,,,,,2016,Q3,Glycosylated haemoglobin increased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11941,AUROBINDO,GANDOLFO.M. UNA SFIDA TERAPEUTICA RISOLTA GRAZIE A DAPAGLIFOZIN. 2016;78,62.0,YR,,M,Y,,,20160929.0,,OT,IT,IT,2016,Q3,Adult
127912801,12791280,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 + 20 + 20 IU,,,U,U,,,,,,,,2016,Q3,Weight increased,,2016,Q3,1,I,,20160914.0,20160929,20160929,EXP,,IT-AUROBINDO-AUR-APL-2016-11941,AUROBINDO,GANDOLFO.M. UNA SFIDA TERAPEUTICA RISOLTA GRAZIE A DAPAGLIFOZIN. 2016;78,62.0,YR,,M,Y,,,20160929.0,,OT,IT,IT,2016,Q3,Adult
127988781,12798878,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 UNITS. BEFORE MEALS AND AT BEDTIME.,,,,,,,,,,,,2016,Q3,Constipation,,2016,Q3,1,I,20160703.0,20160703.0,20160930,20160930,PER,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1607-000400,FRESENIUS MEDICAL CARE,,66.0,YR,,M,Y,115.2,KG,20160930.0,,OT,US,US,2016,Q3,Elderly
127988781,12798878,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 UNITS. BEFORE MEALS AND AT BEDTIME.,,,,,,,,,,,,2016,Q3,Peritonitis,,2016,Q3,1,I,20160703.0,20160703.0,20160930,20160930,PER,,US-FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP-FMC-1607-000400,FRESENIUS MEDICAL CARE,,66.0,YR,,M,Y,115.2,KG,20160930.0,,OT,US,US,2016,Q3,Elderly
127993911,12799391,6,C,LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Face oedema,,2016,Q3,1,I,20160904.0,20160907.0,20160930,20160930,EXP,,US-BAXTER-2016BAX047285,BAXTER,,59.0,YR,,M,Y,79.7,KG,20160930.0,,CN,US,US,2016,Q3,Adult
127993911,12799391,6,C,LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q3,Hypoglycaemic seizure,,2016,Q3,1,I,20160904.0,20160907.0,20160930,20160930,EXP,,US-BAXTER-2016BAX047285,BAXTER,,59.0,YR,,M,Y,79.7,KG,20160930.0,,CN,US,US,2016,Q3,Adult
127993911,12799391,7,C,LISPRO,INSULIN LISPRO,1,Unknown,2 UNITS,,,,,,,,,,,,2016,Q3,Face oedema,,2016,Q3,1,I,20160904.0,20160907.0,20160930,20160930,EXP,,US-BAXTER-2016BAX047285,BAXTER,,59.0,YR,,M,Y,79.7,KG,20160930.0,,CN,US,US,2016,Q3,Adult
127993911,12799391,7,C,LISPRO,INSULIN LISPRO,1,Unknown,2 UNITS,,,,,,,,,,,,2016,Q3,Hypoglycaemic seizure,,2016,Q3,1,I,20160904.0,20160907.0,20160930,20160930,EXP,,US-BAXTER-2016BAX047285,BAXTER,,59.0,YR,,M,Y,79.7,KG,20160930.0,,CN,US,US,2016,Q3,Adult
128003091,12800309,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2016,Q3,Fatigue,,2016,Q3,1,I,20160927.0,20160927.0,20160930,20160930,PER,,US-ELI_LILLY_AND_COMPANY-US201609010974,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20160930.0,,CN,US,US,2016,Q3,Adult
128003091,12800309,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U,,,20563.0,,,INJECTION,,2016,Q3,Injury associated with device,,2016,Q3,1,I,20160927.0,20160927.0,20160930,20160930,PER,,US-ELI_LILLY_AND_COMPANY-US201609010974,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20160930.0,,CN,US,US,2016,Q3,Adult
69688344,6968834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2016,Q3,Myocardial infarction,,2016,Q3,4,F,20090330.0,20160831.0,20090414,20160907,EXP,,US-PFIZER INC-2009192070,PFIZER,"CAMIDGE, D.. SUNITINIB COMBINED WITH PEMETREXED AND CISPLATIN: RESULTS OF A PHASE I DOSE-ESCALATION AND PHARMACOKINETIC STUDY IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, WITH AN EXPANDED COHORT IN NONSMALL CELL LUNG CANCER AND MESOTHELIOMA. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2013;71 (2):307-319",66.0,YR,,M,Y,81.63,KG,20160907.0,,OT,US,US,2016,Q3,Elderly
84628909,8462890,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 TO 14 UNITS Q6H PRN,,,,,,,,,,,,2016,Q3,Death,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 TO 14 UNITS Q6H PRN,,,,,,,,,,,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 TO 14 UNITS Q6H PRN,,,,,,,,,,,,2016,Q3,Haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 TO 14 UNITS Q6H PRN,,,,,,,,,,,,2016,Q3,Pain,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 TO 14 UNITS Q6H PRN,,,,,,,,,,,,2016,Q3,Ulcer haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-14 UNIT, Q6H PRN",,,,,,,,,,,,2016,Q3,Death,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-14 UNIT, Q6H PRN",,,,,,,,,,,,2016,Q3,Gastrointestinal haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-14 UNIT, Q6H PRN",,,,,,,,,,,,2016,Q3,Haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-14 UNIT, Q6H PRN",,,,,,,,,,,,2016,Q3,Pain,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
84628909,8462890,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-14 UNIT, Q6H PRN",,,,,,,,,,,,2016,Q3,Ulcer haemorrhage,,2016,Q3,9,F,2009.0,20160914.0,20120316,20160927,EXP,,US-SANOFI-AVENTIS-2012SA017173,AVENTIS,,94.0,YR,E,F,Y,63.5,KG,20160927.0,,MD,US,US,2016,Q3,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Blood creatinine abnormal,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Blood glucose abnormal,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Chills,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Diarrhoea,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Fatigue,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Hypotension,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Renal disorder,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Renal function test abnormal,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
105250704,10525070,5,C,LISPRO,INSULIN LISPRO,1,,"6 IU, UNK, (6 UNITS BEFORE EACH MEAL, INJECTED)",,,,,,,,6.0,IU,INJECTION,,2016,Q4,Tremor,,2016,Q4,4,F,20140930.0,20161021.0,20141017,20161027,PER,,US-PFIZER INC-2014280265,PFIZER,,66.0,YR,,F,Y,79.0,KG,20161027.0,,MD,US,US,2016,Q4,Elderly
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Cardiac arrest,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Cardiomegaly,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Disseminated intravascular coagulation,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Hyponatraemia,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Liver disorder,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Pneumonia aspiration,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Polyuria,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Pulmonary arterial hypertension,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Pulmonary haemorrhage,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Pulmonary veno-occlusive disease,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Thrombocytopenia,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
1099561010,10995610,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"1-6 UNITS, QID, WITH MEALS AND AT BEDTIME",,,,,,,,,,,,2016,Q4,Toxicity to various agents,,2016,Q4,10,F,2015.0,20161123.0,20150407,20161201,EXP,,US-UNITED THERAPEUTICS-UNT-2015-003710,UNITED THERAPEUTICS,,52.0,YR,,F,Y,118.8,KG,20161201.0,,CN,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Acute respiratory distress syndrome,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Acute respiratory failure,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Ascites,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Asthenia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood alkaline phosphatase increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood bilirubin increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood pressure increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Breath sounds abnormal,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cardiac arrest,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cardioactive drug level increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cardiogenic shock,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cardiomegaly,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Chest discomfort,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Disseminated intravascular coagulation,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Electrocardiogram abnormal,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Heart rate increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hepatic congestion,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hepatic enzyme increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypercapnia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypervolaemia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hyponatraemia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypotension,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypovolaemia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypoxia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Infection,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Oedema,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Oliguria,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pneumonia aspiration,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pneumonitis,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pollakiuria,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary arterial hypertension,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary congestion,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary haemorrhage,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary hypertension,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary veno-occlusive disease,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Right atrial pressure increased,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Sinus tachycardia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Tachycardia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Thrombocytopenia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Toxicity to various agents,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
114900166,11490016,16,C,LISPRO-INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Ventricular tachycardia,,2016,Q4,6,F,20150621.0,20161214.0,20150909,20161216,EXP,,US-ABBVIE-15P-163-1459623-00,ABBVIE,,52.0,YR,,F,Y,118.8,KG,20161216.0,,MD,US,US,2016,Q4,Adult
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Constipation,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Cytomegalovirus infection,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Encephalopathy,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Glucose tolerance impaired,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Hypokalaemia,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Hypomagnesaemia,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Insomnia,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Orthostatic intolerance,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Osteoporosis,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118301046,11830104,14,SS,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,12 TO 17 UNITS,,,U,,,,,,,,,2016,Q4,Schizophrenia,,2016,Q4,6,F,20151019.0,20161208.0,20151214,20161218,EXP,,JP-ROCHE-1675602,ROCHE,,14.0,YR,,M,Y,,,20161219.0,,MD,JP,JP,2016,Q4,Youth
118696567,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Cardiac pacemaker insertion,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Myocarditis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Myositis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Rhabdomyolysis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Cardiac pacemaker insertion,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Myocarditis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Myositis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
118696567,11869656,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2016,Q4,Rhabdomyolysis,,2016,Q4,7,F,20151218.0,20161221.0,20151228,20161226,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090230,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,85.0,KG,20161226.0,,OT,US,US,2016,Q4,Adult
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Abasia,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Adjustment disorder with depressed mood,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Asthenia,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Bacterial sepsis,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood glucose increased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cough,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Dyspnoea exertional,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Fatigue,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Forced vital capacity decreased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hepatic enzyme increased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypoxia,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Lung disorder,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Nasal congestion,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Oedema peripheral,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Oxygen saturation decreased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary function test decreased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Sinusitis,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Supraventricular tachycardia,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Urinary tract infection,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
1189771911,11897719,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Weight decreased,,2016,Q4,11,F,20151219.0,20161202.0,20160108,20161207,EXP,,CA-ROCHE-1690197,ROCHE,,68.0,YR,,M,Y,75.6,KG,20161207.0,,MD,CA,CA,2016,Q4,Elderly
120849223,12084922,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"5 UNIT, UNK",,,U,,,,,5.0,DF,,QD,2016,Q4,Acute kidney injury,,2016,Q4,3,F,20151108.0,20160921.0,20160217,20161003,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-011704,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,149.0,KG,20161003.0,,OT,US,US,2016,Q4,Adult
120849223,12084922,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"5 UNIT, UNK",,,U,,,,,5.0,DF,,QD,2016,Q4,Colitis,,2016,Q4,3,F,20151108.0,20160921.0,20160217,20161003,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-011704,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,149.0,KG,20161003.0,,OT,US,US,2016,Q4,Adult
120849223,12084922,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"5 UNIT, UNK",,,U,,,,,5.0,DF,,QD,2016,Q4,Intestinal perforation,,2016,Q4,3,F,20151108.0,20160921.0,20160217,20161003,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-011704,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,149.0,KG,20161003.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Fluid retention,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Hypoxia,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Localised oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Oedema peripheral,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Pleural effusion,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Pulmonary arterial hypertension,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Sleep apnoea syndrome,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
1209417310,12094173,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2016,Q4,Weight decreased,,2016,Q4,10,F,20160202.0,20161130.0,20160219,20161212,EXP,,US-ACTELION-A-NJ2016-131530,ACTELION,,60.0,YR,A,F,Y,,,20161212.0,,OT,US,US,2016,Q4,Adult
121612023,12161202,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,,U,,,20563.0,35.0,IU,INJECTION,BID,2016,Q4,Blood glucose increased,,2016,Q4,3,F,20160127.0,20160208.0,20160308,20161117,PER,,US-ELI_LILLY_AND_COMPANY-US201602003215,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20161117.0,,CN,US,US,2016,Q4,Adult
121612023,12161202,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, BID",,,,U,,,20563.0,35.0,IU,INJECTION,BID,2016,Q4,Chest pain,,2016,Q4,3,F,20160127.0,20160208.0,20160308,20161117,PER,,US-ELI_LILLY_AND_COMPANY-US201602003215,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20161117.0,,CN,US,US,2016,Q4,Adult
122112832,12211283,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,INJECTION,TID,2016,Q4,Drug intolerance,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,INJECTION,TID,2016,Q4,Klebsiella bacteraemia,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,INJECTION,TID,2016,Q4,Klebsiella infection,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,INJECTION,TID,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,21,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-5UNITS,,,,,,,,,,INJECTION,,2016,Q4,Drug intolerance,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,21,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-5UNITS,,,,,,,,,,INJECTION,,2016,Q4,Klebsiella bacteraemia,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,21,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-5UNITS,,,,,,,,,,INJECTION,,2016,Q4,Klebsiella infection,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,21,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-5UNITS,,,,,,,,,,INJECTION,,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,22,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,15.0,IU,INJECTION,TID,2016,Q4,Drug intolerance,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,22,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,15.0,IU,INJECTION,TID,2016,Q4,Klebsiella bacteraemia,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,22,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,15.0,IU,INJECTION,TID,2016,Q4,Klebsiella infection,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122112832,12211283,22,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 MILLIGRAM,,,,,,,,15.0,IU,INJECTION,TID,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20160208.0,20161012.0,20160325,20161020,PER,,US-CELGENEUS-USA-2016030635,CELGENE,,60.0,YR,,F,Y,131.66,KG,20161020.0,,MD,US,US,2016,Q4,Adult
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Bedridden,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Cardiac failure,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Dysstasia,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Hypokalaemia,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Inappropriate schedule of drug administration,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Incorrect route of drug administration,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Metabolic alkalosis,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Quadriparesis,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Rhabdomyolysis,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Troponin increased,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Type 2 diabetes mellitus,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122383915,12238391,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25 16,",,,,,,,,,,,/hr,2016,Q4,Urinary tract infection,,2016,Q4,5,F,201512.0,20161130.0,20160405,20161207,EXP,,DE-OTSUKA-2015_016400,OTSUKA,,70.0,YR,,F,Y,,,20161207.0,,MD,DE,DE,2016,Q4,Elderly
122709264,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Myocardial infarction,,2016,Q4,4,F,20150727.0,20161025.0,20160415,20161101,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20161101.0,,OT,US,US,2016,Q4,Elderly
122709264,12270926,13,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Pneumonia,,2016,Q4,4,F,20150727.0,20161025.0,20160415,20161101,EXP,,US-CELGENEUS-USA-2015080052,CELGENE,,74.0,YR,,M,Y,76.2,KG,20161101.0,,OT,US,US,2016,Q4,Elderly
124258852,12425885,14,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,1 UNIT,,,,,,,,,,UNKNOWN,,2016,Q4,Pneumonia,,2016,Q4,2,F,20160509.0,20161026.0,20160601,20161031,PER,,US-CELGENEUS-USA-2016056271,CELGENE,,70.0,YR,,M,Y,,,20161031.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Aphasia,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Asthenia,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Fatigue,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Headache,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Mouth ulceration,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Neurological symptom,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Swelling face,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
125662554,12566255,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"2 IU, THRICE DAILY 30 MINUTES BEFORE MEALS",,,D,U,,,,2.0,IU,INJECTION,TID,2016,Q4,Weight decreased,,2016,Q4,4,F,201601.0,20161214.0,20160718,20161221,EXP,,US-ASTELLAS-2016US021323,ASTELLAS,,73.0,YR,,F,Y,,,20161221.0,,OT,US,US,2016,Q4,Elderly
126000023,12600002,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 4X/DAY(100 MG UNIT/ML SOLUTION; 1-5 UNITS )(ROUTE 4 TIMES DAILY (TAKE WITH MEALS AND AT BED",,,,,,,,,,,QID,2016,Q4,Fall,,2016,Q4,3,F,20151128.0,20161102.0,20160727,20161108,EXP,,US-PFIZER INC-2016352111,PFIZER,,64.0,YR,,F,Y,46.0,KG,20161108.0,,MD,US,US,2016,Q4,Adult
126000023,12600002,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 4X/DAY(100 MG UNIT/ML SOLUTION; 1-5 UNITS )(ROUTE 4 TIMES DAILY (TAKE WITH MEALS AND AT BED",,,,,,,,,,,QID,2016,Q4,Head injury,,2016,Q4,3,F,20151128.0,20161102.0,20160727,20161108,EXP,,US-PFIZER INC-2016352111,PFIZER,,64.0,YR,,F,Y,46.0,KG,20161108.0,,MD,US,US,2016,Q4,Adult
126000023,12600002,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 4X/DAY(100 MG UNIT/ML SOLUTION; 1-5 UNITS )(ROUTE 4 TIMES DAILY (TAKE WITH MEALS AND AT BED",,,,,,,,,,,QID,2016,Q4,Seizure,,2016,Q4,3,F,20151128.0,20161102.0,20160727,20161108,EXP,,US-PFIZER INC-2016352111,PFIZER,,64.0,YR,,F,Y,46.0,KG,20161108.0,,MD,US,US,2016,Q4,Adult
126257613,12625761,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (WITH MEALS AND HS)",,,,,,,,,,,,2016,Q4,Epistaxis,,2016,Q4,3,F,20160209.0,20161116.0,20160805,20161123,EXP,,US-PFIZER INC-2016172478,PFIZER,,63.0,YR,,F,Y,127.75,KG,20161123.0,,MD,US,US,2016,Q4,Adult
126257613,12625761,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (WITH MEALS AND HS)",,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,3,F,20160209.0,20161116.0,20160805,20161123,EXP,,US-PFIZER INC-2016172478,PFIZER,,63.0,YR,,F,Y,127.75,KG,20161123.0,,MD,US,US,2016,Q4,Adult
127152212,12715221,11,C,Insulin lispro,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q4,Anaplastic thyroid cancer,,2016,Q4,2,F,20160303.0,20160930.0,20160906,20161012,EXP,,JP-UCBSA-2016033001,UCB,,73.0,YR,,F,Y,51.7,KG,20161012.0,,MD,JP,JP,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Aortic calcification,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Arteriosclerosis,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Blindness,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Bundle branch block left,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Cardiac arrest,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Coma,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Constipation,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Coronary artery disease,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,End stage renal disease,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Feeling abnormal,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Granulomatous liver disease,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Hypertension,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Ischaemic cardiomyopathy,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Mitral valve incompetence,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Pulmonary hypertension,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Rectal cancer,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Splenic granuloma,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Tricuspid valve incompetence,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Type 2 diabetes mellitus,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127214893,12721489,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 UNITS, 3 TIMES A DAY WITH MEALS AS DIRECTED",,,,,,,,,,,,2016,Q4,Vascular stent occlusion,,2016,Q4,3,F,201511.0,20161024.0,20160907,20161101,EXP,,US-ASTRAZENECA-2016SE92175,ASTRAZENECA,,755.0,MON,,M,Y,90.7,KG,20161102.0,,,US,US,2016,Q4,Elderly
127251072,12725107,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"30 U IN AM, 15 U AT LUNCH, 30 U IN PM, PLUS SLIDING SCALE",,,,,,,,,,,,2016,Q4,Rheumatoid arthritis,,2016,Q4,2,F,201608.0,20160928.0,20160908,20161006,EXP,,US-NOVOPROD-508484,NOVO NORDISK,,63.0,YR,A,M,Y,86.62,KG,20161006.0,,CN,US,US,2016,Q4,Adult
127556833,12755683,27,C,insulin lispro,INSULIN LISPRO,1,Unknown,1 UNIT,,,,,,,,,,UNKNOWN,,2016,Q4,Death,,2016,Q4,3,F,20160906.0,20161111.0,20160916,20161123,EXP,,US-CELGENEUS-USA-2016091742,CELGENE,,70.0,YR,,M,Y,,,20161123.0,,MD,US,US,2016,Q4,Elderly
127681913,12768191,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Fall,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Joint injury,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Off label use,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127681913,12768191,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Oxygen saturation decreased,,2016,Q4,3,F,20160828.0,20161005.0,20160921,20161011,EXP,,US-UNITED THERAPEUTICS-UNT-2016-013800,UNITED THERAPEUTICS,,72.0,YR,,M,Y,95.69,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Ascites,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Bleeding varicose vein,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Clostridium difficile infection,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Hepatic cirrhosis,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Hepatic failure,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Peritonitis bacterial,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127761543,12776154,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"1 DF, UNK",,,,,,,,1.0,DF,,,2016,Q4,Sepsis,,2016,Q4,3,F,20160614.0,20161111.0,20160923,20161117,EXP,,US-GILEAD-2016-0234331,GILEAD,,64.0,YR,A,F,Y,,,20161117.0,,MD,US,US,2016,Q4,Adult
127818842,12781884,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,15.0,IU,,TID,2016,Q4,Death,,2016,Q4,2,F,20160911.0,20161102.0,20160926,20161111,EXP,,US-LUNDBECK-DKLU2019983,LUNDBECK,,59.0,YR,,M,Y,,,20161111.0,,MD,US,US,2016,Q4,Adult
128027311,12802731,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,20160902.0,,20161001,20161001,DIR,US-FDA-352024,,FDA-CTU,,57.0,YR,,F,N,46.8,KG,20161001.0,Y,CN,US,US,2016,Q4,Adult
128027311,12802731,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypoglycaemia,,2016,Q4,1,I,20160902.0,,20161001,20161001,DIR,US-FDA-352024,,FDA-CTU,,57.0,YR,,F,N,46.8,KG,20161001.0,Y,CN,US,US,2016,Q4,Adult
128055352,12805535,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q4,Leukopenia,,2016,Q4,2,F,20150413.0,20161005.0,20161004,20161012,EXP,,CO-ROCHE-1637143,ROCHE,,65.0,YR,,F,Y,65.0,KG,20161012.0,,MD,CO,CO,2016,Q4,Elderly
128055352,12805535,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q4,Neutropenia,,2016,Q4,2,F,20150413.0,20161005.0,20161004,20161012,EXP,,CO-ROCHE-1637143,ROCHE,,65.0,YR,,F,Y,65.0,KG,20161012.0,,MD,CO,CO,2016,Q4,Elderly
128056741,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,20160624.0,20160803.0,20161004,20161004,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20161004.0,,MD,FR,FR,2016,Q4,Young Adult
128056741,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2016,Q4,Pharyngitis,,2016,Q4,1,I,20160624.0,20160803.0,20161004,20161004,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20161004.0,,MD,FR,FR,2016,Q4,Young Adult
128056741,12805674,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: MEAN,,,,,,,,53.0,IU,,QD,2016,Q4,Skin mass,,2016,Q4,1,I,20160624.0,20160803.0,20161004,20161004,EXP,,"FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51361BI",BOEHRINGER INGELHEIM,,27.0,YR,,F,Y,60.0,KG,20161004.0,,MD,FR,FR,2016,Q4,Young Adult
128071692,12807169,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, QD",,,,, C464987D,,20563.0,24.0,IU,,QD,2016,Q4,Expired product administered,,2016,Q4,2,F,20160910.0,20160926.0,20161004,20161010,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201609009170,ELI LILLY AND CO,,34.0,YR,,F,Y,82.0,KG,20161006.0,,CN,MX,MX,2016,Q4,Young Adult
128071692,12807169,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, QD",,,,, C464987D,,20563.0,24.0,IU,,QD,2016,Q4,Maternal exposure during pregnancy,,2016,Q4,2,F,20160910.0,20160926.0,20161004,20161010,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201609009170,ELI LILLY AND CO,,34.0,YR,,F,Y,82.0,KG,20161006.0,,CN,MX,MX,2016,Q4,Young Adult
128071692,12807169,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, QD",,,,, C464987D,,20563.0,24.0,IU,,QD,2016,Q4,Uterine haemorrhage,,2016,Q4,2,F,20160910.0,20160926.0,20161004,20161010,EXP,,MX-ELI_LILLY_AND_COMPANY-MX201609009170,ELI LILLY AND CO,,34.0,YR,,F,Y,82.0,KG,20161006.0,,CN,MX,MX,2016,Q4,Young Adult
128090222,12809022,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,WITH EACH MEAL,,,,,,,,5.0,IU,,,2016,Q4,Blood glucose abnormal,,2016,Q4,2,F,20160913.0,20161129.0,20161004,20161202,EXP,,CO-ABBVIE-16P-036-1744189-00,ABBVIE,,42.0,YR,,M,Y,63.0,KG,20161202.0,,CN,CO,CO,2016,Q4,Adult
128253822,12825382,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,GENETICAL RECOMBINATION,,,,,,,,34.0,IU,,QD,2016,Q4,Diabetes mellitus management,,2016,Q4,2,F,20160804.0,20161209.0,20161006,20161216,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-51007BI",BOEHRINGER INGELHEIM,,54.0,YR,,M,Y,94.0,KG,20161216.0,,MD,JP,JP,2016,Q4,Adult
128261401,12826140,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, C540784K,,20563.0,,,INJECTION,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,20161004.0,20161004.0,20161006,20161006,PER,,US-ELI_LILLY_AND_COMPANY-US201610001269,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20161006.0,,CN,US,US,2016,Q4,Adult
128261401,12826140,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, C540784K,,20563.0,,,INJECTION,,2016,Q4,Drug dose omission,,2016,Q4,1,I,20161004.0,20161004.0,20161006,20161006,PER,,US-ELI_LILLY_AND_COMPANY-US201610001269,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20161006.0,,CN,US,US,2016,Q4,Adult
128264191,12826419,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Cholecystitis,,2016,Q4,1,I,20160923.0,20160926.0,20161006,20161006,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080557,BRISTOL MYERS SQUIBB,,38.0,YR,,M,Y,81.0,KG,20161006.0,,OT,US,US,2016,Q4,Adult
128308863,12830886,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STRENGTH:100 UNITS/ML,,,,,,,,,,ORAL SOLUTION,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,3,F,20151127.0,20161003.0,20161007,20161012,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-67589BI",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,103.8,KG,20161012.0,,MD,US,US,2016,Q4,Elderly
128308863,12830886,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STRENGTH:100 UNITS/ML,,,,,,,,,,ORAL SOLUTION,,2016,Q4,Hypoglycaemia,,2016,Q4,3,F,20151127.0,20161003.0,20161007,20161012,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-67589BI",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,103.8,KG,20161012.0,,MD,US,US,2016,Q4,Elderly
128308863,12830886,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STRENGTH:100 UNITS/ML,,,,,,,,,,ORAL SOLUTION,,2016,Q4,Squamous cell carcinoma,,2016,Q4,3,F,20151127.0,20161003.0,20161007,20161012,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-67589BI",BOEHRINGER INGELHEIM,,66.0,YR,,M,Y,103.8,KG,20161012.0,,MD,US,US,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Acute coronary syndrome,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Cardiac failure,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Disturbance in attention,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Metabolic disorder,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Pulmonary congestion,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128366322,12836632,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE PER APPLICATION AND DAILY DOSE: 105IE,,,,,,,,,,,QD,2016,Q4,Renal failure,,2016,Q4,2,F,20160405.0,20161025.0,20161011,20161109,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-21346BI",BOEHRINGER INGELHEIM,,84.0,YR,,M,Y,105.0,KG,20161109.0,,MD,DE,DE,2016,Q4,Elderly
128368852,12836885,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,MIX 50 (9-0-7),,,,,,,,,,,,2016,Q4,Condition aggravated,,2016,Q4,2,F,,20161028.0,20161011,20161102,EXP,,JP-SA-2016SA185489,AVENTIS,"SUEMARU M, SUEMARU D, MATSUMOTO A, TAKEUCHI M. A CASE OF DIABETIC NEPHROPATHY STAGE 3 IN WHICH THE REGIONAL DIABETES MELLITUS NETWORK WAS INTRODUCED FOR EFFECTIVE GUIDANCE TO PREVENT DIALYSIS AND COOPERATION BETWEEN REGISTERED DIETITIANS WAS ALSO ATTEMPTED.",75.0,YR,E,M,Y,,,20161102.0,,MD,JP,JP,2016,Q4,Elderly
128368852,12836885,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,MIX 50 (9-0-7),,,,,,,,,,,,2016,Q4,Diabetic nephropathy,,2016,Q4,2,F,,20161028.0,20161011,20161102,EXP,,JP-SA-2016SA185489,AVENTIS,"SUEMARU M, SUEMARU D, MATSUMOTO A, TAKEUCHI M. A CASE OF DIABETIC NEPHROPATHY STAGE 3 IN WHICH THE REGIONAL DIABETES MELLITUS NETWORK WAS INTRODUCED FOR EFFECTIVE GUIDANCE TO PREVENT DIALYSIS AND COOPERATION BETWEEN REGISTERED DIETITIANS WAS ALSO ATTEMPTED.",75.0,YR,E,M,Y,,,20161102.0,,MD,JP,JP,2016,Q4,Elderly
128368852,12836885,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,MIX 50 (9-0-7),,,,,,,,,,,,2016,Q4,Glomerular filtration rate abnormal,,2016,Q4,2,F,,20161028.0,20161011,20161102,EXP,,JP-SA-2016SA185489,AVENTIS,"SUEMARU M, SUEMARU D, MATSUMOTO A, TAKEUCHI M. A CASE OF DIABETIC NEPHROPATHY STAGE 3 IN WHICH THE REGIONAL DIABETES MELLITUS NETWORK WAS INTRODUCED FOR EFFECTIVE GUIDANCE TO PREVENT DIALYSIS AND COOPERATION BETWEEN REGISTERED DIETITIANS WAS ALSO ATTEMPTED.",75.0,YR,E,M,Y,,,20161102.0,,MD,JP,JP,2016,Q4,Elderly
128368852,12836885,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,MIX 50 (9-0-7),,,,,,,,,,,,2016,Q4,Renal impairment,,2016,Q4,2,F,,20161028.0,20161011,20161102,EXP,,JP-SA-2016SA185489,AVENTIS,"SUEMARU M, SUEMARU D, MATSUMOTO A, TAKEUCHI M. A CASE OF DIABETIC NEPHROPATHY STAGE 3 IN WHICH THE REGIONAL DIABETES MELLITUS NETWORK WAS INTRODUCED FOR EFFECTIVE GUIDANCE TO PREVENT DIALYSIS AND COOPERATION BETWEEN REGISTERED DIETITIANS WAS ALSO ATTEMPTED.",75.0,YR,E,M,Y,,,20161102.0,,MD,JP,JP,2016,Q4,Elderly
128399531,12839953,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"CARBOHYDRATE CORRECTION AS BOLUS, OTHER",,,,,,,20563.0,,,INJECTION,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,201606.0,20160929.0,20161012,20161012,EXP,,US-ELI_LILLY_AND_COMPANY-US201610000536,ELI LILLY AND CO,,67.0,YR,,M,Y,108.8,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
128399531,12839953,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"CARBOHYDRATE CORRECTION AS BOLUS, OTHER",,,,,,,20563.0,,,INJECTION,,2016,Q4,Nerve compression,,2016,Q4,1,I,201606.0,20160929.0,20161012,20161012,EXP,,US-ELI_LILLY_AND_COMPANY-US201610000536,ELI LILLY AND CO,,67.0,YR,,M,Y,108.8,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
128399531,12839953,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"CARBOHYDRATE CORRECTION AS BOLUS, OTHER",,,,,,,20563.0,,,INJECTION,,2016,Q4,Renal disorder,,2016,Q4,1,I,201606.0,20160929.0,20161012,20161012,EXP,,US-ELI_LILLY_AND_COMPANY-US201610000536,ELI LILLY AND CO,,67.0,YR,,M,Y,108.8,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
128399531,12839953,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"CARBOHYDRATE CORRECTION AS BOLUS, OTHER",,,,,,,20563.0,,,INJECTION,,2016,Q4,Seizure,,2016,Q4,1,I,201606.0,20160929.0,20161012,20161012,EXP,,US-ELI_LILLY_AND_COMPANY-US201610000536,ELI LILLY AND CO,,67.0,YR,,M,Y,108.8,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
128399531,12839953,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"CARBOHYDRATE CORRECTION AS BOLUS, OTHER",,,,,,,20563.0,,,INJECTION,,2016,Q4,Weight increased,,2016,Q4,1,I,201606.0,20160929.0,20161012,20161012,EXP,,US-ELI_LILLY_AND_COMPANY-US201610000536,ELI LILLY AND CO,,67.0,YR,,M,Y,108.8,KG,20161011.0,,CN,US,US,2016,Q4,Elderly
128448171,12844817,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q4,Bile duct obstruction,,2016,Q4,1,I,20151115.0,20151208.0,20161013,20161013,EXP,,US-PFIZER INC-3107483,PFIZER,,59.0,YR,,M,Y,69.0,KG,20161013.0,,MD,US,US,2016,Q4,Adult
128448171,12844817,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q4,Blood bilirubin increased,,2016,Q4,1,I,20151115.0,20151208.0,20161013,20161013,EXP,,US-PFIZER INC-3107483,PFIZER,,59.0,YR,,M,Y,69.0,KG,20161013.0,,MD,US,US,2016,Q4,Adult
128448171,12844817,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,20151115.0,20151208.0,20161013,20161013,EXP,,US-PFIZER INC-3107483,PFIZER,,59.0,YR,,M,Y,69.0,KG,20161013.0,,MD,US,US,2016,Q4,Adult
128460121,12846012,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q4,Cough,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128460121,12846012,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q4,Diarrhoea,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128460121,12846012,13,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2016,Q4,Fixed drug eruption,,2016,Q4,1,I,,20160510.0,20161014,20161014,PER,,US-LUPIN PHARMACEUTICALS INC.-2016-02033,LUPIN,"STEBER C, PERKINS S, HARRIS K. METFORMIN-INDUCED FIXED-DRUG ERUPTION CONFIRMED BY MULTIPLE EXPOSURES. AM-J-CASE-REP. 2016;17:231-234.",56.0,YR,,F,Y,118.0,KG,20161013.0,,OT,US,US,2016,Q4,Adult
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Angiopathy,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Malaise,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Skin discolouration,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Somnolence,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128471741,12847174,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2016,Q4,Wrong technique in product usage process,,2016,Q4,1,I,,20161009.0,20161014,20161014,EXP,,US-SA-2016SA187461,AVENTIS,,68.0,YR,E,M,Y,,,20161014.0,,CN,US,US,2016,Q4,Elderly
128508412,12850841,33,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, TID",,,,U,,,,,,INJECTION,TID,2016,Q4,Muscular weakness,,2016,Q4,2,F,20160926.0,20161018.0,20161014,20161024,EXP,,US-TAKEDA-2016MPI008447,TAKEDA,,73.0,YR,,M,Y,72.6,KG,20161024.0,,MD,US,US,2016,Q4,Elderly
128508412,12850841,33,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, TID",,,,U,,,,,,INJECTION,TID,2016,Q4,Respiratory failure,,2016,Q4,2,F,20160926.0,20161018.0,20161014,20161024,EXP,,US-TAKEDA-2016MPI008447,TAKEDA,,73.0,YR,,M,Y,72.6,KG,20161024.0,,MD,US,US,2016,Q4,Elderly
128508412,12850841,34,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, QD",,,,U,,,,,,INJECTION,QD,2016,Q4,Muscular weakness,,2016,Q4,2,F,20160926.0,20161018.0,20161014,20161024,EXP,,US-TAKEDA-2016MPI008447,TAKEDA,,73.0,YR,,M,Y,72.6,KG,20161024.0,,MD,US,US,2016,Q4,Elderly
128508412,12850841,34,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, QD",,,,U,,,,,,INJECTION,QD,2016,Q4,Respiratory failure,,2016,Q4,2,F,20160926.0,20161018.0,20161014,20161024,EXP,,US-TAKEDA-2016MPI008447,TAKEDA,,73.0,YR,,M,Y,72.6,KG,20161024.0,,MD,US,US,2016,Q4,Elderly
128519634,12851963,6,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,900 MILLILITER,,,,,,,,20.0,IU,INJECTION,,2016,Q4,Renal failure,,2016,Q4,4,F,20160929.0,20161108.0,20161017,20161122,EXP,,CA-CELGENEUS-CAN-2016101100,CELGENE,,69.0,YR,,M,Y,97.2,KG,20161122.0,,OT,CA,CA,2016,Q4,Elderly
128519634,12851963,6,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,900 MILLILITER,,,,,,,,20.0,IU,INJECTION,,2016,Q4,Respiratory failure,,2016,Q4,4,F,20160929.0,20161108.0,20161017,20161122,EXP,,CA-CELGENEUS-CAN-2016101100,CELGENE,,69.0,YR,,M,Y,97.2,KG,20161122.0,,OT,CA,CA,2016,Q4,Elderly
128548092,12854809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2016,Q4,Colitis,,2016,Q4,2,F,20160924.0,20161027.0,20161017,20161103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080879,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,119.7,KG,20161103.0,,OT,US,US,2016,Q4,Adult
128577252,12857725,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Blood glucose increased,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128577252,12857725,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Incorrect dose administered,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128577252,12857725,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Shock hypoglycaemic,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128577252,12857725,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH EVENING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Blood glucose increased,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128577252,12857725,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH EVENING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Incorrect dose administered,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128577252,12857725,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH EVENING",,,,, C455641A,,20563.0,12.0,IU,INJECTION,QD,2016,Q4,Shock hypoglycaemic,,2016,Q4,2,F,2013.0,20161019.0,20161018,20161101,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201610002742,ELI LILLY AND CO,,56.0,YR,,F,Y,65.0,KG,20161021.0,,CN,CN,CN,2016,Q4,Adult
128588002,12858800,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, UNKNOWN,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,2,F,20160913.0,20161108.0,20161018,20161116,EXP,,US-NOVOPROD-511009,NOVO NORDISK,,75.0,YR,E,M,Y,94.33,KG,20161116.0,,MD,US,US,2016,Q4,Elderly
128588002,12858800,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, UNKNOWN,,,,,,,2016,Q4,Blood glucose decreased,,2016,Q4,2,F,20160913.0,20161108.0,20161018,20161116,EXP,,US-NOVOPROD-511009,NOVO NORDISK,,75.0,YR,E,M,Y,94.33,KG,20161116.0,,MD,US,US,2016,Q4,Elderly
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cardiac failure congestive,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cardiomyopathy,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Cerebrovascular accident,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Chest pain,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Coronary artery bypass,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Ejection fraction decreased,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Implantable defibrillator insertion,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128631913,12863191,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,3,F,20160411.0,20161122.0,20161019,20161128,EXP,,US-GILEAD-2016-0238527,GILEAD,,63.0,YR,A,M,Y,,,20161128.0,,CN,US,US,2016,Q4,Adult
128680102,12868010,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood bilirubin increased,,2016,Q4,2,F,,20161013.0,20161020,20161025,EXP,,TR-GILEAD-2016-0238386,GILEAD,,65.0,YR,E,F,Y,,,20161025.0,,MD,TR,TR,2016,Q4,Elderly
128680102,12868010,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood creatinine increased,,2016,Q4,2,F,,20161013.0,20161020,20161025,EXP,,TR-GILEAD-2016-0238386,GILEAD,,65.0,YR,E,F,Y,,,20161025.0,,MD,TR,TR,2016,Q4,Elderly
128680102,12868010,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood bilirubin increased,,2016,Q4,2,F,,20161013.0,20161020,20161025,EXP,,TR-GILEAD-2016-0238386,GILEAD,,65.0,YR,E,F,Y,,,20161025.0,,MD,TR,TR,2016,Q4,Elderly
128680102,12868010,7,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood creatinine increased,,2016,Q4,2,F,,20161013.0,20161020,20161025,EXP,,TR-GILEAD-2016-0238386,GILEAD,,65.0,YR,E,F,Y,,,20161025.0,,MD,TR,TR,2016,Q4,Elderly
128829252,12882925,5,C,INSULIN LISPRO  (NON-ABBVIE),,2,,IN THE MORNING,,,,,,,,,,,,2016,Q4,Acute myocardial infarction,,2016,Q4,2,F,20161002.0,20161128.0,20161025,20161201,EXP,,CO-ABBVIE-16P-036-1762742-00,ABBVIE,,78.0,YR,,F,Y,78.0,KG,20161201.0,,CN,CO,CO,2016,Q4,Elderly
128829252,12882925,5,C,INSULIN LISPRO  (NON-ABBVIE),,2,,IN THE MORNING,,,,,,,,,,,,2016,Q4,Haematuria,,2016,Q4,2,F,20161002.0,20161128.0,20161025,20161201,EXP,,CO-ABBVIE-16P-036-1762742-00,ABBVIE,,78.0,YR,,F,Y,78.0,KG,20161201.0,,CN,CO,CO,2016,Q4,Elderly
128848132,12884813,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Discomfort,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128848132,12884813,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Faeces discoloured,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128848132,12884813,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Upper gastrointestinal haemorrhage,,2016,Q4,2,F,20161007.0,20161110.0,20161026,20161120,EXP,,US-ROCHE-1843936,ROCHE,,78.0,YR,,M,Y,53.7,KG,20161120.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Enterocolitis,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Neutropenia,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128850842,12885084,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Thrombocytopenia,,2016,Q4,2,F,20160322.0,20161018.0,20161026,20161031,EXP,,US-CELGENEUS-USA-2016041246,CELGENE,,76.0,YR,,M,Y,47.22,KG,20161031.0,,MD,US,US,2016,Q4,Elderly
128872971,12887297,11,C,Insulin lispro,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q4,Diarrhoea haemorrhagic,,2016,Q4,1,I,20160409.0,20160419.0,20161026,20161026,PER,,US-JAZZ-2016-US-007364,JAZZ,,15.0,YR,,F,Y,39.0,KG,20161026.0,,OT,US,US,2016,Q4,Youth
128873491,12887349,2,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"400 U, PRN",,,,U,,,,,,INJECTION,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20140402.0,20160803.0,20161026,20161026,PER,,US-JAZZ-2016-US-014582,JAZZ,,29.0,YR,,M,Y,179.0,KG,20161026.0,,MD,US,US,2016,Q4,Young Adult
128881571,12888157,9,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2016,Q4,Death,,2016,Q4,1,I,20160414.0,20161018.0,20161027,20161027,EXP,,CO-BAXTER-2016BAX053828,BAXTER,,63.0,YR,,M,Y,73.5,KG,20161027.0,,OT,CO,CO,2016,Q4,Adult
128908701,12890870,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, C594436E,,20563.0,,,,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,201610.0,20161021.0,20161027,20161027,PER,,US-ELI_LILLY_AND_COMPANY-US201610008499,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20161027.0,,CN,US,US,2016,Q4,Elderly
128908701,12890870,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, C594436E,,20563.0,,,,,2016,Q4,Incorrect dose administered,,2016,Q4,1,I,201610.0,20161021.0,20161027,20161027,PER,,US-ELI_LILLY_AND_COMPANY-US201610008499,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20161027.0,,CN,US,US,2016,Q4,Elderly
128976871,12897687,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, Q4HR",,,,U,,,,,,,Q4H,2016,Q4,Pneumonia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, Q4HR",,,,U,,,,,,,Q4H,2016,Q4,Pyrexia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, Q4HR",,,,U,,,,,,,Q4H,2016,Q4,Tachycardia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128976871,12897687,13,C,Insulin lispro,INSULIN LISPRO,1,,,,,,U,,,,,,,,2016,Q4,Tachycardia,,2016,Q4,1,I,20160904.0,20161021.0,20161031,20161031,EXP,,US-EMERGENT BIOSOLUTIONS-16BA00134SP,EMERGENT BIOSOLUTIONS,,49.0,YR,,M,Y,61.92,KG,20161031.0,,PH,US,US,2016,Q4,Adult
128998741,12899874,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"12 IU IN THE MORNING, 8 IU ON NOON, 7 IU IN THE EVENING, 3X/DAY",,,,,,,,,,,TID,2016,Q4,Dizziness,,2016,Q4,1,I,,20161025.0,20161101,20161101,EXP,,SI-PFIZER INC-2016502222,PFIZER,,87.0,YR,,F,Y,71.0,KG,20161101.0,,MD,SI,SI,2016,Q4,Elderly
128998741,12899874,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"12 IU IN THE MORNING, 8 IU ON NOON, 7 IU IN THE EVENING, 3X/DAY",,,,,,,,,,,TID,2016,Q4,Glomerular filtration rate decreased,,2016,Q4,1,I,,20161025.0,20161101,20161101,EXP,,SI-PFIZER INC-2016502222,PFIZER,,87.0,YR,,F,Y,71.0,KG,20161101.0,,MD,SI,SI,2016,Q4,Elderly
128998741,12899874,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"12 IU IN THE MORNING, 8 IU ON NOON, 7 IU IN THE EVENING, 3X/DAY",,,,,,,,,,,TID,2016,Q4,"Hallucination, auditory",,2016,Q4,1,I,,20161025.0,20161101,20161101,EXP,,SI-PFIZER INC-2016502222,PFIZER,,87.0,YR,,F,Y,71.0,KG,20161101.0,,MD,SI,SI,2016,Q4,Elderly
128998741,12899874,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"12 IU IN THE MORNING, 8 IU ON NOON, 7 IU IN THE EVENING, 3X/DAY",,,,,,,,,,,TID,2016,Q4,Memory impairment,,2016,Q4,1,I,,20161025.0,20161101,20161101,EXP,,SI-PFIZER INC-2016502222,PFIZER,,87.0,YR,,F,Y,71.0,KG,20161101.0,,MD,SI,SI,2016,Q4,Elderly
128998741,12899874,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"12 IU IN THE MORNING, 8 IU ON NOON, 7 IU IN THE EVENING, 3X/DAY",,,,,,,,,,,TID,2016,Q4,Tremor,,2016,Q4,1,I,,20161025.0,20161101,20161101,EXP,,SI-PFIZER INC-2016502222,PFIZER,,87.0,YR,,F,Y,71.0,KG,20161101.0,,MD,SI,SI,2016,Q4,Elderly
129010031,12901003,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"60 U, BID",,,,,,,20563.0,60.0,IU,,BID,2016,Q4,Fluid retention,,2016,Q4,1,I,20161004.0,20161020.0,20161101,20161101,EXP,,US-ELI_LILLY_AND_COMPANY-US201610007379,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20161101.0,,CN,US,US,2016,Q4,Adult
129010031,12901003,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"60 U, BID",,,,,,,20563.0,60.0,IU,,BID,2016,Q4,Gout,,2016,Q4,1,I,20161004.0,20161020.0,20161101,20161101,EXP,,US-ELI_LILLY_AND_COMPANY-US201610007379,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20161101.0,,CN,US,US,2016,Q4,Adult
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Acute hepatic failure,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Alanine aminotransferase increased,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Aspartate aminotransferase increased,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Hepatic encephalopathy,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Liver function test abnormal,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Multiple sclerosis,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129048303,12904830,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 ML, UNK",,,,U,,,,100.0,ML,,,2016,Q4,Pneumonia,,2016,Q4,3,F,20160825.0,20161110.0,20161102,20161123,EXP,,US-ACTELION-A-NJ2016-142353,ACTELION,,71.0,YR,E,F,Y,,,20161123.0,,CN,US,US,2016,Q4,Elderly
129077433,12907743,8,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2016,Q4,Septic shock,,2016,Q4,3,F,20160930.0,20161215.0,20161103,20161228,EXP,,US-CELGENEUS-USA-2016106645,CELGENE,,21.0,YR,,F,Y,57.07,KG,20161228.0,,MD,US,US,2016,Q4,Youth
129095292,12909529,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 UNIT, TID",,,U,,,,,6.0,DF,,TID,2016,Q4,Diabetic ketoacidosis,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129095292,12909529,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 UNIT, TID",,,U,,,,,6.0,DF,,TID,2016,Q4,Pleural effusion,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129095292,12909529,14,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 UNIT, TID",,,U,,,,,6.0,DF,,TID,2016,Q4,Pneumonia,,2016,Q4,2,F,20160726.0,20161107.0,20161104,20161114,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062782,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,66.2,KG,20161114.0,,OT,CA,CA,2016,Q4,Elderly
129158541,12915854,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Acute kidney injury,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cerebral small vessel ischaemic disease,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hypokalaemia,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Mental status changes,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129158541,12915854,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,1,I,20160729.0,,20161103,20161103,DIR,,,FDA-CTU,,62.0,YR,,F,N,99.8,KG,20161024.0,N,MD,US,US,2016,Q4,Adult
129421112,12942111,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Bronchopulmonary aspergillosis allergic,,2016,Q4,2,F,20161107.0,20161129.0,20161114,20161205,EXP,,US-GILEAD-2016-0242909,GILEAD,,9.0,YR,C,M,Y,,,20161205.0,,CN,US,US,2016,Q4,Child
129430262,12943026,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, BEFORE EVERY MEAL",,,,,,,,,,,,2016,Q4,Gangrene,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, BEFORE EVERY MEAL",,,,,,,,,,,,2016,Q4,Osteomyelitis,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, BEFORE EVERY MEAL",,,,,,,,,,,,2016,Q4,Pain,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, BEFORE EVERY MEAL",,,,,,,,,,,,2016,Q4,Peripheral arterial occlusive disease,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129430262,12943026,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, BEFORE EVERY MEAL",,,,,,,,,,,,2016,Q4,Toe amputation,,2016,Q4,2,F,201610.0,20161206.0,20161115,20161219,EXP,,"US-SMITH AND NEPHEW, INC-2016SMT00964",SMITH AND NEPHEW,,50.0,YR,,F,Y,124.72,KG,20161219.0,,OT,US,US,2016,Q4,Adult
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Cellulitis,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Disease progression,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Hepatitis,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Platelet count decreased,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Respiratory failure,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Splenomegaly,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129499471,12949947,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Therapy change,,2016,Q4,1,I,20161017.0,,20161116,20161116,DIR,US-FDA-355899,,FDA-CTU,,74.0,YR,,M,N,113.85,KG,20161116.0,Y,OT,US,US,2016,Q4,Elderly
129501571,12950157,9,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Urinary tract infection,,2016,Q4,1,I,20161027.0,,20161116,20161116,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20161116.0,Y,PH,US,US,2016,Q4,Elderly
129588381,12958838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Dyspnoea,,2016,Q4,1,I,20161010.0,,20161117,20161117,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20161018.0,N,PH,US,US,2016,Q4,Adult
129588381,12958838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Haemoglobin decreased,,2016,Q4,1,I,20161010.0,,20161117,20161117,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20161018.0,N,PH,US,US,2016,Q4,Adult
129588381,12958838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Haemorrhage,,2016,Q4,1,I,20161010.0,,20161117,20161117,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20161018.0,N,PH,US,US,2016,Q4,Adult
129588381,12958838,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,International normalised ratio increased,,2016,Q4,1,I,20161010.0,,20161117,20161117,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20161018.0,N,PH,US,US,2016,Q4,Adult
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Acute respiratory failure,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Fluid overload,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Haemoptysis,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Hyperkalaemia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Iron deficiency anaemia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Pleural effusion,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Pneumonia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Pulmonary oedema,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2016,Q4,Tumour lysis syndrome,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Acute respiratory failure,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Fluid overload,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Haemoptysis,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Hyperkalaemia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Iron deficiency anaemia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Pleural effusion,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Pneumonia,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Pulmonary oedema,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129629172,12962917,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2016,Q4,Tumour lysis syndrome,,2016,Q4,2,F,20160826.0,20161122.0,20161122,20161125,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20161125.0,,MD,US,US,2016,Q4,Elderly
129697011,12969701,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"8 IU, BID",,,U,U,,,20563.0,8.0,IU,,BID,2016,Q4,Blood glucose increased,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129697011,12969701,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"8 IU, BID",,,U,U,,,20563.0,8.0,IU,,BID,2016,Q4,Cerebrovascular accident,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129697011,12969701,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"8 IU, BID",,,U,U,,,20563.0,8.0,IU,,BID,2016,Q4,Wrong drug administered,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129697011,12969701,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"4 IU, QD",,,U,U,,,20563.0,4.0,IU,,QD,2016,Q4,Blood glucose increased,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129697011,12969701,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"4 IU, QD",,,U,U,,,20563.0,4.0,IU,,QD,2016,Q4,Cerebrovascular accident,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129697011,12969701,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"4 IU, QD",,,U,U,,,20563.0,4.0,IU,,QD,2016,Q4,Wrong drug administered,,2016,Q4,1,I,2015.0,20161111.0,20161123,20161123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201611005207,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20161123.0,,CN,DE,DE,2016,Q4,Elderly
129704992,12970499,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Anaemia,,2016,Q4,2,F,20161012.0,20161130.0,20161123,20161213,EXP,,US-CELGENEUS-USA-2016115329,CELGENE,,79.0,YR,,F,Y,52.39,KG,20161213.0,,OT,US,US,2016,Q4,Elderly
129704992,12970499,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Confusional state,,2016,Q4,2,F,20161012.0,20161130.0,20161123,20161213,EXP,,US-CELGENEUS-USA-2016115329,CELGENE,,79.0,YR,,F,Y,52.39,KG,20161213.0,,OT,US,US,2016,Q4,Elderly
129704992,12970499,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Decreased appetite,,2016,Q4,2,F,20161012.0,20161130.0,20161123,20161213,EXP,,US-CELGENEUS-USA-2016115329,CELGENE,,79.0,YR,,F,Y,52.39,KG,20161213.0,,OT,US,US,2016,Q4,Elderly
129704992,12970499,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Fatigue,,2016,Q4,2,F,20161012.0,20161130.0,20161123,20161213,EXP,,US-CELGENEUS-USA-2016115329,CELGENE,,79.0,YR,,F,Y,52.39,KG,20161213.0,,OT,US,US,2016,Q4,Elderly
129704992,12970499,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2016,Q4,Neutrophil count decreased,,2016,Q4,2,F,20161012.0,20161130.0,20161123,20161213,EXP,,US-CELGENEUS-USA-2016115329,CELGENE,,79.0,YR,,F,Y,52.39,KG,20161213.0,,OT,US,US,2016,Q4,Elderly
129875361,12987536,2,C,HUMALOG KWIKPEN INSULIN LISPRO INJECTION,,2,,,,,,,,,,,,,,2016,Q4,Internal haemorrhage,,2016,Q4,1,I,20150527.0,,20161130,20161130,DIR,,,FDA-CTU,,66.0,YR,,F,N,189.0,LBS,20161119.0,N,CN,US,US,2016,Q4,Elderly
129875361,12987536,2,C,HUMALOG KWIKPEN INSULIN LISPRO INJECTION,,2,,,,,,,,,,,,,,2016,Q4,Intestinal ulcer,,2016,Q4,1,I,20150527.0,,20161130,20161130,DIR,,,FDA-CTU,,66.0,YR,,F,N,189.0,LBS,20161119.0,N,CN,US,US,2016,Q4,Elderly
129875361,12987536,2,C,HUMALOG KWIKPEN INSULIN LISPRO INJECTION,,2,,,,,,,,,,,,,,2016,Q4,Myocardial infarction,,2016,Q4,1,I,20150527.0,,20161130,20161130,DIR,,,FDA-CTU,,66.0,YR,,F,N,189.0,LBS,20161119.0,N,CN,US,US,2016,Q4,Elderly
129918933,12991893,9,C,Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2016,Q4,Intestinal obstruction,,2016,Q4,3,F,20161006.0,20161214.0,20161201,20161221,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-067376",BOEHRINGER INGELHEIM,,31.0,YR,,M,Y,73.0,KG,20161221.0,,MD,CA,CA,2016,Q4,Young Adult
129943121,12994312,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"2.5 IU, BID",,,,,,,20563.0,2.5,IU,,BID,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,201609.0,20161119.0,20161202,20161202,EXP,,EG-ELI_LILLY_AND_COMPANY-EG201611007644,ELI LILLY AND CO,,7.0,MON,,F,Y,11.5,KG,20161201.0,,CN,EG,EG,2016,Q4,Child
129943121,12994312,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"2.5 IU, BID",,,,,,,20563.0,2.5,IU,,BID,2016,Q4,Coma,,2016,Q4,1,I,201609.0,20161119.0,20161202,20161202,EXP,,EG-ELI_LILLY_AND_COMPANY-EG201611007644,ELI LILLY AND CO,,7.0,MON,,F,Y,11.5,KG,20161201.0,,CN,EG,EG,2016,Q4,Child
129943121,12994312,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"2.5 IU, BID",,,,,,,20563.0,2.5,IU,,BID,2016,Q4,Hyperglycaemia,,2016,Q4,1,I,201609.0,20161119.0,20161202,20161202,EXP,,EG-ELI_LILLY_AND_COMPANY-EG201611007644,ELI LILLY AND CO,,7.0,MON,,F,Y,11.5,KG,20161201.0,,CN,EG,EG,2016,Q4,Child
129943121,12994312,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"2.5 IU, BID",,,,,,,20563.0,2.5,IU,,BID,2016,Q4,Seizure,,2016,Q4,1,I,201609.0,20161119.0,20161202,20161202,EXP,,EG-ELI_LILLY_AND_COMPANY-EG201611007644,ELI LILLY AND CO,,7.0,MON,,F,Y,11.5,KG,20161201.0,,CN,EG,EG,2016,Q4,Child
129943121,12994312,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"2.5 IU, BID",,,,,,,20563.0,2.5,IU,,BID,2016,Q4,Tremor,,2016,Q4,1,I,201609.0,20161119.0,20161202,20161202,EXP,,EG-ELI_LILLY_AND_COMPANY-EG201611007644,ELI LILLY AND CO,,7.0,MON,,F,Y,11.5,KG,20161201.0,,CN,EG,EG,2016,Q4,Child
129975891,12997589,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Q6H",,,U,,,,,,,,QID,2016,Q4,Acute respiratory distress syndrome,,2016,Q4,1,I,20161129.0,20161130.0,20161205,20161205,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-103511,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,,,20161205.0,,OT,US,US,2016,Q4,Elderly
130036753,13003675,5,C,"Mixed-type insulin (Lispro plus NPH: neutral, protamine Hagedorn)",,2,,"UNK (50-16-30 IU), RESPECTIVELY)",,,,,,,,,,,,2016,Q4,Carotid artery thrombosis,,2016,Q4,3,F,,20161222.0,20161206,20161229,EXP,,ES-PFIZER INC-2016565496,PFIZER,"VARGAS, M.. FREE FLOATING THROMBUS IN THE INTERNAL CAROTID AND VASCULAR RISK: PRESENTATION OF A CASE.. SEMERGEN-MEDICINA DE FAMILIA. 2016;42 (4):274-276",71.0,YR,,F,Y,,,20161229.0,,OT,ES,ES,2016,Q4,Elderly
130036753,13003675,5,C,"Mixed-type insulin (Lispro plus NPH: neutral, protamine Hagedorn)",,2,,"UNK (50-16-30 IU), RESPECTIVELY)",,,,,,,,,,,,2016,Q4,Dizziness,,2016,Q4,3,F,,20161222.0,20161206,20161229,EXP,,ES-PFIZER INC-2016565496,PFIZER,"VARGAS, M.. FREE FLOATING THROMBUS IN THE INTERNAL CAROTID AND VASCULAR RISK: PRESENTATION OF A CASE.. SEMERGEN-MEDICINA DE FAMILIA. 2016;42 (4):274-276",71.0,YR,,F,Y,,,20161229.0,,OT,ES,ES,2016,Q4,Elderly
130036753,13003675,5,C,"Mixed-type insulin (Lispro plus NPH: neutral, protamine Hagedorn)",,2,,"UNK (50-16-30 IU), RESPECTIVELY)",,,,,,,,,,,,2016,Q4,Lacunar infarction,,2016,Q4,3,F,,20161222.0,20161206,20161229,EXP,,ES-PFIZER INC-2016565496,PFIZER,"VARGAS, M.. FREE FLOATING THROMBUS IN THE INTERNAL CAROTID AND VASCULAR RISK: PRESENTATION OF A CASE.. SEMERGEN-MEDICINA DE FAMILIA. 2016;42 (4):274-276",71.0,YR,,F,Y,,,20161229.0,,OT,ES,ES,2016,Q4,Elderly
130036753,13003675,5,C,"Mixed-type insulin (Lispro plus NPH: neutral, protamine Hagedorn)",,2,,"UNK (50-16-30 IU), RESPECTIVELY)",,,,,,,,,,,,2016,Q4,Spinal osteoarthritis,,2016,Q4,3,F,,20161222.0,20161206,20161229,EXP,,ES-PFIZER INC-2016565496,PFIZER,"VARGAS, M.. FREE FLOATING THROMBUS IN THE INTERNAL CAROTID AND VASCULAR RISK: PRESENTATION OF A CASE.. SEMERGEN-MEDICINA DE FAMILIA. 2016;42 (4):274-276",71.0,YR,,F,Y,,,20161229.0,,OT,ES,ES,2016,Q4,Elderly
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Blindness,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Endophthalmitis,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Eye oedema,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Off label use,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Pain,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Suspected counterfeit product,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130051782,13005178,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2016,Q4,Suspected transmission of an infectious agent via product,,2016,Q4,2,F,20161203.0,20161215.0,20161207,20161221,EXP,,MX-ROCHE-1864501,ROCHE,,41.0,YR,,M,Y,69.0,KG,20161222.0,,MD,MX,MX,2016,Q4,Adult
130065151,13006515,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"17 U, EACH MORNING",,,U,U, C528688,,20563.0,17.0,IU,,QD,2016,Q4,Drug dose omission,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"17 U, EACH MORNING",,,U,U, C528688,,20563.0,17.0,IU,,QD,2016,Q4,Neuralgia,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"17 U, EACH MORNING",,,U,U, C528688,,20563.0,17.0,IU,,QD,2016,Q4,Oedema peripheral,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"17 U, EACH MORNING",,,U,U, C528688,,20563.0,17.0,IU,,QD,2016,Q4,Weight decreased,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U, C528688,,20563.0,7.0,IU,,QD,2016,Q4,Drug dose omission,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U, C528688,,20563.0,7.0,IU,,QD,2016,Q4,Neuralgia,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U, C528688,,20563.0,7.0,IU,,QD,2016,Q4,Oedema peripheral,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130065151,13006515,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U, C528688,,20563.0,7.0,IU,,QD,2016,Q4,Weight decreased,,2016,Q4,1,I,20161119.0,20161122.0,20161207,20161207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201611009374,ELI LILLY AND CO,,77.0,YR,,F,Y,45.0,KG,20161202.0,,CN,CN,CN,2016,Q4,Elderly
130075221,13007522,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"MORNING, 15 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Hypoacusis,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"MORNING, 15 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Ototoxicity,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"MORNING, 15 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Overdose,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"MORNING, 15 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Tinnitus,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"AT LUNCH, 17 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Hypoacusis,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"AT LUNCH, 17 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Ototoxicity,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"AT LUNCH, 17 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Overdose,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"AT LUNCH, 17 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Tinnitus,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"EVENING, 5 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Hypoacusis,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"EVENING, 5 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Ototoxicity,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"EVENING, 5 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Overdose,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130075221,13007522,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"EVENING, 5 UNITS, QD",,,,U,,,,,,,QD,2016,Q4,Tinnitus,,2016,Q4,1,I,,20161125.0,20161207,20161207,EXP,,ES-ALLERGAN-1679298US,ALLERGAN,,52.0,YR,,M,Y,108.0,KG,20161207.0,,MD,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Blood pressure decreased,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Coma,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Deafness bilateral,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Hypoventilation,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Overdose,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Pyrexia,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Tinnitus,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130100553,13010055,11,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,"37 UNIT, DAILY",,,,U,,,,37.0,DF,,,2016,Q4,Urinary tract infection,,2016,Q4,3,F,,20161129.0,20161208,20161223,EXP,,ES-PURDUE-DEU-2016-0018457,PURDUE,"LEACHE L, AQUERRETA I, MORAZA L, ORTEGA A. MORPHINE-INDUCED HEARING LOSS. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2016;73(22):1840-1843",52.0,YR,,M,Y,,,20161223.0,,OT,ES,ES,2016,Q4,Adult
130130281,13013028,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,UNK,,,,, C506926E,,,,,,,2016,Q4,Blood glucose increased,,2016,Q4,1,I,201611.0,20161129.0,20161209,20161209,PER,,US-ELI_LILLY_AND_COMPANY-US201611011248,ELI LILLY AND CO,,43.0,YR,,F,Y,,,20161209.0,,CN,US,US,2016,Q4,Adult
130130412,13013041,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2016,Q4,Renal failure,,2016,Q4,2,F,,20161227.0,20161209,20161228,EXP,,CN-009507513-1612CHN002518,MERCK,,58.0,YR,,F,Y,,,20161228.0,,OT,CN,CN,2016,Q4,Adult
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Decreased appetite,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Erythema,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Feeling hot,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Inflammation,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Panniculitis,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Pyrexia,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130338061,13033806,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,,,2016,Q4,Swelling,,2016,Q4,1,I,,20161201.0,20161216,20161216,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-107401,BRISTOL MYERS SQUIBB,YASUDA.. A CASE OF PANNICULITIS WHICH DEVELOPED IN PATIENT RECEIVING TREATMENT FOR DIABETIC KETOACIDOSIS. PROGRAM AND ABSTRACTS OF THE PAPERS FOR THE 54TH KYUSHU LOCAL MEETING OF THE JAP. 2016;205,68.0,YR,,M,Y,,,20161216.0,,MD,JP,JP,2016,Q4,Elderly
130532041,13053204,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 UNIT, UNK",,,U,,,,,4.0,DF,,,2016,Q4,Hyponatraemia,,2016,Q4,1,I,20150224.0,20150619.0,20161222,20161222,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-042342,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,89.6,KG,20161222.0,,CN,US,US,2016,Q4,Elderly
130532041,13053204,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 UNIT, UNK",,,U,,,,,4.0,DF,,,2016,Q4,Hypopituitarism,,2016,Q4,1,I,20150224.0,20150619.0,20161222,20161222,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-042342,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,89.6,KG,20161222.0,,CN,US,US,2016,Q4,Elderly
130655021,13065502,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 UNIT, TID",,,,U,,,,10.0,DF,,,2016,Q4,Diabetic ketoacidosis,,2016,Q4,1,I,20161116.0,20161209.0,20161227,20161227,EXP,,CA-NAPPMUNDI-GBR-2016-0042374,PURDUE,,50.0,YR,,M,Y,68.0,KG,20161223.0,,MD,CA,CA,2016,Q4,Adult
130655021,13065502,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 UNIT, TID",,,,U,,,,10.0,DF,,,2016,Q4,Nausea,,2016,Q4,1,I,20161116.0,20161209.0,20161227,20161227,EXP,,CA-NAPPMUNDI-GBR-2016-0042374,PURDUE,,50.0,YR,,M,Y,68.0,KG,20161223.0,,MD,CA,CA,2016,Q4,Adult
130655021,13065502,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 UNIT, TID",,,,U,,,,10.0,DF,,,2016,Q4,Pancreatic disorder,,2016,Q4,1,I,20161116.0,20161209.0,20161227,20161227,EXP,,CA-NAPPMUNDI-GBR-2016-0042374,PURDUE,,50.0,YR,,M,Y,68.0,KG,20161223.0,,MD,CA,CA,2016,Q4,Adult
130655021,13065502,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 UNIT, TID",,,,U,,,,10.0,DF,,,2016,Q4,Vomiting,,2016,Q4,1,I,20161116.0,20161209.0,20161227,20161227,EXP,,CA-NAPPMUNDI-GBR-2016-0042374,PURDUE,,50.0,YR,,M,Y,68.0,KG,20161223.0,,MD,CA,CA,2016,Q4,Adult
130691271,13069127,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C615588A,,20563.0,,,INJECTION,,2016,Q4,Blood glucose decreased,,2016,Q4,1,I,20161126.0,20161217.0,20161228,20161228,EXP,,US-ELI_LILLY_AND_COMPANY-US201612007647,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20161226.0,,CN,US,US,2016,Q4,Elderly
130691271,13069127,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C615588A,,20563.0,,,INJECTION,,2016,Q4,Loss of consciousness,,2016,Q4,1,I,20161126.0,20161217.0,20161228,20161228,EXP,,US-ELI_LILLY_AND_COMPANY-US201612007647,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20161226.0,,CN,US,US,2016,Q4,Elderly
130743691,13074369,17,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,,2016,Q4,Hypertensive crisis,,2016,Q4,1,I,,20161216.0,20161230,20161230,EXP,,US-VELOXIS PHARMACEUTICALS-1061406,VELOXIS PHARMACEUTICALS,,54.0,YR,,M,Y,,,20161230.0,,MD,US,US,2016,Q4,Adult
130743691,13074369,17,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,,2016,Q4,Myocardial infarction,,2016,Q4,1,I,,20161216.0,20161230,20161230,EXP,,US-VELOXIS PHARMACEUTICALS-1061406,VELOXIS PHARMACEUTICALS,,54.0,YR,,M,Y,,,20161230.0,,MD,US,US,2016,Q4,Adult
130886091,13088609,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Blood HIV RNA increased,,2016,Q4,1,I,20161010.0,,20161230,20161230,DIR,US-FDA-359094,,FDA-CTU,,66.0,YR,,F,N,58.05,KG,20161230.0,Y,MD,US,US,2016,Q4,Elderly
130886091,13088609,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Drug effect decreased,,2016,Q4,1,I,20161010.0,,20161230,20161230,DIR,US-FDA-359094,,FDA-CTU,,66.0,YR,,F,N,58.05,KG,20161230.0,Y,MD,US,US,2016,Q4,Elderly
130886091,13088609,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2016,Q4,Product substitution issue,,2016,Q4,1,I,20161010.0,,20161230,20161230,DIR,US-FDA-359094,,FDA-CTU,,66.0,YR,,F,N,58.05,KG,20161230.0,Y,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Drug intolerance,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Gastrointestinal haemorrhage,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Memory impairment,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Oedema,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Sleep apnoea syndrome,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
98119103,9811910,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEFORE MEALS AND AFTER BEDTIME DOSE:7 UNIT(S),,,,,,,,,,INJECTION,,2016,Q4,Subdural haematoma,,2016,Q4,3,F,201109.0,20161004.0,20140110,20161219,PER,,US-SANOFI-AVENTIS-2013SA068551,AVENTIS,,69.0,YR,E,M,Y,99.7,KG,20161219.0,,MD,US,US,2016,Q4,Elderly
